Available codes for the COUNTRY dimension:
| IndicatorCode | IndicatorName | Language |
|---|---|---|
| AIR_61 | Household and ambient air pollution attributable DALYs (per 100 000 capita) | EN |
| AIR_8 | Ambient air pollution attributable DALYs in children under 5 years | EN |
| AIR_90 | Ambient air pollution attributable DALYs (per 100 000 population, age-standardized) | EN |
| AMR_GI_002 | Status of National coordination center establishment | EN |
| AMR_GI_003 | Status of National plans to implement and strengthen antimicrobial surveillance | EN |
| AIR_7 | Ambient air pollution attributable DALYs | EN |
| AMRGLASS_COORD02 | Establishment of National Coordination Centre (NCC) | EN |
| AMRGLASS_COORD04 | Establishment of national reference laboratory (NRL) | EN |
| AMRGLASS_QA01 | EQA provided to the national reference laboratory (NRL) | EN |
| AMRGLASS_QA04 | GLASS pathogens testing covered by EQA | EN |
| AMRGLASS_QA05 | Types of AST standards followed by countries | EN |
| AMRGLASS_SURVL01 | Number of national surveillance sites in each country providing data to GLASS: hospital category | EN |
| AMRGLASS_COORD03 | Nomination of National Focal Point (NFP) | EN |
| AMRGLASS_QA03 | EQA provided to local laboratories participating in GLASS | EN |
| AMRGLASS_SURVL02 | Number of National surveillance sites in each country providing data to GLASS: outpatient facility category | EN |
| AIR_63 | Household and ambient air pollution attributable DALYs in children under 5 years (’000) | EN |
| AIR_9 | Ambient air pollution attributable DALYs (per 100 000 population) | EN |
| AMR_GI_001 | Status of countries enrolled in GLASS | EN |
| AMRGLASS_COORD01 | Functioning national AMR surveillance plan | EN |
| GDO_q3x3a_2 | Existence of legislation to file appeals protecting the rights of people with dementia | EN |
| GDO_q3x3a_4 | Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside | EN |
| GDO_q3x3b_1 | Existence of legislation to end coercieve practices for people with dementia | EN |
| GDO_q3x4_2 | Existence of legislation to end discrimination against people with dementia | EN |
| GDO_q3x4_1 | Existence of legislation for advanced care directives for people with dementia | EN |
| GDO_q4x1x2 | Existence of approved government dementia standards/ guidelines/ protocols | EN |
| GDO_q4x2_3 | Existence of standards/ guidelines/ protocols for management of dementia | EN |
| AMRGLASS_SURVL03 | Number of local clinical laboratories in each country performing AST to support national AMR surveillance sites | EN |
| anc1 | Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (% | EN |
| anc15 | Antenatal care coverage - at least one visit (in the five years preceding the survey) (%) | EN |
| anc4 | Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%) | EN |
| AIR_62 | Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized) | EN |
| AMRGLASS_QA02 | EQA provided for bacterial identification and AST | EN |
| anc45 | Antenatal care coverage - at least four visits (in the five years preceding the survey) (%) | EN |
| GDO_q4x3x4_3 | Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia | EN |
| GDO_q5x1x1_1 | Identification of different sectors in dementia care coordination (Health) | EN |
| asfr1 | Adolescent fertility rate (per 1000 women aged 15-19 years) | EN |
| ASSISTIVETECH_METNEED | Prevalence of met need of assistive products (%) | EN |
| Camp_airtime | Process evaluation was employed to assess implementation | EN |
| Camp_media_planning | Campaign utilized media planning | EN |
| Camp_news | Earned media/public relations were used to promote the campaign | EN |
| Camp_tv_radio | Campaign aired on television and/or radio | EN |
| carep | Children aged < 5 years with pneumonia symptoms taken to a health facility (%) | EN |
| GDO_q4x1 | Existence of dementia standards/ guidelines/ protocols | EN |
| GDO_q4x1x1_SQ001 | Implementation level of dementia standards/ guidelines/ protocols (National) | EN |
| GDO_q4x3x4_2 | Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia | EN |
| BP_04 | Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate) | EN |
| CaseCS | Congenital syphilis number of cases, reported | EN |
| CC_3 | Climate change attributable deaths per 100’000 capita | EN |
| CC_5 | Climate change attributable deaths (’000) in children under 5 years | EN |
| CC_6 | Climate change attributable deaths per 100’000 children under 5 years | EN |
| GDO_q5x1x1_4 | Identification of different sectors in dementia care coordination (Employment) | EN |
| GDO_q5x1x1_8 | Identification of different sectors in dementia care coordination (Private sector) | EN |
| GDO_q5x1x1_other | Identification of different sectors in dementia care coordination (Other) | EN |
| GDO_q6x1_3 | Number of geriatricians or psychogeriatricians (per 100,000) | EN |
| GDO_q6x2_2 | Inclusion of basic dementia competencies in training of specialists | EN |
| Camp_aud_research | Formative research was conducted | EN |
| Camp_gov_prog | Campaign was part of a comprehensive tobacco control programme | EN |
| Camp_mat_tested | Campaign was pre-tested | EN |
| GDO_q8x1 | Existence of community-based health or social care services for dementia | EN |
| GDO_q8x2_4 | Availability of activities of daily living support services in community for dementia | EN |
| CCO_2 | Human development index rank | EN |
| CATARACTSURGICALEFFECTIVE | Effective cataract surgical coverage of adults aged 50 and over (%) | EN |
| CC_1 | Climate change attributable deaths | EN |
| CC_4 | Climate change attributable DALYs per 100’000 capita | EN |
| cci2030 | Composite coverage index (%) | EN |
| GDO_q5x1 | Availability of mechanisms to coordinate dementia care across sectors | EN |
| GDO_q5x1x1_6 | Identification of different sectors in dementia care coordination (Housing) | EN |
| GDO_q6x1_2 | Number of neurologists (per 100,000) | EN |
| GDO_q6x2_4 | Inclusion of basic dementia competencies in training of pharmaceutical personnel | EN |
| GDO_q6x2_5 | Inclusion of basic dementia competencies in training of social workers | EN |
| GDO_q8x2_5 | Availability of palliative and end-of-life care services in community for dementia | EN |
| CHILDMORT5TO14 | Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) | EN |
| CHOLERA_0000000001 | Number of reported cases of cholera | EN |
| CM_01 | Number of under-five deaths | EN |
| CM_02 | Number of infant deaths | EN |
| DEVICES07 | Types of lists recommending health technology for high burden diseases | EN |
| MALARIA003 | Estimated number of malaria deaths | EN |
| MCV2 | Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) | EN |
| MDG_0000000006_AGE1519 | Unmet need for family planning, among girls aged 15-19 (%) | EN |
| MDG_0000000007 | Under-five mortality rate (probability of dying by age 5 per 1000 live births) | EN |
| MDG_0000000011 | Median consumer price ratio of selected generic medicines - Public | EN |
| MDG_0000000014 | Children aged <5 years with fever who received treatment with any antimalarial (%) | EN |
| MDG_0000000016 | Deaths due to malaria (per 100 000 population) | EN |
| GDO_q8x2_6 | Availability of social and financial protection for dementia | EN |
| GDO_q8x3_5 | Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] | EN |
| GDO_q8x4_2 | Majority provider of behaviour and psychological management in community for dementia [public, private] | EN |
| GDO_q8x4_4 | Majority provider of activities of daily living support services in community for dementia [public, private] | EN |
| MALARIA001 | Malaria - number of reported deaths | EN |
| AIR_1 | Ambient air pollution attributable deaths | EN |
| AIR_11 | Household air pollution attributable deaths | EN |
| AIR_13 | Household air pollution attributable deaths per 100’000 capita | EN |
| AIR_14 | Household air pollution attributable deaths per 100’000 children under 5 years | EN |
| AIR_17 | Household air pollution attributable DALYs (per 100 000 population) | EN |
| GDO_q3x3a_1 | Existence of legislation for supported decision making for people with dementia | EN |
| GDO_q3x3a_3 | Existence of legislation to promote community-based services for people with dementia | EN |
| GDO_q4x1x1_SQ002 | Implementation level of dementia standards/ guidelines/ protocols (Sub-national) | EN |
| AIR_2_1 | Ambient air pollution in urban areas (Annual PM10 [μg/m3]) | EN |
| AIR_3_1 | Percent of urban inhabitants living in cities covered by PM measurements | EN |
| AIR_39 | Household air pollution attributable DALYs (per 100 000, age-standardized) | EN |
| AIR_41 | Ambient air pollution attributable deaths | EN |
| AIR_43 | Ambient air pollution attributable DALYs | EN |
| AIR_44 | DALYs attributable to ambient air pollution (age-standardized) | EN |
| MDG_0000000023 | Prevalence of tuberculosis (per 100 000 population) | EN |
| MDG_0000000029 | Prevalence of HIV among adults aged 15 to 49 (%) | EN |
| MDG_0000000030 | Smear-positive tuberculosis case-detection rate (%) | EN |
| GDO_q4x2_2 | Existence of standards/ guidelines/ protocols for diagnosis of dementia | EN |
| GDO_q4x2_4 | Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia | EN |
| GDO_q4x3x4_1 | Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia | EN |
| GDO_q5x1x1_2 | Identification of different sectors in dementia care coordination (Social) | EN |
| MDG_0000000010 | Median availability of selected generic medicines (%) - Public | EN |
| MDG_0000000013 | Children aged <5 years sleeping under insecticide-treated nets (%) | EN |
| MDG_0000000017 | Deaths due to tuberculosis among HIV-negative people (per 100 000 population) | EN |
| MDG_0000000022 | Tuberculosis detection rate under DOTS (%) | EN |
| MDG_0000000025 | Births attended by skilled health personnel (%) | EN |
| CCO_WHS9_85 | Literacy rate among adults aged >= 15 years (%) | EN |
| CHOLERA_0000000003 | Cholera case fatality rate | EN |
| cpmo | Contraceptive prevalence - modern methods (%) | EN |
| DEVICES01 | Total density per 100 000 population: Health posts | EN |
| DEVICES02 | Total density per 100 000 population: Health centres | EN |
| DEVICES06 | Availability of national standards or recommended lists of medical devices | EN |
| DEVICES10 | Total density per million population: Positron Emission tomography | EN |
| BP_05 | Mean systolic blood pressure (crude estimate) | EN |
| BP_06 | Mean systolic blood pressure (age-standardized estimate) | EN |
| Camp_eval_impact | Outcome evaluation was employed to assess effectiveness | EN |
| Camp_nat | At least one national mass media campaign ran during the survey period | EN |
| CATARACTSURGICAL | Cataract surgical coverage of adults aged 50 and over (%) | EN |
| DEVICES13 | Type of nomenclature system | EN |
| DEVICES14 | Use of nomenclature system | EN |
| DEVICES18 | Availability of national list of approved medical devices for procurement or reimbursement | EN |
| AIR_15 | Household air pollution attributable DALYs | EN |
| AIR_2 | Ambient air pollution (Annual PM10 [ug/m3]) | EN |
| CC_2 | Climate change attributable DALYs (’000) | EN |
| CC_8 | Climate change attributable DALYs per 100’000 children under 5 years | EN |
| CCO_1 | Poverty headcount ratio at $1.25 a day (PPP) (% of population) | EN |
| GDO_q5x1x1_3 | Identification of different sectors in dementia care coordination (Education) | EN |
| GDO_q5x1x1_5 | Identification of different sectors in dementia care coordination (Justice) | EN |
| GDO_q5x1x3 | Presence of formal agreement/joint plan for dementia care coordination | EN |
| GDO_q5x2 | Availability of dementia care coordination standards/ guidelines/ protocols | EN |
| GDO_q6x2_1 | Inclusion of basic dementia competencies in training of physicians | EN |
| AIR_45 | Ambient air pollution attributable YLLs | EN |
| GDO_q7x1_AVAIL | Availability of dementia diagnostic rate | EN |
| GDO_q8x2_2 | Availability of behaviour and psychological management in community for dementia | EN |
| AIR_10 | Ambient air pollution attributable DALYs per 100’000 children under 5 years | EN |
| AIR_12 | Household air pollution attributable deaths in children under 5 years | EN |
| NCD_BMI_25A | Prevalence of overweight among adults, BMI ≥ 25 (age-standardized estimate) (%) | EN |
| MDG_0000000034 | Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines | EN |
| AIR_16 | Household air pollution attributable DALYs in children under 5 years | EN |
| AIR_3 | Percentage of the total population living in cities > 100’000 inhabitants | EN |
| AIR_35 | Joint effects of air pollution attributable deaths | EN |
| AIR_36 | Joint effects of air pollution attributable deaths in children under 5 years | EN |
| AIR_42 | Ambient air pollution attributable death rate (per 100 000 population, age-standardized) | EN |
| MALARIA002 | Estimated number of malaria cases | EN |
| MALARIA005 | Malaria incidence per 100 000 population | EN |
| MH_13 | Beds for mental health in general hospitals (per 100,000) | EN |
| MH_16 | Beds in mental hospitals (per 100,000) | EN |
| MH_18 | Mental health units in general hospitals (per 100,000) | EN |
| MH_22 | Occupational therapists in mental health sector (per 100,000) | EN |
| MH_3 | Stand-alone mental health legislation | EN |
| MDG_0000000003 | Adolescent birth rate (per 1000 women aged 15-19 years) | EN |
| MDG_0000000005_AGE1519 | Contraceptive prevalence, among girls aged 15-19 (%) | EN |
| MDG_0000000015 | Prevalence of condom use by adults during higher-risk sex (15-49) (%) | EN |
| MDG_0000000021 | Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%) | EN |
| MDG_0000000024 | Tuberculosis treatment success under DOTS (%) | EN |
| AIR_46 | YLLs attributable to ambient air pollution (age-standardized) | EN |
| AIR_5 | Ambient air pollution attributable death rate (per 100 000 population) | EN |
| AIR_6 | Ambient air pollution attributable deaths per 100’000 children under 5 years | EN |
| AIR_60 | Household and ambient air pollution attributable DALYs (’000) | EN |
| NCD_BMI_18A | Prevalence of underweight among adults, BMI < 18 (age-standardized estimate) (%) | EN |
| NCD_BMI_30C | Prevalence of obesity among adults, BMI ≥ 30 (crude estimate) (%) | EN |
| NCD_BMI_MINUS2A | Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (age-standardized estimate) (%) | EN |
| NCD_BMI_MINUS2C | Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%) | EN |
| GDO_q3x4_3 | Existence of legislation to end discrimination against carers of people with dementia | EN |
| GDO_q4x2_1 | Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia | EN |
| GDO_q4x2_5 | Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia | EN |
| bcgv | BCG immunization coverage among one-year-olds (%) | EN |
| BP_03 | Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate) | EN |
| CC_7 | Climate change attributable DALYs (’000) in children under 5 years | EN |
| cci | Composite coverage index (%) | EN |
| CCO_3 | Gender inequality index rank | EN |
| GDO_q4x3x4_4 | Existence of standards/ guidelines/ protocols of care in hospital for people with dementia | EN |
| CM_03 | Number of neonatal deaths | EN |
| csection5 | Births by caesarean section (in the five years preceding the survey) (%) | EN |
| DEVICES03 | Total density per 100 000 population: District/rural hospitals | EN |
| DEVICES04 | Total density per 100 000 population: Provincial hospitals | EN |
| GDO_q5x1x1_7 | Identification of different sectors in dementia care coordination (Civil society) | EN |
| GDO_q5x1x2 | Implementation level [national/subnational] of dementia care coordination | EN |
| DEVICES08 | Total density per million population: Magnetic Resonance Imaging | EN |
| DEVICES09 | Total density per million population: Computed tomography units | EN |
| DEVICES11 | Total density per million population: Gamma camera or Nuclear medicine | EN |
| DEVICES12 | Total density per million population: Linear Accelerator | EN |
| DEVICES16 | Unit in the Ministry of Health responsible for the management of medical devices | EN |
| DEVICES17 | Procurement of medical devices carried out at the national level | EN |
| DEVICES19 | National guidelines, policies or recommendations on the procurement of medical devices | EN |
| E1_nat_tv_radio | Ban on advertising: National TV and radio | EN |
| E10_promo_discounts | Ban on promotional discounts | EN |
| E11_brand_stretching | Ban on non-tobacco goods AND services identified with tobacco brand names | EN |
| E11_compliance | Compliance of ban on non-tobacco goods AND services identified with tobacco brand names | EN |
| E12_brand_sharing | Ban on brand name of non-tobacco products used for tobacco product | EN |
| E12_compliance | Compliance of ban on brand name of non-tobacco products used for tobacco product | EN |
| E13_compliance | Compliance of ban on appearance of tobacco brands in TV and/or films (product placement) | EN |
| E14_compliance | Compliance of ban on appearance of tobacco products in TV and/or films | EN |
| E14b_movies_anti_tob_ads | Requirement to present prescribed anti-tobacco ads before, during or after the broadcasting or showing of any visual entertainment media product that depicts tobacco products, use or images | EN |
| E15_compliance | Compliance of ban on sponsored events | EN |
| E15_sponsored_events | Sponsored events | EN |
| E15a_sponsorship | Complete ban on sponsorship | EN |
| E15b_sponsor_contribution | Ban on any form of contribution (financial or other support) to any event, activity or individual | EN |
| MENING_1 | Number of suspected meningitis deaths reported | EN |
| MENING_2 | Number of suspected meningitis cases reported | EN |
| MH_10 | Mental health outpatient facilities (per 100,000) | EN |
| MH_11 | Mental health day treatment facilities (per 100,000) | EN |
| DEVICES20 | Availability of technical specifications of medical devices to support procurement or donations | EN |
| DEVICES21 | Total density per million population: Telecobalt Unit | EN |
| DEVICES22 | Total density per million population: Radiotherapy units | EN |
| E_Group | Enforcing bans on tobacco advertising, promotion and sponsorship | EN |
| E10_compliance | Compliance of ban on promotional discounts | EN |
| E13_brand_placement | Ban on appearance of tobacco brands in TV and/or films (product placement) | EN |
| E14_prod_tv_films | Appearance of tobacco products in TV and/or films | EN |
| MH_24 | Mental health units in general hospitals admissions (per 100,000) | EN |
| MH_25 | Stand-alone policy or plan for mental health | EN |
| MH_5 | Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%) | EN |
| MH_6 | Psychiatrists working in mental health sector (per 100,000) | EN |
| MORT_200 | Deaths per 1 000 live births | EN |
| dptv | DTP3 immunization coverage among one-year-olds (%) | EN |
| MDG_0000000026 | Maternal mortality ratio (per 100 000 live births) | EN |
| MDG_0000000033 | Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%) | EN |
| MH_12 | Age-standardized suicide rates (per 100 000 population) | EN |
| MH_14 | Community residential facilities (per 100,000) | EN |
| MH_15 | Beds in community residential facilities (per 100,000) | EN |
| MH_19 | Mental hospital admissions (per 100,000) | EN |
| MH_20 | Outpatient visits (per 100,000) | EN |
| MH_21 | Total workforce in mental health sector (per 100,000) | EN |
| MH_23 | Other non-specialized doctors in mental health sector (per 100,000) | EN |
| GDO_q6x2_3 | Inclusion of basic dementia competencies in training of nurses | EN |
| GDO_q6x2_6 | Inclusion of basic dementia competencies in training of personal support workers | EN |
| GDO_q8x2_1 | Availability of diagnostic services in community for dementia | EN |
| GDO_q8x2_3 | Availability of psychosocial and rehabilitation services in community for dementia | EN |
| GDO_q8x3_2 | Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] | EN |
| GDO_q8x4_5 | Majority provider of palliative and end-of-life care services in community for dementia [public, private] | EN |
| GDO_q8x4_6 | Majority provider of social and financial protection for dementia [public, private] | EN |
| GDO_q8x5_3 | Estimated number of people receiving psychosocial and rehabilitation services in community for dementia | EN |
| MALARIA004 | Number of under-five deaths from malaria | EN |
| MDG_0000000001 | Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) | EN |
| MDG_0000000005 | Contraceptive prevalence (%) | EN |
| MDG_0000000018 | Deaths due to tuberculosis among HIV-positive people (per 100 000 population) | EN |
| MDG_0000000019 | Prevalence of HIV among adults aged >=15 years (per 100 000 population) | EN |
| MDG_0000000020 | Incidence of tuberculosis (per 100 000 population per year) | EN |
| AIR_18 | Household air pollution attributable DALYs per 100’000 children under 5 years | EN |
| AIR_4 | Ambient air pollution attributable deaths in children under 5 years | EN |
| AIR_50 | Ambient air pollution attributable deaths (per 100 000 population, age-standardized) | EN |
| AIR_51 | Household air pollution attributable death rate (per 100 000 population) | EN |
| AIR_52 | Household air pollution attributable death rate (per 100 000 population, age-standardized) | EN |
| CHOLERA_0000000002 | Number of reported deaths from cholera | EN |
| cpmt | Contraceptive prevalence - modern and traditional methods (%) | EN |
| csection | Births by caesarean section (in the two or three years preceding the survey) (%) | EN |
| MORT_400 | Deaths per 100 000 population | EN |
| MORTADO | Adolescent mortality rate (per 100 000 population) | EN |
| RADON_Q803 | Inclusion of radon in national cancer control strategy | EN |
| Rev_imp_other | Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies) | EN |
| NCD_BMI_MEAN | Mean BMI (kg/m²) (age-standardized estimate) | EN |
| NCD_BMI_MEANC | Mean BMI (kg/m²) (crude estimate) | EN |
| NCD_BMI_PLUS1A | Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (age-standardized estimate) (%) | EN |
| NCD_BMI_PLUS2C | Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%) | EN |
| NCD_CCS_Aspirin | General availability of aspirin (100 mg) in the public health sector | EN |
| Rev_type | Annual tax revenues - tobacco products included | EN |
| RHR_IPV | Intimate partner violence prevalence among ever partnered women (%) | EN |
| MH_4 | Government expenditures on mental health as a percentage of total government expenditures on health (%) | EN |
| MORT_600 | Projection of number of deaths | EN |
| mslv | Measles immunization coverage among one-year-olds (%) | EN |
| RHR_NPSV | Non-partner sexual violence prevalence (%) | EN |
| ROTAC | Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) | EN |
| RS_194 | Number of registered vehicles | EN |
| RS_198 | Estimated road traffic death rate (per 100 000 population) | EN |
| RS_204 | Existence of a national drink-driving law | EN |
| RS_205 | Definition of drink-driving by BAC | EN |
| RS_207 | Blood Alcohol Concentration (BAC) limit for drivers | EN |
| RADON_Q801 | Existence of national radon risk communication strategy | EN |
| RateCS | Congenital syphilis rate per 100 000 live births, reported | EN |
| Rev_VAT | Annual tax revenues - value added tax (vat) and other sales taxes | EN |
| RS_193 | Income level | EN |
| RS_228 | Existence of a national road safety strategy | EN |
| RS_238 | Existence of a universal access telephone number for pre-hospital care | EN |
| NCD_CCS_CCBlkrs | General availability of CC blockers in the public health sector | EN |
| NCD_CCS_CervCy | General availability of cervical cytology at the primary health care level | EN |
| NCD_CCS_cervicalcancerpgmcvg | Coverage of national cervical cancer screening program (%) | EN |
| RS_209 | Existence of a national seat-belt law | EN |
| NCD_CCS_ACE | General availability of ACE inhibitors in the public health sector | EN |
| NCD_CCS_betablockers | General availability of beta blockers in the public health sector | EN |
| NCD_CCS_BowelCancer | General availability of colon cancer screening at the primary health care level | EN |
| MH_9 | Psychologists working in mental health sector (per 100,000) | EN |
| MORT_500 | Number of deaths | EN |
| MORT_700 | Projection of deaths per 100 000 population | EN |
| Rev_curr | Annual tax revenues - currency | EN |
| Rev_govt_total | Annual tax revenues - total revenues | EN |
| RS_1845 | Population | EN |
| RS_196 | Estimated number of road traffic deaths | EN |
| RS_208 | Attribution of road traffic deaths to alcohol (%) | EN |
| NCD_CCS_chemo | General availability of chemotherapy in the public health system | EN |
| NCD_CCS_CRDPlan | Existence of operational policy/strategy/action plan for chronic respiratory diseases | EN |
| NCD_CCS_diabtest | General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level | EN |
| NCD_CCS_dietpaaware | Implementation of diet and/or physical activity public awareness program | EN |
| NCD_BMI_PLUS2A | Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (age-standardized estimate) (%) | EN |
| NCD_CCS_breastcancerscreening | Existence of national screening program for breast cancer | EN |
| NCD_CCS_cervicalcancermethod | Most widely used screening method in national cervical cancer screening program | EN |
| NCD_CCS_cervicalcancerscreening | Existence of national screening program for cervical cancer | EN |
| NCD_CCS_CholMsmt | General availability of total cholesterol measurement at the primary health care level | EN |
| RS_214 | Existence of national speed limits | EN |
| RS_217 | Maximum speed limits | EN |
| NCD_CCS_CancerRegNational | Existence of population-based cancer registry | EN |
| NCD_CCS_cervicalcancerpgmtype | Type of national cervical cancer screening program | EN |
| NCD_CCS_hpv | Existence of national HPV vaccination programme | EN |
| NCD_CCS_integNCDplan | Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors | EN |
| RS_225 | Existence of a road safety lead agency | EN |
| RS_237 | Existence of a formal pre-hospital care system | EN |
| RS_242 | Vehicle standards | EN |
| RSUD_10 | National survey on substance use among children and adolescents | EN |
| RSUD_11 | Data on substance use disorders disseminated in national annual reports | EN |
| RSUD_110 | Ministry/office that takes primary responsibility for prevention for substance use | EN |
| RSUD_12 | Substance use policy at the national level | EN |
| RS_212 | Seat-belt wearing rate (%) | EN |
| RS_246 | Distribution of road traffic deaths by type of road user (%) | EN |
| RS_576 | Gross national income per capita (Atlas method) | EN |
| RSUD_100 | Government unit/official responsible for prevention for substance use | EN |
| RSUD_14 | Policy documents on the pharmacological treatment of substance use disorders | EN |
| RSUD_15 | Guidelines on the pharmacological treatment of substance use disorders | EN |
| RSUD_17 | Legislative provision for compulsory treatment | EN |
| RSUD_120 | Five years change in international cooperation for prevention for substance use | EN |
| RSUD_18 | Drug courts | EN |
| RSUD_13 | Substance use policy at the national level, level of integration | EN |
| RSUD_140 | Ministry/office that takes primary responsibility for treatment of substance use disorders | EN |
| RSUD_150 | Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders | EN |
| NCD_CCS_DiabetesReg | Existence of a diabetes registry | EN |
| NCD_CCS_DietPlan | Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs | EN |
| NCD_CCS_HbA1c | General availability of diabetes testing (by HbA1c) at the primary health care level | EN |
| NCD_CCS_Insulin | General availability of insulin in the public health sector | EN |
| NCD_CCS_NCDGuide | Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach | EN |
| NCD_CCS_NCDIndicators | Existence of a set of national NCD indicators and has set time-bound national targets for these indicators | EN |
| NCD_CCS_DiabetesTest | General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level | EN |
| NCD_CCS_DiabPlan | Existence of operational policy/strategy/action plan for diabetes | EN |
| DEVICES00 | Total density per 100 000 population: Hospitals | EN |
| DEVICES05 | Total density per 100 000 population: Specialized hospitals | EN |
| DEVICES15 | Health technology (medical device) national policy | EN |
| DEVICES23 | Total density per million females aged from 50 to 69 years old: Mammography units | EN |
| MDG_0000000025_AGE1519 | Births attended by skilled health personnel, among girls aged 15-19 (%) | EN |
| MDG_0000000027 | Children aged <5 years stunted (%) | EN |
| MDG_0000000031 | Smear-positive tuberculosis treatment-success rate (%) | EN |
| MDG_0000000032 | Maternal mortality ratio (per 100 000 live births) - Country reported estimates | EN |
| MENING_3 | Number of meningitis epidemic districts | EN |
| MH_1 | Mental health policy | EN |
| MH_17 | Mental hospitals (per 100,000) | EN |
| MH_2 | Mental health plan | EN |
| NCD_BMI_18C | Prevalence of underweight among adults, BMI < 18 (crude estimate) (%) | EN |
| NCD_BMI_25C | Prevalence of overweight among adults, BMI ≥ 25 (crude estimate) (%) | EN |
| NCD_BMI_30A | Prevalence of obesity among adults, BMI ≥ 30 (age-standardized estimate) (%) | EN |
| NCD_BMI_PLUS1C | Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%) | EN |
| E1_compliance | Compliance of ban on advertising on national TV and radio | EN |
| NCD_CCS_OralMorph | General availability of oral morphine in the public health sector | EN |
| NCD_CCS_palliative_home | General availability of palliative care in community or home-based care in the public health system | EN |
| RSUD_190 | Five years change in international cooperation for treatment of substance use disorders | EN |
| RSUD_2 | Point prevalence (%), drug use disorders, 15+ years | EN |
| NCD_CCS_Nicotine | General availability of nicotine replacement therapy in the public health sector | EN |
| NCD_CCS_oralhealthplan | Existence of operational policy/strategy/action plan for oral health | EN |
| NCD_CCS_palliative_prim | General availability of palliative care in primary health care in the public health system | EN |
| NCD_CCS_photocoag | General availability of retinal photocoagulation in the public health system | EN |
| NCD_CCS_Metformin | General availability of metformin in the public health sector | EN |
| NCD_CCS_Mkting | Existence of any policies on marketing of foods to children | EN |
| RSUD_16 | Legislative provision for treatment and rehabilitation of substance use disorders | EN |
| RSUD_230 | Compulsory treatment for people with alcohol use disorders in the criminal justice system | EN |
| RSUD_260 | Five-year change in government resources for treatment of substance use disorders | EN |
| RSUD_20 | Confidentiality of health records on substance use disorders protected by law | EN |
| RSUD_200 | Confidentiality of people in treatment for substance use disorders | EN |
| RSUD_21 | Government unit for substance use disorder treatment | EN |
| RSUD_240 | Compulsory treatment for people with drug use disorders in the criminal justice system | EN |
| RSUD_250 | Five-year change in government resources for prevention for substance use | EN |
| RSUD_170 | Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs | EN |
| RSUD_19 | Programmes diverting clients from the justice system towards treatment | EN |
| RSUD_27 | Government benefits for alcohol use disorders, subsidy or disability pension | EN |
| RSUD_280 | Financing methods for treatment for drug use disorders | EN |
| RSUD_30 | Sector for inpatient treatment of alcohol dependence | EN |
| RSUD_300 | Government benefits for people with alcohol use disorders | EN |
| RSUD_31 | Sector for outpatient treatment of alcohol dependence | EN |
| RSUD_320 | Main sector for treatment for alcohol use disorders | EN |
| RSUD_270 | Financing methods for treatment for alcohol use disorders | EN |
| RSUD_23 | Financing method for substance use disorder treatment | EN |
| RSUD_26 | Governement benefits for persons with substance use disorders | EN |
| RSUD_28 | Government benefits for drug use disorders, subsidy or disability pension | EN |
| RSUD_29 | Sector for inpatient detoxification of alcohol use disorders | EN |
| RSUD_340 | Treatment programmes for children and adolescents with alcohol use disorders | EN |
| RSUD_350 | Treatment programmes for children and adolescents with drug use disorders | EN |
| E16_csr_promo_self | Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities | EN |
| NCD_CCS_PAPlan | Existence of operational policy/strategy/action plan to reduce physical inactivity | EN |
| NCD_CCS_renaltrans | General availability of renal replacement by transplantation in the public health system | EN |
| E21_vending_machines | Complete ban on tobacco vending machines | EN |
| E24_internet_sales_ban | Ban on internet sales of tobacco products | EN |
| E26_direct_ad_fines | Law requires fines for violations of direct advertising bans | EN |
| E19_indirect_ad_fines | Law requires fines for violations of indirect advertising bans | EN |
| E19_movies_anti_tob_ads | Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images | EN |
| E2_intl_tv_radio | Ban on advertising: International TV and radio (broadcast from abroad, including satellite) | EN |
| NCD_CCS_SatFat | Existence of national policies on saturated fatty acids / trans-fats | EN |
| NCD_CCS_SSBTAX | Existence of tax on sugar-sweetened beverages | EN |
| NCD_CCS_stroke | Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities | EN |
| E15d_csr_ban | Ban on Corporate Social Responsibility activities (CSR) | EN |
| E18_csr_anti_tobacco_media | Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth | EN |
| RSUD_3 | Age-standardized death rates, alcohol and drug use disorders, per 100 000 | EN |
| RSUD_310 | Government benefits for people with drug use disorders | EN |
| RSUD_32 | Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions | EN |
| E14a_prod_tv_films | Ban on appearance of tobacco products in TV and/or films | EN |
| E15c_sponsor_publicity | Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals | EN |
| E17_csr_promo_others | Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility activities of the tobacco companies | EN |
| MH_7 | Nurses working in mental health sector (per 100,000) | EN |
| MH_8 | Social workers working in mental health sector (per 100,000) | EN |
| MORT_100 | Number of deaths | EN |
| MORT_300 | Distribution of causes of death among children aged < 5 years (%) | EN |
| MORT_MATERNALNUM | Number of maternal deaths | EN |
| RADON_Q706 | Existence of training/education on prevention/mitigation | EN |
| RADON_Q802 | Inclusion of radon measurements in property transactions | EN |
| Rev_excise | Annual tax revenues - total excise (specific and ad valorem) | EN |
| Rev_year | Annual tax revenues - year | EN |
| NCD_CCS_AlcPlan | Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol | EN |
| NCD_CCS_BreastCancer | General availability of breast cancer screening (by palpation or mammogram) at the primary health care level | EN |
| NCD_CCS_Bronchodilators | General availability of bronchodilators in the public health sector | EN |
| NCD_CCS_CancerPlan | Existence of operational policy/strategy/action plan for cancer | EN |
| E5_billboards | Ban on advertising: Billboards and outdoor advertising | EN |
| NCD_CCS_PeakFlow | General availability of peak flow measurement at the primary health care level | EN |
| NCD_CCS_rheumfollowup | Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease | EN |
| NCD_CCS_Statins | General availability of statins in the public health sector | EN |
| NCD_CCS_SurvMonRep9NCD | Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets | EN |
| NCD_CCS_coronary | General availability of coronary bypass or stenting in the public health system | EN |
| NCD_CCS_CVDPlan | Existence of operational policy/strategy/action plan for cardiovascular diseases | EN |
| E23_subnat_complete_bans_exist | Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place | EN |
| NCD_CCS_rheumreg | Existence of a register of patients who had rheumatic fever and rheumatic heart disease | EN |
| NCD_CCS_Steroid | General availability of steroid inhalers in the public health sector | EN |
| RSUD_380 | Specialized treatment facilities for drug use disorders | EN |
| RSUD_390 | Self-help groups | EN |
| NCD_GLUC_02 | Mean fasting blood glucose (mmol/l) (crude estimate) | EN |
| NCD_GLUC_03 | Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate) | EN |
| NCD_PAA | Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) | EN |
| NCD_PAC_ADO | Insufficiently active (crude estimate) | EN |
| NCD_CCS_UrineAlbumin | General availability of urine testing for albumin | EN |
| NCD_DTH_TOT | Total NCD Deaths (in thousands) | EN |
| RSUD_33 | Sector for residential long-term rehabilitation of alcohol use disorders | EN |
| RSUD_330 | Main sector for treatment for drug use disorders | EN |
| RSUD_34 | Sector for inpatient detoxification of drug use disorders | EN |
| RSUD_35 | Sector for inpatient treatment of drug dependence | EN |
| NCD_GLUC_04 | Raised fasting blood glucose (>=7.0 mmol/L) (age-standardized estimate) | EN |
| NCD_PAC | Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%) | EN |
| NCD_UNDER70 | Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths | EN |
| NHAGGHEGDP | General government expenditure on health as percentage of gross domestic product | EN |
| NHAOOPSTHE | Out-of-Pocket expenditure on health as percentage of total health expenditure?? | EN |
| NHAPREPAIDTHE | Prepaid plans as percentage of total health expenditure? | EN |
| NTCP_FTE | Number of full-time equivalent staff in national agency | EN |
| RSUD_400 | Main substance at treatment entry | EN |
| RSUD_420 | Guidelines on pharmacological treatment for substance use disorders | EN |
| RSUD_360 | Specialized treatment facilities for substance use disorders | EN |
| RSUD_37 | Sector for substitution maintenance therapy of opioid dependence | EN |
| RSUD_40 | Treatment setting for substance use disorders, most common | EN |
| RSUD_41 | Specialized treatment services for drug use disoders and HIV/AIDS | EN |
| RSUD_410 | Reported treatment coverage for substance dependence | EN |
| NHABASIS | Basis for NHA estimate | EN |
| RSUD_43 | Open access services for substance use disorders | EN |
| RSUD_440 | Pharmacotherapy with buprenorphine | EN |
| RSUD_450 | Pharmacotherapy with buprenorphine/naloxone | EN |
| RSUD_46 | Length of stay for inpatient detoxification, days | EN |
| RSUD_48 | Length of stay for inpatient long-term residential treatment, days | EN |
| RSUD_49 | Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance) | EN |
| RSUD_50 | Timeframe of opioid agonist treatment | EN |
| RSUD_510 | Registration of naloxone for injection for opioid overdose | EN |
| RSUD_52 | Methadone used for detoxification or maintenance | EN |
| RSUD_54 | Buprenorphine used for the treatment of opioid dependence | EN |
| RSUD_55 | Buprenorphine used for detoxification or maintenance | EN |
| RSUD_44 | Treatment slots for alcohol and drug use disorders, outpatient, per 10 000 | EN |
| RSUD_45 | Beds for the treatment of substance use disorders, per 100 000 | EN |
| RSUD_47 | Length of stay for inpatient short-term treatment, days | EN |
| RSUD_470 | Timeframe for maintenance treatment of opioid dependence | EN |
| RS_210 | Applicability of seat-belt law to all occupants | EN |
| RS_213 | Existence of a national child-restraint law | EN |
| RS_219 | Applicability of national motorcycle helmet law to all occupants | EN |
| RS_223_BIS | Law requires helmet to be fastened | EN |
| RS_229 | Availability of funding for national road safety strategy | EN |
| RSUD_1 | Point prevalence (%), alcohol use disorders, 15+ years | EN |
| RSUD_57 | Buprenorphine/naloxone used for detoxification or maintenance | EN |
| E20_subnational_exists | Subnational laws or regulations exist banning some or all types of tobacco advertising, promotion and sponsorship | EN |
| RSUD_130 | Government unit/official responsible for treatment of substance use disorders | EN |
| NCD_CCS_dialysis | General availability of dialysis in the public health system | EN |
| E27_indirect_ad_fines | Law requires fines for violations of indirect advertising bans | EN |
| NCD_CCS_MultisecComm | Existence of a national multisectoral commission, agency or mechanism for NCDs | EN |
| NCD_CCS_NCDUnit_Operational | Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs | EN |
| NCD_CCS_paaware | Implementation of physical activity public awareness program | EN |
| RSUD_500 | Registration of medications for opioid withdrawal | EN |
| RSUD_51 | Methadone used for the treatment of opioid dependence | EN |
| E3_compliance | Compliance of ban on advertising on local magazines and newspapers | EN |
| E4_intl_print | Ban on advertising: International magazines and newspapers | EN |
| NTD_1 | Number of new reported cases of Buruli ulcer | EN |
| NCDMORT3070 | Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease | EN |
| nmr | Neonatal mortality rate (deaths per 1000 live births) | EN |
| NTCP_agcy | National agency for tobacco control exists | EN |
| NTCP_budget_year | Budget year | EN |
| E6_pt_of_sale | Ban on advertising: Point of sale | EN |
| E8_direct_ad_fines | Law requires fines for violations of direct advertising bans | EN |
| ebreast5 | Early initiation of breastfeeding (in the five years preceding the survey) (%) | EN |
| EC_indirect_compliance | Compliance with bans on promotion and sponsorship | EN |
| EMFLIMITELECTRIC900 | Electric field limit at 900 MHz (V/m) | EN |
| EMFLIMITELECTRICLF | Electric field (kV/m) | EN |
| EMFLIMITPOWERDENSITY1800 | Power density limit at 1800 MHz (W/m^2) | EN |
| NTD_LEISHCNUM | Number of cases of cutaneous leishmaniasis reported | EN |
| NTD_LEPR3 | Leprosy - Number of cases registered for treatment | EN |
| NTD_LEPR4 | Leprosy registered prevalence rate per 1 000 000 population | EN |
| NTD_LEPR7 | Leprosy - New leprosy cases with G2D rate per 1 000 000 population | EN |
| NTD_4 | Number of new reported cases of human African trypanosomiasis (T.b. gambiense) | EN |
| NTD_5 | Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense) | EN |
| NTD_7 | Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem | EN |
| NTCP_curr | Reported currency | EN |
| NTCP_govt_exp | Annual budget for tobacco control in currency reported | EN |
| NTD_2 | Dracunculiasis certification status of countries at the beginning of the year | EN |
| NTD_6 | Status of elimination of trachoma as a public health problem | EN |
| NTD_TRA5 | Number of people operated for trachomatous trichiasis | EN |
| RSUD_590 | Prevention programmes for specific populations for alcohol | EN |
| RSUD_62 | Supervision requirements for buprenorphine administration | EN |
| NTD_LEISHVEND | Status of endemicity of visceral leishmaniasis | EN |
| RSUD_490 | Registration of medications for opioid dependence | EN |
| RSUD_5 | Age-standardized DALYs, alcohol and drug use disorders, per 100 000 | EN |
| RSUD_53 | Methadone formulation used for the treatment of opiod dependence | EN |
| RSUD_530 | Screening and brief intervention for substance use in primary health care | EN |
| NTD_8 | Number of people who received treatment with antibiotics for trachoma | EN |
| NTD_BEJELSTATUS | Status of bejel endemicity | EN |
| NTD_DRACASES | Dracunculiasis cases | EN |
| NTD_LEISHCEND | Status of endemicity of cutaneous leishmaniasis | EN |
| NTD_LEISHCNUM_IM | Number of imported cases of cutaneous leishmaniasis reported | EN |
| NTD_LEISHVNUM | Number of cases of visceral leishmaniasis reported | EN |
| NTD_LEISHVNUM_IM | Number of imported cases of visceral leishmaniasis reported | EN |
| RSUD_630 | Programmes readily available | EN |
| RSUD_64 | Prescription requirements for methadone | EN |
| RSUD_65 | Prescription requirements for buprenorphine | EN |
| RSUD_660 | Treatment programmes for women with alcohol use disorders | EN |
| RSUD_680 | Special housing services for alcohol use disorders | EN |
| RSUD_560 | Recommendations for screening and brief interventions for substance use in antenatal services | EN |
| RSUD_580 | Prevention programmes for alcohol | EN |
| RSUD_59 | Buprenorphine provision in clinical and community-based settings | EN |
| RSUD_520 | Availability of naloxone | EN |
| RSUD_540 | Screening and brief intervention for substance use in antenatal services | EN |
| RSUD_550 | Recommendations for screening and brief interventions for substance use in primary health care | EN |
| RSUD_56 | Buprenorphine/naloxone used for the treatment of opioid dependence | EN |
| RSUD_570 | Groups and agencies involved in prevention programs | EN |
| RSUD_60 | Buprenorphine/naloxone provision in clinical and community-based settings | EN |
| RSUD_61 | Supervision requirements for methadone administration | EN |
| RSUD_70 | Pharmacotherapy used for the management of cannabis withdrawal | EN |
| RSUD_71 | Essential list of medicines | EN |
| RSUD_72 | Essential list of medicines, pharmacotherapy for substance use disorders | EN |
| EMFLIMITELECTRICRF | Electric field (V/m) | EN |
| EMFLIMITMAGNETIC | Magnetic flux density (microT) | EN |
| EQ_CONDOMUSE | People who identify the use of condoms as a way to avoid AIDS (%) | EN |
| EMFLIMITELECTRIC1800 | Electric field limit at 1800 MHz (V/m) | EN |
| EMFLIMITPOWERDENSITY900 | Power density limit at 900 MHz (W/m^2) | EN |
| EMFPOWERFREQUENCY | Power frequency (Hz) | EN |
| FINPROTECTION_CATA_ESTIMATE_AVAILABLE | Availability of estimates on large health expenditures as a share of total expenditure or income | EN |
| FINPROTECTION_CATA_TOT_25_LEVEL_SH | Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (%) | EN |
| RSUD_160 | Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders | EN |
| RSUD_180 | Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs | EN |
| RSUD_210 | Voluntary treatment for people with alcohol use disorders in the criminal justice system | EN |
| RSUD_22 | Budget line for substance use disorder treatment | EN |
| RSUD_220 | Voluntary treatment for people with drug use disorders in the criminal justice system | EN |
| NCD_CCS_PM3_Surv | Has a STEPS survey or a comprehensive health examination survey every 5 years | EN |
| NCD_CCS_rheum | Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities | EN |
| NCD_CCS_riskstrat | Availability of cardiovascular risk stratification in 50% or more primary health care facilities | EN |
| NCD_CCS_SaltPol | Existence of any policies to reduce population salt consumption | EN |
| NCD_CCS_Spirom | General availability of spirometry at the primary health care level | EN |
| NCD_CCS_sulphonylurea | General availability of sulphonylurea(s) in the public health sector | EN |
| NCD_CCS_targets | Existence of a set of time-bound national targets based on WHO guidance | EN |
| NCD_CCS_Thiazide | General availability of thiazide diuretics in the public health sector | EN |
| NCD_CCS_thrombolytic | General availability of thrombolytic therapy in the public health system | EN |
| NCD_CCS_TobPlan | Existence of operational policy/strategy/action plan to decrease tobacco use | EN |
| RSUD_290 | Hypothecated taxes to be spent on prevention and treatment for substance use disorders | EN |
| RSUD_36 | Sector for outpatient treatment of drug dependence | EN |
| RSUD_370 | Specialized treatment facilities for alcohol use disorders | EN |
| RSUD_38 | Sector for residential long-term rehabilitation of drug use disorders | EN |
| RSUD_39 | Treatment system for substance use disorders | EN |
| RSUD_42 | Specialized treatment services for substance use disorders and TB | EN |
| E22_subnational_exists | Subnational bans on tobacco advertising, promotion and sponsorship | EN |
| E25_ban_display_pt_of_sale | Ban on display of tobacco products at points of sale | EN |
| E3_nat_print | Ban on advertising: Local magazines and newspapers | EN |
| E5_compliance | Compliance of ban on advertising on billboards and outdoor advertising | EN |
| E6_compliance | Compliance of ban on advertising at point of sale | EN |
| E6b_ban_display_pt_of_sale | Ban on display of tobacco products at points of sale | EN |
| E7_internet | Ban on advertising: Internet | EN |
| RSUD_610 | Prevention programmes for specific populations for drugs | EN |
| RSUD_620 | HIV, Hepatitis counselling and treatment availability in specialized facilities and services | EN |
| RSUD_66 | Prescription requirements for buprenorphine/naloxone | EN |
| RSUD_690 | Special housing services for drug use disorders | EN |
| RSUD_74 | Budget line for substance use disorder prevention | EN |
| RSUD_75 | Funding method for substance use disorder prevention | EN |
| RSUD_750 | Standards of care for professionals providing treatment for alcohol and drug use disorders | EN |
| RSUD_77 | Programmes for the prevention of substance use disorders for special populations | EN |
| NTD_TSOL3 | Number of pigs in the country | EN |
| NTD_YAWSEND | Status of yaws endemicity | EN |
| NUTRITION_570 | Early initiation of breastfeeding (%) | EN |
| NUTRITION_ANT_WHZ_NE2 | Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), survey-based estimates | EN |
| RSUD_770 | Postgraduate training programme in prevention | EN |
| RSUD_8 | Epidemiological data collection system for substance use disorders | EN |
| RSUD_81 | Clinical supervision of health care staff | EN |
| RSUD_810 | Continuing professional development in treatment | EN |
| RSUD_820 | Epidemiological data collection for substance use | EN |
| RSUD_83 | Standards of care for health professionals, maintenance | EN |
| NUTRITION_WH_2 | Wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD), survey-based estimates | EN |
| NUTSEVWASTINGPREV | Severe wasted prevalence among children under 5 years of age (%), model-based estimates | EN |
| NUTSTUNTINGPREV | Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates | EN |
| NTD_LEPR11 | Number of female leprosy new cases | EN |
| NTD_LEPR2 | New leprosy case detection rate per 1 000 000 population | EN |
| NTD_LEPR8 | Leprosy - Number of new leprosy cases among children (less than 15 years of age) | EN |
| NTD_LEPR9 | Number of new leprosy cases with G2D among children (less than 15 years of age) | EN |
| NTD_ONCHSTATUS | Status of endemicity of onchocerciasis | EN |
| NTD_ONCTREAT | Reported number of individuals treated for onchocerciasis | EN |
| NTD_PINTASTATUS | Status of pinta endemicity | EN |
| NTD_RAB2 | Reported number of human rabies deaths | EN |
| NTD_TSOL2 | Presence of porcine cysticercosis | EN |
| RSUD_730 | Open access interventions for drugs | EN |
| RSUD_76 | Prevention activities for substance use disorders, main focus | EN |
| RSUD_800 | Postgraduate training programme in treatment | EN |
| RSUD_86 | NGOs for drug use disorders | EN |
| NTD_TSOL4 | Practice of backyard pig production | EN |
| NTD_YAWSNUM | Number of cases of yaws reported | EN |
| NUTOVERWEIGHTPREV | Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates | EN |
| NUTRITION_564 | Children aged <5 years wasted for age (%) | EN |
| NUTRITION_ANT_HAZ_NE2 | Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), survey-based estimates | EN |
| NUTOVERWEIGHTNUM | Overweight numbers among children under 5 years of age (millions), model-based estimates | EN |
| NUTRITION_2005 | Proportion of children aged 6-23 months who receive a minimum acceptable diet | EN |
| NUTRITION_579 | Exclusive breastfeeding under 6 months (%) | EN |
| RSUD_84 | Standards of care for health professionals, human rights | EN |
| RSUD_840 | Regular reports on epidemiological and service delivery data for substance use | EN |
| RSUD_85 | NGOs for alcohol use disorders | EN |
| RSUD_850 | System of monitoring alcohol involvement in forensic pathology | EN |
| RSUD_87 | Self-help groups for substance use disorders | EN |
| RSUD_870 | Epidemiological data collection system for substance use among children and adolescents | EN |
| EMFSTANDARD | Existence of standards | EN |
| NUTSEVWASTINGNUM | Severe wasted numbers among children under 5 years of age (millions), model-based estimates | EN |
| NUTSTUNTINGNUM | Stunting numbers among children under 5 years of age (millions), model-based estimates | EN |
| RSUD_63 | Supervision requirements for buprenorphine/naloxone administration | EN |
| RSUD_67 | Commencement of treatment with opioid agonists | EN |
| RSUD_69 | Pharmacotherapy used for the management of benzodiazepine withdrawal | EN |
| RSUD_7 | Psychoactive substance causing entry into treatment | EN |
| RSUD_700 | Employment services for alcohol use disorders | EN |
| RSUD_710 | Employment services for drug use disorders | EN |
| FINPROTECTION_IMP_PG_190 | Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars | EN |
| FINPROTECTION_IMP_PG_190_STD | Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%) | EN |
| RSUD_720 | Open access interventions for alcohol | EN |
| RSUD_73 | Government unit for substance use disorder prevention | EN |
| RSUD_740 | Health professionals providing treatment for alcohol and drug use disorders | EN |
| RSUD_79 | Harm reduction programmes for IDUs | EN |
| NUTRITION_WH_3 | Severe wasted prevalence among children under 5 years of age (% weight-for-height <-3 SD), survey-based estimates | EN |
| NUTUNDERWEIGHTNUM | Underweight numbers among children under 5 years of age (millions), model-based estimates | EN |
| NUTUNDERWEIGHTPREV | Underweight prevalence among children under 5 years of age (%), model-based estimates | EN |
| O_Avail_community | Treatment for tobacco dependence available in the community | EN |
| O_Avail_hosp | Treatment for tobacco dependence available in hospitals | EN |
| O_Avail_off_hlth_prof | Treatment for tobacco dependence available in offices of health professionals | EN |
| O_Bup_where | Bupropion - place available | EN |
| FINPROTECTION_IMP_NP_190_LEVEL_SH | Total population pushed below the $1.90 a day poverty line by household health expenditures (%) | EN |
| FINPROTECTION_IMP_NP310_POP | Population pushed below the $3.20 a day poverty line by household health expenditures (%, national, rural, urban) | EN |
| FINPROTECTION_IMP_PG_310 | Increase in poverty gap due to household health expenditures at the $3.10a day poverty line, in cents of international dollars | EN |
| FINPROTECTION_IMP_PG_310_STD | Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a-day poverty line (%, national, rural, urban) | EN |
| E9_compliance | Compliance of ban on free distribution of tobacco products in the mail or through other means | EN |
| E9_free_distrib | Ban on free distribution of tobacco products in the mail or through other means | EN |
| ebreast | Early initiation of breastfeeding (in the two or three years preceding the survey) (%) | EN |
| NCD_GLUC_01 | Mean fasting blood glucose (mmol/l) (age-standardized estimate) | EN |
| NTCP_govt_obj | Government objectives on tobacco control exist | EN |
| NTD_3 | Annual incidence of dracunculiasis cases | EN |
| RSUD_430 | Pharmacotherapy with methadone | EN |
| RSUD_460 | Access restrictions to maintenance treatment | EN |
| RSUD_480 | Registration of medications for alcohol dependence and withdrawal | EN |
| fpsmo | Demand for family planning satisfied - modern methods (%) | EN |
| RSUD_80 | Health professionals mostly involved in treatment of substance use disorders | EN |
| RSUD_82 | Standards of care for health professionals | EN |
| RSUD_830 | Service delivery data collection for substance use | EN |
| RSUD_860 | System of monitoring drugs involvement in forensic pathology | EN |
| RSUD_88 | Groups and agencies for the prevention of substance use disorders | EN |
| RSUD_880 | Epidemiological data collection system for substance use among children and adolescents | EN |
| RSUD_58 | Methadone provision in clinical and community-based settings | EN |
| FINPROTECTION_IMPOV_ESTIMATE_AVAILABLE | Availability of estimates on impoverishment due to out-of-pocket health expenditures | EN |
| GDO_q10x1x1 | Availability of generic anti-dementia medication | EN |
| GDO_q10x1x2 | Availability of at least one anti-dementia medication approved for on-label use reimbursement | EN |
| RSUD_89 | Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance) | EN |
| RSUD_890 | Treatment programmes for children and adolescents with alcohol use disorders | EN |
| SA_0000001398 | Alcohol, consumption of pure alcohol by type of beverage (%) | EN |
| SA_0000001400_ARCHIVED | Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol) | EN |
| FINPROTECTION_IMP_NP190_POP | Population pushed below the $1.90 a day poverty line by household health expenditures (%) | EN |
| fps | Demand for family planning satisfied - modern and traditional methods (%) | EN |
| RSUD_9 | Service delivery data collection system for substance use disorders | EN |
| SA_0000001398_ARCHIVED | Alcohol, consumption of pure alcohol by type of beverage (%) | EN |
| SA_0000001400 | Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol) | EN |
| SA_0000001401 | Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average | EN |
| SA_0000001402_ARCHIVED | Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010 | EN |
| SA_0000001403 | Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) | EN |
| SA_0000001403_ARCHIVED | Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) | EN |
| SA_0000001401_ARCHIVED | Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average | EN |
| SA_0000001402 | Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010 | EN |
| SA_0000001405_ARCHIVED | Alcohol, tourist consumption (in litres of pure alcohol) | EN |
| SA_0000001406 | Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) | EN |
| O_Avail_other | Treatment for tobacco dependence available in other settings | EN |
| O_Bup_ins | Bupropion - cost covered | EN |
| O_Ins_community | Treatment for tobacco dependence in the community cost covered | EN |
| O_Ins_hlth_clin | Treatment for tobacco dependence in health clinics or other primary care facilities cost covered | EN |
| OA_DMFT | Decayed, missing, or filled teeth | EN |
| obesewm | Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%) | EN |
| OCC_11 | Occupational carcinogens attributable deaths per 100’000 capita | EN |
| O_Ins_hosp | Treatment for tobacco dependence in hospitals cost covered | EN |
| SA_0000001405 | Alcohol, tourist consumption (in litres of pure alcohol) | EN |
| NUTWASTINGNUM | Wasted numbers among children under 5 years of age (millions), model-based estimates | EN |
| NUTWASTINGPREV | Wasted prevalence among children under 5 years of age (%), model-based estimates | EN |
| OCC_16 | Occupational ergonomic stressors attributable DALYs (’000) | EN |
| OCC_17 | Occupational ergonomic stressors attributable deaths per 100’000 capita | EN |
| OCC_20 | Occupational injuries attributable DALYs (’000) | EN |
| GDO_q10x2_HOSUE | Availability of atleast one housing adjustment for people with dementia | EN |
| GDO_q11x2x1 | Dementia nongovernmental organization equipped with office | EN |
| O_Ins_other | Treatment for tobacco dependence in other settings cost covered | EN |
| O_NRT_EML | Nicotine replacement therapy on the Essential Medicines List | EN |
| O_NRT_sold | Nicotine replacement therapy - legally sold | EN |
| O_Quitline | Access to a toll-free quit line | EN |
| O_Varen_ins | Varenicline - cost covered | EN |
| O_Varen_sold | Varenicline - legally sold | EN |
| O_Avail_hlthSPACEclin | Treatment for tobacco dependence available in health clinics or other primary care facilities | EN |
| O_Group | Offering help to quit tobacco use | EN |
| O_NRT_ins | Nicotine replacement therapy - cost covered | EN |
| GDO_q12x2_2 | Existence of psycho-social supports for dementia carers | EN |
| GDO_q12x2_3 | Existence of respite care for dementia carers | EN |
| GDO_q12x2_4 | Existence of information on legal rights for dementia carers | EN |
| GDO_q12x2x1x1_1PUB | Majority provider of dementia carer training and education (Public sector) | EN |
| GDO_q10x2_TECH | Availability of atleast one assistive technology for people with dementia | EN |
| GDO_q11x1 | Existence of dementia national nongovernmental organization | EN |
| O_Varen_where | Varenicline - place available | EN |
| GBD_DALYRTAGE | Age-standardized DALYs (per 100,000) | EN |
| GDO_q11x2x2_1 | Dementia nongovernmental organization office branches (Sub-national) | EN |
| GDO_q11x2x2_2 | Dementia nongovernmental organization office branches (Local) | EN |
| GDO_q11x2x2_3 | Dementia nongovernmental organization office branches (National only) | EN |
| GDO_q11x2x6 | Dementia nongovernmental organization’s involvement in policy development | EN |
| GDO_q12x1x3 | Existence of implementation plan for dementia carer support services | EN |
| GDO_q12x2_5 | Existence of financial benefits/social protection for dementia carers | EN |
| GDO_q12x1 | Existence of dementia carer support services | EN |
| GDO_q12x1x1 | Implementation level [national/subnational] of dementia carer support services | EN |
| GDO_q12x1x2 | Existence of dedicated resources for dementia carer support services | EN |
| NTD_LEPR5 | Number of new G2D leprosy cases | EN |
| NTD_ONCHEMO | Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis | EN |
| NTD_TSOL1 | Status of endemicity of Taenia solium | EN |
| EC_direct_compliance | Compliance with bans on direct advertising | EN |
| EMFLIMITELECTRIC | Electric field (kV/m) | EN |
| EMFLIMITPOWERDENSITY | Power density (W/m^2) | EN |
| EMFSAR | Specific absorption rate (SAR) (W/kg) | EN |
| EMFSTATUS | Legislative status | EN |
| EQ_OVERWEIGHTADULT | Prevalence of overweight and obesity | EN |
| FINPROTECTION_CATA_TOT_10_LEVEL_MILLION | Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (millions) | EN |
| FINPROTECTION_CATA_TOT_10_LEVEL_SH | Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (%) | EN |
| FINPROTECTION_CATA_TOT_10_POP | Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, reported data) (%) | EN |
| FINPROTECTION_CATA_TOT_25_LEVEL_MILLION | Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (millions) | EN |
| FINPROTECTION_CATA_TOT_25_POP | Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, reported data) (%) | EN |
| FINPROTECTION_IMP_NP_190_LEVEL_MILLION | Total population pushed below the \(1.90 a day poverty line by household health expenditures (millions) |EN | |RSUD_600 |Prevention programmes for drugs |EN | |RSUD_640 |Standards of treatment and care for public specialized treatment facilities |EN | |RSUD_650 |Special treatment programmes for gambling disorder |EN | |RSUD_670 |Treatment programmes for women with drug use disorders |EN | |RSUD_68 |Pharmacotherapy used for the management of alcohol withdrawal |EN | |RSUD_760 |Educational attainment in prevention |EN | |RSUD_78 |Screening and brief interventions for substance use and substance use disorders |EN | |RSUD_780 |Continuing professional development in prevention |EN | |RSUD_790 |Educational attainment in treatment |EN | |GDO_q12x2x1x1_1NGO |Majority provider of dementia carer training and education (NGO) |EN | |SA_0000001404_ARCHIVED |Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol |EN | |GDO_q12x2x1x1_2NGO |Majority provider of psycho-social supports for dementia carers (NGO) |EN | |SA_0000001414 |Alcohol, former drinkers (%) |EN | |SA_0000001409 |Alcohol, abstainers lifetime (%) |EN | |SA_0000001410 |Abstainers (15-19 years), lifetime (%) |EN | |SA_0000001411 |Alcohol, abstainers past 12 months (%) |EN | |SA_0000001412 |Abstainers (15-19 years), past 12 months (%) |EN | |SA_0000001416 |Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%) |EN | |SA_0000001415_ARCHIVED |Alcohol, heavy episodic drinking (population) past 30 days (%) |EN | |SA_0000001416_ARCHIVED |Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%) |EN | |SA_0000001419 |Age-standardized DALYs, breast cancer, per 100,000 |EN | |SA_0000001422 |Age-standardized DALYs, drownings, per 100,000 |EN | |SA_0000001426 |Age-standardized DALYs, liver cancer, per 100,000 |EN | |GDO_q12x2x1x1_1 |Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_1PRV |Majority provider of dementia carer training and education (Private sector) |EN | |GDO_q12x2x1x1_2 |Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_3PUB |Majority provider of respite care for dementia carers (Public sector) |EN | |GDO_q12x2x1x1_4NGO |Majority provider of information on legal rights for dementia carers (NGO) |EN | |SA_0000001433 |Age-standardized DALYs, road traffic accidents, per 100,000 |EN | |GDO_q12x2x1x1_2PRV |Majority provider of psycho-social supports for dementia carers (Private sector) |EN | |GDO_q12x2x1x1_3PRV |Majority provider of respite care for dementia carers (Private sector) |EN | |GDO_q12x2x1x1_4 |Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_4PUB |Majority provider of information on legal rights for dementia carers (Public sector) |EN | |GDO_q12x2x1x1_5NGO |Majority provider of information on financial benefits/social protection for dementia carers (NGO) |EN | |GDO_q12x2x1x1_5 |Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_5PRV |Majority provider of information on financial benefits/social protection for dementia carers (Private sector) |EN | |SA_0000001413_ARCHIVED |Alcohol, consumers past 12 months (%) |EN | |SA_0000001420 |Age-standardized DALYs, colon and rectum cancers, per 100,000 |EN | |GDO_q14x1 |Availability of dementia-friendly initiatives that improve accessibility |EN | |GDO_q14x2_2 |Existence of dementia-friendly initiative to improve accessibility of public transportation |EN | |OCC_22 |Occupational injuries attributable DALYs per 100'000 capita |EN | |OCC_6 |Occupational airborne particulates attributable DALYs ('000) |EN | |OCC_7 |Occupational airborne particulates attributable deaths per 100'000 capita |EN | |OCC_9 |Occupational carcinogens attributable deaths |EN | |SA_0000001421 |Age-standardized DALYs, diabetes mellitus, per 100,000 |EN | |SA_0000001423 |Age-standardized DALYs, falls, per 100,000 |EN | |SA_0000001427 |Age-standardized DALYs, liver cirrhosis, per 100,000 |EN | |SA_0000001430 |Age-standardized DALYs, oesophagus cancer, per 100,000 |EN | |SA_0000001431 |Age-standardized DALYs, poisoning, per 100,000 |EN | |SA_0000001432 |Age-standardized DALYs, prematurity and low birth rate, per 100,000 |EN | |ORGANTOTALDECRATE |Total actual deceased donors (per million) |EN | |ort |Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%) |EN | |overwgt3 |Overweight prevalence in children aged <three years (%) |EN | |OCC_15 |Occupational ergonomic stressors attributable deaths |EN | |OCC_5 |Occupational airborne particulates attributable deaths |EN | |ODA_3 |Donor disbursements (Million, constant 2009 US\)) | EN |
| ODA_4 | Disbursements to recipient countries (Million, constant 2009 US$) | EN |
| ORGANLIVERNUM | Liver transplants (absolute number) | EN |
| ORGANTOTALRATE | Total organs transplanted (per million) | EN |
| NUTRITION_WA_2 | Underweight prevalence among children under 5 years of age (% weight-for-age <-2 SD), survey-based estimates | EN |
| O_Avail_hlth_clin | Treatment for tobacco dependence available in health clinics or other primary care facilities | EN |
| O_Bup_sold | Bupropion - legally sold | EN |
| FINPROTECTION_IMP_NP_310_LEVEL_MILLION | Total population pushed below the $3.20 a day poverty line by household health expenditures (millions) | EN |
| FINPROTECTION_IMP_NP_310_LEVEL_SH | Total population pushed below the \(3.20 a day poverty line by household health expenditures (%, regional, global) |EN | |fullv |Full immunization coverage among one-year-olds (%) |EN | |GB_XPD_RSDV |Research and development (R&D) expenditure as a proportion of GDP |EN | |GDO_q10x1 |National regulator approval of anti-dementia medication |EN | |GDO_q10x2_1AVAIL |Availability of atleast one adult hygiene products for people with dementia |EN | |RSUD_900 |Treatment programmes for children and adolescents with drug use disorders |EN | |SA_0000001404 |Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol |EN | |overwgt5 |Overweight prevalence in children aged <five years (%) |EN | |P_Group |Protecting people from tobacco smoke |EN | |P1_compliance |Compliance of ban on smoking in HEALTH-CARE FACILITIES |EN | |P12_fines_establishment |National smoking ban: FINES ON THE ESTABLISHMENT |EN | |GDO_q12x2x5x3 |Estimated number of dementia carers receiving financial benefits/social protection |EN | |ODA_1 |Donor commitments (Million, constant 2009 US\)) | EN |
| ODA_2 | Commitments to recipient countries (Million, constant 2009 US\() |EN | |ORGANKIDNEYRATE |Kidney transplants (per million) |EN | |ORGANLIVERRATE |Liver transplants (per million) |EN | |ORGANPOP |Population (millions) |EN | |ORGANTOTALDECNUM |Total actual deceased donors (absolute number) |EN | |GDO_q13x3x1 |Implementation level [national/subnational] of dementia risk reduction campaign |EN | |GDO_q14x2_1 |Existence of dementia-friendly initiative to improve accessibility of public spaces |EN | |GDO_q12x2x1x1_5PUB |Majority provider of information on financial benefits/social protection for dementia carers (Public sector) |EN | |GDO_q12x2x2x3 |Estimated number of dementia carers receiving psycho-social supports |EN | |GDO_q12x2x3x3 |Estimated number of dementia carers receiving respite care |EN | |GDO_q12x2x4x3 |Estimated number of dementia carers receiving information on legal rights |EN | |GDO_q13x1 |Existence of at least one functioning dementia awareness campaign |EN | |GDO_q13x1x1 |Implementation level [national/subnational] of dementia awareness campaign |EN | |P1_healthcare |National smoking ban in HEALTH-CARE FACILITIES |EN | |GDO_q14x2_3 |Existence of dementia-friendly initiative for assistance with home modification |EN | |GDO_q14x2_4 |Existence of dementia-friendly initiative with assistive technology for loss of capacity |EN | |GDO_q14x2_5 |Existence of dementia-friendly initiative supporting community places for older people |EN | |GDO_q13x3 |Existence of at least one functioning risk reduction campaign |EN | |GDO_q15x1 |Inclusion of dementia training and education for non-health workers |EN | |GDO_q15x2_1 |Existence of dementia training for volunteers |EN | |P10_subnat_auth_exists |Subnational smoking bans - authority exists |EN | |GDO_q15x2_5 |Existence of dementia training for community workers |EN | |GDO_q16x1 |Routine monitoring of people with dementia |EN | |GDO_q16x1x1_1 |Data sources used to routinely monitor people with dementia (Clinical records) |EN | |GDO_q16x1x1_3 |Data sources used to routinely monitor people with dementia (Administrative data) |EN | |GDO_q16x1x1_4 |Data sources used to routinely monitor people with dementia (Facility survey or records) |EN | |P13_fines_smoker |National smoking ban: FINES ON THE PATRON |EN | |P15_complaints |National smoking ban: CITIZEN COMPLAINTS AND INVESTIGATIONS |EN | |P16_subnat_complete_bans_exist |Comprehensive bans in place subnationally |EN | |P2_compliance |Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES |EN | |P2_education |National smoking ban in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES |EN | |P4_compliance |Compliance of ban on smoking in GOVERNMENT FACILITIES |EN | |P11_fines_any |National smoking ban: FINES FOR VIOLATIONS |EN | |P4_govt |National smoking ban in GOVERNMENT FACILITIES |EN | |P5_compliance |Compliance of ban on smoking in INDOOR OFFICES |EN | |P9_all_other |National smoking ban in ALL OTHER INDOOR PUBLIC PLACES |EN | |PC_sfe_compliance |Compliance with regulations on smoke-free environments (national legislation) |EN | |GDO_q15x2_7 |Existence of dementia training for financial service staff |EN | |GDO_q15x2_8 |Existence of dementia training for retail and hospitality staff |EN | |P14_funds_for_enforce |National smoking ban: DEDICATED FUNDS FOR ENFORCEMENT |EN | |P8_compliance |Compliance of ban on smoking in PUBLIC TRANSPORT |EN | |PercposANC |Antenatal care attendees who were positive for syphilis (%), reported |EN | |PercposMSM |Men who have sex with men (MSM) with active syphilis (%) |EN | |SA_0000001435 |Age-standardized DALYs, other unintentional injuries, per 100,000 |EN | |SA_0000001436 |Age-standardized DALYs, violence, per 100,000 |EN | |SA_0000001440 |Age-standardized death rates, diabetes mellitus, per 100,000 |EN | |pncall3 |Postnatal care visit within two days of birth (in the three years preceding the survey) (%) |EN | |pnchome |Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%) |EN | |P3_compliance |Compliance of ban on smoking in UNIVERSITIES |EN | |P3_universities |National smoking ban in UNIVERSITIES |EN | |P6_compliance |Compliance of ban on smoking in RESTAURANTS |EN | |P6_restaurants |National smoking ban in RESTAURANTS |EN | |P7_compliance |Compliance of ban on smoking in PUBS AND BARS |EN | |SA_0000001437 |Age-standardized death rates, alcohol use disorders, per 100,000 |EN | |SA_0000001438 |Age-standardized death rates, breast cancer, per 100,000 |EN | |SA_0000001442 |Age-standardized death rates, falls, per 100,000 |EN | |SA_0000001446 |Age-standardized death rates, liver cirrhosis, per 100,000 |EN | |SA_0000001448 |Age-standardized death rates, mouth and oropharynx cancer, per 100,000 |EN | |SA_0000001441 |Age-standardized death rates, drownings, per 100,000 |EN | |SA_0000001443 |Age-standardized death rates, fires, per 100,000 |EN | |SA_0000001452 |Age-standardized death rates, road traffic accidents, per 100,000 |EN | |SA_0000001454 |Age-standardized death rates, other unintentional injuries, per 100,000 |EN | |P8_pub_transp |National smoking ban in PUBLIC TRANSPORT |EN | |PCV3 |Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) |EN | |SA_0000001429 |Age-standardized DALYs, mouth and oropharynx cancer, per 100,000 |EN | |SA_0000001406_ARCHIVED |Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) |EN | |SA_0000001409_ARCHIVED |Alcohol, abstainers lifetime (%) |EN | |SA_0000001411_ARCHIVED |Alcohol, abstainers past 12 months (%) |EN | |SA_0000001413 |Alcohol, consumers past 12 months (%) |EN | |O_Ins_off_hlth_prof |Treatment for tobacco dependence in offices of health professionals cost covered |EN | |O_NRT_where |Nicotine replacement therapy - place available |EN | |OCC_1 |Occupational risk factors attributable deaths |EN | |OCC_10 |Occupational carcinogens attributable DALYs ('000) |EN | |OCC_12 |Occupational carcinogens attributable DALYs per 100'000 capita |EN | |OCC_13 |Occupational noise attributable DALYs ('000) |EN | |OCC_14 |Occupational noise attributable DALYs per 100'000 capita |EN | |OCC_18 |Occupational ergonomic stressors attributable DALYs per 100'000 capita |EN | |OCC_19 |Occupational injuries attributable deaths |EN | |OCC_2 |Occupational risk factors attributable DALYs ('000) |EN | |OCC_21 |Occupational injuries attributable deaths per 100'000 capita |EN | |OCC_3 |Occupational risk factors attributable deaths per 100'000 capita |EN | |OCC_4 |Occupational risk factors attributable DALYs per 100'000 capita |EN | |OCC_8 |Occupational airborne particulates attributable DALYs per 100'000 capita |EN | |GDO_q11x2x3 |Dementia nongovernmental organization staff primarily salaried/volunteer |EN | |GDO_q11x2x5 |Provision of governmental funding to dementia nongovernmental organization for activities/services |EN | |GDO_q12x2x1x1_2PUB |Majority provider of psycho-social supports for dementia carers (Public sector) |EN | |GDO_q12x2x1x1_3 |Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q12x2x1x1_3NGO |Majority provider of respite care for dementia carers (NGO) |EN | |GDO_q12x2x1x1_4PRV |Majority provider of information on legal rights for dementia carers (Private sector) |EN | |SA_0000001453 |Age-standardized death rates, self-inflicted injury, per 100,000 |EN | |SA_0000001455 |Age-standardized death rates, violence, per 100,000 |EN | |SA_0000001457 |Liver cirrhosis, age-standardized death rates (15+), per 100,000 population |EN | |GDO_q12x2x1x3 |Estimated number of dementia carers receiving training and education |EN | |SA_0000001449 |Age-standardized death rates, oesophagus cancer, per 100,000 |EN | |SA_0000001456 |Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000 |EN | |GDO_q15x2_4 |Existence of dementia training for legal professionals |EN | |GDO_q15x2_6 |Existence of dementia training for school children |EN | |GDO_q16x1x1_other |Data sources used to routinely monitor people with dementia (Other) |EN | |GDO_q16x1x2_1 |Electronic availability of data sources used to routinely monitor people with dementia |EN | |GDO_q16x2_1 |Availability of routine hospital admissions records for people with dementia for monitoring purposes |EN | |GDO_q16x2_2 |Availability of routine outpatient visit records for people with dementia for monitoring purposes |EN | |GDO_q16x2_4 |Availability of routine pharmaceutical records for people with dementia for monitoring purposes |EN | |GDO_q17x2 |Dementia integrated into other national research plan/programme |EN | |GDO_q16x2_5 |Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes |EN | |GDO_q16x3 |Availability and status of dementia reporting in the past two years |EN | |GDO_q17x1 |Existence of a current dementia research plan/programme |EN | |GDO_q17x2x2 |Implementation level [national/subnational] of research plan in which dementia is integrated |EN | |GDO_q17x2x1_4 |Identification of other research plans in which dementia is integrated (NCD) |EN | |PercposSW |Sex workers with active syphilis (%) |EN | |PerctestedANC |Women accessing antenatal care (ANC) services who were tested for syphilis (%), reported |EN | |pncall |Postnatal care visit within two days of birth (in the x years preceding the survey) (%) |EN | |GDO_q17x2x1_3 |Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease) |EN | |pnchome5 |Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%) |EN | |R_Ad_val_average |Average - taxes as a % of cigarette price - ad valorem excise |EN | |R_admin_duty_free_allowance |Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks) |EN | |GDO_q18x2x3_3 |Total expenditure on dementia implementation research (local currency, self-report) |EN | |GDO_q19x2 |Number of people with dementia involved in research routinely monitored |EN | |GDO_q19x3x1_1 |Number of investigational pharmaceutical trials for dementia |EN | |GDO_q18x2x1_1 |Total expenditure on dementia research (local currency, self-report) |EN | |GDO_q19x3 |Availability of investigational pharmaceutical trials for dementia |EN | |SA_0000001458 |Age-standardized death rates (15+ years), poisoning, per 100,000 |EN | |SA_0000001460 |Age-standardized death rates (15+ years), violence, per 100,000 |EN | |SA_0000001461 |Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI |EN | |R_Curr_mp |Most sold brand of cigarettes - currency reported |EN | |R_Curr_premium_cost |Premium brand of cigarettes - currency reported |EN | |poliov |Polio immunization coverage among one-year-olds (%) |EN | |R_admin_duty_free_limited |Tax administration: Bans or limits on duty free imports by travellers |EN | |R_afford_price_dispersion |Affordability: Price dispersion: share of cheapest brand price in premium brand price (the higher the % the smaller the gap) |EN | |R_afford_tax_auto_adjust |Affordability: Specific tax component automatically adjusted for inflation (or other) |EN | |SA_0000001463_ARCHIVED |Alcoholic psychosis, incidence, per 100,000 |EN | |SA_0000001464_ARCHIVED |Cautions and arrests for drink-driving, per 100,000 population |EN | |SA_0000001469 |Treatment admissions (inpatient), alcoholic psychosis, per 100,000 |EN | |SA_0000001470 |Alcohol-related road traffic crashes, per 100,000 population |EN | |SA_0000001471 |Alcohol-related road traffic crashes (% of all traffic crashes) |EN | |SA_0000001471_ARCHIVED |Alcohol-related road traffic crashes (% of all traffic crashes) |EN | |SA_0000001464 |Cautions and arrests for drink-driving, per 100,000 population |EN | |SA_0000001465 |Hospital discharges, alcohol-related injuries and poisoning, per 100,000 |EN | |SA_0000001472 |Alcohol-related injury mortality, per 1,000 |EN | |SA_0000001461_ARCHIVED |Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI |EN | |SA_0000001463 |Alcoholic psychosis, incidence, per 100,000 |EN | |SA_0000001467 |Perceived trend in alcohol-related harm and consequences |EN | |SA_0000001414_ARCHIVED |Alcohol, former drinkers (%) |EN | |SA_0000001417 |Alcohol, patterns of drinking score |EN | |SA_0000001417_ARCHIVED |Alcohol, patterns of drinking score |EN | |SA_0000001418 |Age-standardized DALYs, alcohol use disorders, per 100,000 |EN | |SA_0000001424 |Age-standardized DALYs, fires, per 100,000 |EN | |SA_0000001425 |Age-standardized DALYs, ischaemic heart disease, per 100,000 |EN | |SA_0000001434 |Age-standardized DALYs, self-inflicted injury, per 100,000 |EN | |SA_0000001439 |Age-standardized death rates, colon and rectum cancers, per 100,000 |EN | |ORGANKIDNEYNUM |Kidney transplants (absolute number) |EN | |ORGANTOTALNUM |Total organs transplanted (absolute number) |EN | |ors |Children aged < 5 years with diarrhoea receiving oral rehydration salts (%) |EN | |P_count_places_sf |National smoking ban: NUMBER OF PLACES SMOKE-FREE |EN | |GDO_q14x2_6 |Existence of dementia-friendly initiative supporting social opportunities |EN | |GDO_q15x2_2 |Existence of dementia training for police and fire services |EN | |GDO_q15x2_3 |Existence of dementia training for first responders |EN | |GDO_q16x1x1_2 |Data sources used to routinely monitor people with dementia (Household surveys) |EN | |GDO_q16x1x2_2 |Data used to routinely monitor people with dementia can be disaggregated |EN | |GDO_q16x2_3 |Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes |EN | |SA_0000001473 |Alcohol-related disease mortality, per 100,000 (15+ years) |EN | |SA_0000001475 |Annual revenues from alcohol excise tax in millions US\) | EN |
| GDO_q18x2x3_1 | Total expenditure on dementia basic research (local currency, self-report) | EN |
| GDO_q18x2x3_2 | Total expenditure on dementia clinical/translational research (local currency, self-report) | EN |
| GDO_q1x1x1 | Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease] | EN |
| GDO_q2x1 | Existence of dementia national plan | EN |
| GDO_q2x1x2 | Availability of funding for dementia national plan | EN |
| GDO_q2x2x1_other | Identification of other plans in which dementia is integrated (Other) | EN |
| GDO_q2x4_4 | Inclusion of multisectoral collaboration as a guiding principles of the dementia plan | EN |
| GDO_q2x4_5 | Inclusion of universal health coverage as a guiding principle of the dementia plan | EN |
| R_excise_specific_reliance | Tax structure: Greater reliance on specific tax in mixed excise regime | EN |
| R_excise_type | Tax structure: Type of excise tax applied | EN |
| R_excise_uniform_varied | Tax structure: Uniform excise tax | EN |
| R_Price_premium_estimate | Premium brand of cigarettes - price in currency reported | EN |
| R_Sp_excise_average | Average - taxes as a % of cigarette price - specific excise | EN |
| R_total_tax_average | Average - taxes as a % of cigarette price - total tax | EN |
| R_total_tax_estimate | Most sold brand of cigarettes - taxes as a % of price - total tax | EN |
| R_VAT_average | Average - taxes as a % of cigarette price - value added tax | EN |
| RADON_Q302 | National radon concentration levels | EN |
| RADON_Q303 | Existence of national radon database | EN |
| SA_0000001476 | Alcohol expenditure as a per cent of total household expenditure | EN |
| SA_0000001476_ARCHIVED | Alcohol expenditure as a per cent of total household expenditure | EN |
| SA_0000001502 | Adopted written national policy on alcohol | EN |
| GDO_q20 | Total number of published dementia research output | EN |
| GDO_q2x1x3 | Targets for monitoring implementation of dementia national plan | EN |
| GDO_Q2x2x1_AGE | Identification of other plans in which dementia is integrated (Ageing) | EN |
| GDO_Q2x2x1_MENTAL | Identification of other plans in which dementia is integrated (Mental health) | EN |
| GDO_Q2x2x1_NCD | Identification of other plans in which dementia is integrated (NCD) | EN |
| GDO_q2x5_1 | Inclusion of dementia-friendly communities as a specific action of the dementia plan | EN |
| GDO_q2x5_3 | Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan | EN |
| GDO_q2x5_6 | Inclusion of improved information system as a specific action of the dementia plan | EN |
| GDO_q3x1 | Existence of dementia legislation | EN |
| GDO_q2x3 | Existence of dementia sub-national plan(s) | EN |
| GDO_q2x3x1_1 | Percentage of sub-national regions covered by dementia plan | EN |
| GDO_q2x5_7 | Inclusion of research and innovation as a specific action of the dementia plan | EN |
| SA_0000001470_ARCHIVED | Alcohol-related road traffic crashes, per 100,000 population | EN |
| GDO_q1x2 | Existence of dementia representative in ministry | EN |
| GDO_q2x2 | Dementia integrated into other national plan | EN |
| GDO_Q2x2x1_DISAB | Identification of other plans in which dementia is integrated (Disability) | EN |
| SA_0000001543_ARCHIVED | Government monopoly on retail sales | EN |
| SA_0000001545 | Licence required for retail sales | EN |
| SA_0000001546_ARCHIVED | Excise tax as a per cent of the retail price of alcoholic beverages | EN |
| SA_0000001548 | Excise tax as a per cent of the total retail price for 1 litre of pure alcohol | EN |
| SA_0000001549_ARCHIVED | Duty paid or excise stamp on alcohol container | EN |
| R_Sp_excise_estimate | Most sold brand of cigarettes - taxes as a % of price - specific excise | EN |
| RADON_Q201 | Existence of any national radon activity | EN |
| RADON_Q301 | Existence of national radon survey(s) | EN |
| RADON_Q401 | Existence of national radon action plan | EN |
| RADON_Q403 | Radon in building regulations for new buildings | EN |
| GDO_q2x4_1 | Inclusion of human rights as a guiding principle of the dementia plan | EN |
| GDO_q2x4_2 | Inclusion of equity as a guiding principle of the dementia plan | EN |
| GDO_q2x4_3 | Inclusion of empowerment as a guiding principle of the dementia plan | EN |
| SA_0000001477 | Social costs of alcohol use in millions US$ | EN |
| SA_0000001503 | Alcoholic beverage legally defined | EN |
| SA_0000001504_ARCHIVED | Alcohol use is banned | EN |
| SA_0000001504 | Alcohol use is banned | EN |
| SA_0000001506 | National legislation to prevent illegal alcohol | EN |
| SA_0000001507 | Advertising restrictions on national television | EN |
| SA_0000001507_ARCHIVED | Advertising restrictions on national television | EN |
| SA_0000001509_ARCHIVED | Advertising restrictions on national radio | EN |
| GDO_q2x5_2 | Inclusion of dementia risk reduction as a specific action of the dementia plan | EN |
| GDO_q2x5_4 | Inclusion of dementia workforce training as a specific action of the dementia plan | EN |
| R_afford_gdp | Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand | EN |
| SA_0000001513 | Advertising restrictions on billboards | EN |
| SA_0000001514_ARCHIVED | Advertising restrictions at point-of-sale | EN |
| R_Curr_lowest_cost | Cheapest brand of cigarettes - currency reported | EN |
| R_excise_min_specific | Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime | EN |
| R_excise_proportion | Tax structure: Excise tax proportion of price | EN |
| R_Group | Raising taxes on tobacco | EN |
| R_imp_duty_average | Average - taxes as a % of cigarette price - import duties | EN |
| R_imp_duty_estimate | Most sold brand of cigarettes - taxes as a % of price - import duties | EN |
| SA_0000001545_ARCHIVED | Licence required for retail sales | EN |
| SA_0000001550_ARCHIVED | Excise tax on alcoholic beverages | EN |
| SA_0000001553 | Restrictions on alcohol use in public places | EN |
| R_Other_estimate | Most sold brand of cigarettes - taxes as a % of price - other taxes | EN |
| SA_0000001502_ARCHIVED | Adopted written national policy on alcohol | EN |
| SA_0000001503_ARCHIVED | Alcoholic beverage legally defined | EN |
| SA_0000001506_ARCHIVED | National legislation to prevent illegal alcohol | EN |
| SA_0000001508 | Advertising restrictions on cable television | EN |
| SA_0000001508_ARCHIVED | Advertising restrictions on cable television | EN |
| SA_0000001510 | Advertising restrictions on local radio | EN |
| SA_0000001512_ARCHIVED | Advertising restrictions at cinemas | EN |
| GDO_q2x5_5 | Inclusion of support for dementia carers and families as a specific action of the dementia plan | EN |
| GDO_q3x1x1_1 | Implementation level [national/subnational] of dementia legislation | EN |
| SA_0000001542_ARCHIVED | Government monopoly on production | EN |
| SA_0000001543 | Government monopoly on retail sales | EN |
| SA_0000001544_ARCHIVED | Licence required for production | EN |
| P5_indoor_off | National smoking ban in INDOOR OFFICES | EN |
| P7_pubs | National smoking ban in PUBS AND BARS | EN |
| PerctreatedANC | Antenatal care attendees positive for syphilis who received treatment (%), reported | EN |
| pncall5 | Postnatal care visit within two days of birth (in the five years preceding the survey) (%) | EN |
| pnchome3 | Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%) | EN |
| SA_0000001444 | Age-standardized death rates, ischaemic heart disease, per 100,000 | EN |
| SA_0000001445 | Age-standardized death rates, liver cancer, per 100,000 | EN |
| SA_0000001450 | Age-standardized death rates, poisoning, per 100,000 | EN |
| SA_0000001451 | Age-standardized death rates, prematurity and low birth rate, per 100,000 | EN |
| SA_0000001457_ARCHIVED | Liver cirrhosis, age-standardized death rates (15+), per 100,000 population | EN |
| SA_0000001459 | Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population | EN |
| SA_0000001459_ARCHIVED | Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population | EN |
| GDO_q17x1x1 | Implementation level [national/subnational] of dementia research plan/programme | EN |
| GDO_q17x2x1_1 | Identification of other research plans in which dementia is integrated (Mental health) | EN |
| GDO_q17x2x1_2 | Identification of other research plans in which dementia is integrated (Ageing) | EN |
| GDO_q18x2 | Availability of funding for dementia-specific research plan/programme | EN |
| SA_0000001547_ARCHIVED | Excise duty (average) per hectolitre in Euros | EN |
| SA_0000001549 | Duty paid or excise stamp on alcohol container | EN |
| SA_0000001550 | Excise tax on alcoholic beverages | EN |
| SA_0000001553_ARCHIVED | Restrictions on alcohol use in public places | EN |
| GDO_q1x1 | Inclusion of dementia in ministry portfolio | EN |
| R_Ad_val_estimate | Most sold brand of cigarettes - taxes as a % of price - ad valorem excise | EN |
| SA_0000001509 | Advertising restrictions on national radio | EN |
| SA_0000001511 | Advertising restrictions in print media | EN |
| SA_0000001512 | Advertising restrictions at cinemas | EN |
| SA_0000001513_ARCHIVED | Advertising restrictions on billboards | EN |
| SA_0000001516 | Restrictions on product placement on national television | EN |
| SA_0000001551 | Value-added tax (VAT) on alcohol (%) | EN |
| SA_0000001647 | Awareness activities | EN |
| SA_0000001649 | National drinking guidelines | EN |
| SA_0000001680 | Perceived trend in production | EN |
| SA_0000001681 | Perceived trend in imports | EN |
| SA_0000001555_ARCHIVED | Health warning labels on alcohol containers | EN |
| SA_0000001647_ARCHIVED | Awareness activities | EN |
| SA_0000001648 | Information, education, prevention | EN |
| SA_0000001654 | Surveys, research | EN |
| SA_0000001676 | Production in 1000s hectolitres | EN |
| SA_0000001693 | Level of adoption of national alcohol policy | EN |
| RADON_Q601 | Existence of official protocols for radon measurements | EN |
| RADON_Q604 | Authorization/accreditation required for official radon measurement providers | EN |
| SA_0000001684 | Sales of wine in 1000s hectolitres | EN |
| SA_0000001685 | Sales of spirits in 1000s hectolitres | EN |
| SA_0000001688_ARCHIVED | Total (recorded+unrecorded) alcohol per capita (15+) consumption | EN |
| SA_0000001689 | Age-standardized DALYs, cerebrovascular disease, per 100,000 | EN |
| SA_0000001691_ARCHIVED | Central coordinating entity for alcohol policy implementation | EN |
| SA_0000001692 | Framework of national alcohol policy | EN |
| SA_0000001693_ARCHIVED | Level of adoption of national alcohol policy | EN |
| TB_new_oth | New cases: other | EN |
| TB_new_su | New cases: pulmonary smear unknown/not done | EN |
| TB_newret_oth | Treatment history unknown | EN |
| TB_ret_rel_clindx | Relapse cases: Pulmonary, clinically diagnosed | EN |
| SA_0000001523 | Prices for alcoholic beverages (average, US\() |EN | |SA_0000001525_ARCHIVED |Off-premise sales restrictions on days |EN | |SA_0000001694_ARCHIVED |Sectors represented in national alcohol policy |EN | |SA_0000001696_ARCHIVED |Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities) |EN | |SA_0000001697_ARCHIVED |Adopted written national policy on alcohol, year adopted |EN | |SA_0000001521 |Random breath testing (RBT) use |EN | |SA_0000001523_ARCHIVED |Prices for alcoholic beverages (average, US\)) | EN |
| SA_0000001526 | Off-premise sales restrictions on hours | EN |
| SA_0000001528_ARCHIVED | Off-premise sales restrictions on outlet density | EN |
| SA_0000001529 | Off-premise sales restrictions at specific events | EN |
| SA_0000001530 | Off-premise sales restrictions at petrol stations | EN |
| SA_0000001534 | On-premise sales restrictions on outlet density | EN |
| SA_0000001534_ARCHIVED | On-premise sales restrictions on outlet density | EN |
| SA_0000001535 | On-premise sales restrictions at specific events | EN |
| SA_0000001537 | Restrictions on sponsorship of sporting events | EN |
| RADON_Q702 | Mandatory mitigation measures if legal value is exceeded (existing buildings) | EN |
| R_Price_premium_ppp | Premium brand of cigarettes - price in international dollars | EN |
| R_VAT_estimate | Most sold brand of cigarettes - taxes as a % of price - value added tax | EN |
| RADON_Q304 | Data in national radon database | EN |
| RADON_Q402 | Existence of national radon regulations | EN |
| RADON_Q404 | Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration | EN |
| SA_0000001538_ARCHIVED | Restrictions on sponsorship of youth events | EN |
| SA_0000001696 | Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities) | EN |
| SA_0000001697 | Adopted written national policy on alcohol, year adopted | EN |
| SA_0000001698 | Adopted written national policy on alcohol, year revised | EN |
| TB_effective_treatment_coverage | Tuberculosis effective treatment coverage (%) | EN |
| TB_hivtest_pct | TB patients with known HIV status (%) | EN |
| TB_new_clindx | New or unknown treatment history cases: Pulmonary, clinically diagnosed | EN |
| TB_new_snsuoth | New cases: Pulmonary, smear-negative/unknown/not done and other new cases | EN |
| TB_new_sp | New cases: Pulmonary, smear-positive | EN |
| TB_ret_nrel | Previously treated cases, excluding relapse | EN |
| TB_ret_rel | Relapse cases (pre-2013 definition) | EN |
| RADON_Q603 | Radon concentration measurements for existing buildings | EN |
| RADON_Q701 | Mandatory preventive measures (new buildings) | EN |
| SA_0000001698_ARCHIVED | Adopted written national policy on alcohol, year revised | EN |
| SA_0000001700 | Consumer information on alcohol and health at points of sale | EN |
| SA_0000001701 | Educational programmes involving target groups in school curriculum | EN |
| SA_0000001703 | Server training on a regular basis | EN |
| SA_0000001707 | Persons with alcohol use disorders receiving treatment (%) | EN |
| SA_0000001708 | Designation of alcohol tax revenues to health services | EN |
| SA_0000001650_ARCHIVED | Standard drink measures, in grams per unit | EN |
| SA_0000001652 | Interventions, projects, training | EN |
| SA_0000001653 | Treatment, services | EN |
| SA_0000001655 | Counselling | EN |
| SA_0000001677 | Imports in 1000s hectolitres | EN |
| SA_0000001679 | Exports of beer (barley) in 1000s hectolitres | EN |
| SA_0000001683 | Perceived trend in exports | EN |
| SA_0000001686 | Exports of wine (grape) in 1000s hectolitres | EN |
| SA_0000001687 | Exports of spirits in 1000s hectolitres | EN |
| SA_0000001690 | Age-standardized death rates, cerebrovascular disease, per 100,000 | EN |
| SA_0000001691 | Central coordinating entity for alcohol policy implementation | EN |
| SA_0000001515_ARCHIVED | Advertising restrictions on the internet | EN |
| SA_0000001517_ARCHIVED | Restrictions on product placement on cable television | EN |
| SA_0000001519 | Minimum legal drinking age | EN |
| SA_0000001525 | Off-premise sales restrictions on days | EN |
| SA_0000001527 | Off-premise sales restrictions on places | EN |
| SA_0000001528 | Off-premise sales restrictions on outlet density | EN |
| SA_0000001529_ARCHIVED | Off-premise sales restrictions at specific events | EN |
| SA_0000001530_ARCHIVED | Off-premise sales restrictions at petrol stations | EN |
| SA_0000001531 | On-premise sales restrictions on days | EN |
| SA_0000001531_ARCHIVED | On-premise sales restrictions on days | EN |
| SA_0000001532 | On-premise sales restrictions on hours | EN |
| SA_0000001694 | Sectors represented in national alcohol policy | EN |
| SA_0000001695_ARCHIVED | Cautions and arrests for public drunkenness, per 100,000 population | EN |
| SA_0000001709 | National surveys on drink-driving | EN |
| R_admin_tax_stamps | Tax administration: Tax stamps applied on tobacco products | EN |
| R_excise_incr | Tobacco excises increased over the survey period | EN |
| R_excise_retail_price_base | Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT) | EN |
| SA_0000001462 | Alcohol use disorders (15+), 12 month prevalence (%) with 95% | EN |
| SA_0000001462_ARCHIVED | Alcohol use disorders (15+), 12 month prevalence (%) with 95% | EN |
| SA_0000001466 | Hospital discharges, alcoholic liver disease, per 100,000 | EN |
| SA_0000001468 | Treatment admissions (inpatient), alcohol dependence, per 100,000 | EN |
| SA_0000001474 | Alcoholic excise tax revenue as a per cent of government revenue | EN |
| SA_0000001474_ARCHIVED | Alcoholic excise tax revenue as a per cent of government revenue | EN |
| SA_0000001475_ARCHIVED | Annual revenues from alcohol excise tax in millions US$ | EN |
| SA_0000001477_ARCHIVED | Social costs of alcohol use in millions US$ | EN |
| GDO_q35 | Estimated population-based prevalence of depression | EN |
| GDO_q3x2 | Existence of other laws that apply to the rights of people with dementia | EN |
| SA_0000001542 | Government monopoly on production | EN |
| SA_0000001544 | Licence required for production | EN |
| SA_0000001546 | Excise tax as a per cent of the retail price of alcoholic beverages | EN |
| SA_0000001547 | Excise duty (average) per hectolitre in Euros | EN |
| SA_0000001548_ARCHIVED | Excise tax as a per cent of the total retail price for 1 litre of pure alcohol | EN |
| R_Other_average | Average - taxes as a % of cigarette price - other taxes | EN |
| R_Price_mp_estimate | Most sold brand of cigarettes - price in currency reported | EN |
| R_Price_premium_usd | Premium brand of cigarettes - price in US$ at official exchange rates | EN |
| SA_0000001538 | Restrictions on sponsorship of youth events | EN |
| SA_0000001540 | Restrictions on sales promotion from retailers (sales below cost) | EN |
| WHOSIS_000009 | Children aged <5 years overweight (%) | EN |
| WHS10_2 | Number of cause-of-death registration years available | EN |
| WHS10_3 | Number of national population surveys - child anthropometry | EN |
| WHS10_5 | Number of national population surveys - maternal mortality | EN |
| SA_0000001699_ARCHIVED | Age limits off-premise sales | EN |
| SA_0000001702 | Brief interventions as health promotion/disease prevention | EN |
| SA_0000001706 | National treatment policy for alcohol use disorders | EN |
| SA_0000001713 | Interventions/projects actively involving young people and civil society | EN |
| SA_0000001717 | Prevention/counselling at workplaces for those with alcohol problems | EN |
| SA_0000001724 | National guidelines for implementing effective community-based interventions | EN |
| SA_0000001539 | Restrictions on sales promotion from producers (parties, events) | EN |
| SA_0000001540_ARCHIVED | Restrictions on sales promotion from retailers (sales below cost) | EN |
| SA_0000001541 | Restrictions on sales promotion from owners of pubs and bars (alcohol for free) | EN |
| WHOSIS_000008 | Children aged <5 years underweight (%) | EN |
| WHOSIS_000014 | Stillbirth rate (per 1000 total births) | EN |
| WHS_PBR | Preterm birth rate (per 100 live births) | EN |
| WHS10_10 | International Statistical Classification of Diseases and Related Health Problems (ICD) | EN |
| WHS10_6 | Number of national population surveys - HIV prevalence | EN |
| WHS10_9 | Ill-defined causes in cause-of-death registration (%) | EN |
| WHS2_131 | Age-standardized NCD mortality rate (per 100 000 population) | EN |
| WHS2_152 | Deaths due to malaria (per 100 000 population) | EN |
| WHS2_160 | Age-standardized mortality rate by cause (per 100 000 population) - Cancer | EN |
| SA_0000001712 | Community-based interventions/projects involving stakeholders | EN |
| SA_0000001714 | Training in screening and brief interventions for alcohol problems | EN |
| SA_0000001715 | Counselling to children in families with alcohol problems | EN |
| SA_0000001716 | Counselling to pregnant women with alcohol problems | EN |
| SA_0000001720_ARCHIVED | Restrictions on product placement in films/movies | EN |
| SA_0000001533_ARCHIVED | On-premise sales restrictions on places | EN |
| SA_0000001536 | On-premise sales restrictions to intoxicated persons | EN |
| SA_0000001541_ARCHIVED | Restrictions on sales promotion from owners of pubs and bars (alcohol for free) | EN |
| WHS10_1 | Most recent census (year) | EN |
| WHS10_4 | Number of national population surveys - child mortality | EN |
| TB_hiv_art_pct | HIV-positive TB patients on ART (antiretroviral therapy) (%) | EN |
| TB_hiv_cpt_pct | HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%) | EN |
| TB_hivtest_pos_pct | Tested TB patients HIV-positive (%) | EN |
| TB_new_snuoth | TB new snuoth | EN |
| TB_ret_oth | Retreatment cases: other | EN |
| TB_ret_rel_labconf | Relapse cases: Pulmonary, bacteriologically confirmed | EN |
| TB_ret_tad | Retreatment cases: treatment after default (pulmonary smear and/or culture positive) | EN |
| TB_sldst_avail | Second-line drug susceptibility testing (DST) available | EN |
| TOBACCO_0000000209 | Fines for violations | EN |
| TOBACCO_0000000212 | Dedicated funds for enforcement | EN |
| TOBACCO_0000000213 | Citizen complaints and investigations | EN |
| SA_0000001720 | Restrictions on product placement in films/movies | EN |
| SA_0000001721 | Importance of measures for enhancing compliance with age limits | EN |
| SA_0000001721_ARCHIVED | Importance of measures for enhancing compliance with age limits | EN |
| SA_0000001723 | Community-based interventions involving stakeholders | EN |
| RADON_Q405 | Radon in national drinking-water regulations | EN |
| RADON_Q501 | Existence of national reference level for dwellings and buildings with high public occupancy | EN |
| RADON_Q502 | Existence of national reference level for buildings with high public occupancy | EN |
| SA_0000001510_ARCHIVED | Advertising restrictions on local radio | EN |
| SA_0000001511_ARCHIVED | Advertising restrictions in print media | EN |
| SA_0000001514 | Advertising restrictions at point-of-sale | EN |
| SA_0000001515 | Advertising restrictions on the internet | EN |
| SA_0000001516_ARCHIVED | Restrictions on product placement on national television | EN |
| SA_0000001517 | Restrictions on product placement on cable television | EN |
| SA_0000001518 | Age limits on-premise service | EN |
| SA_0000001518_ARCHIVED | Age limits on-premise service | EN |
| SA_0000001520 | Legal blood alcohol concentration (BAC) limits | EN |
| SA_0000001520_ARCHIVED | Legal blood alcohol concentration (BAC) limits | EN |
| SA_0000001521_ARCHIVED | Random breath testing (RBT) use | EN |
| SA_0000001551_ARCHIVED | Value-added tax (VAT) on alcohol (%) | EN |
| SA_0000001554 | Health warning labels on alcohol advertising | EN |
| SA_0000001554_ARCHIVED | Health warning labels on alcohol advertising | EN |
| SA_0000001555 | Health warning labels on alcohol containers | EN |
| SA_0000001650 | Standard drink measures, in grams per unit | EN |
| SA_0000001651 | Monitoring | EN |
| SA_0000001678 | Sales of beer in 1000s hectolitres | EN |
| SA_0000001682 | Perceived trend in sales | EN |
| SA_0000001688 | Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2) | EN |
| RADON_Q602 | Radon concentration measurements for new buildings | EN |
| RADON_Q703 | Financial support provided for mitigation (existing dwellings) | EN |
| RADON_Q704 | Authorization/accreditation required for prevention/mitigation service providers | EN |
| RADON_Q705 | Official standards/guidelines for prevention/mitigation | EN |
| TB_mdr | Confirmed cases of MDR-TB | EN |
| TB_new_ep | New cases: extrapulmonary | EN |
| TB_new_labconf | New or unknown treatment history cases: Pulmonary, bacteriologically confirmed | EN |
| TB_new_sn | New cases: pulmonary smear-negative | EN |
| WHS2_138 | Deaths due to HIV/AIDS (per 100 000 population) | EN |
| WHS3_47 | Meningitis - number of reported cases | EN |
| WHS3_51 | H5N1 influenza - number of reported cases | EN |
| SA_0000001727 | Sobriety checkpoints | EN |
| SA_0000001727_ARCHIVED | Sobriety checkpoints | EN |
| SA_0000001728 | Detection of marketing infringements | EN |
| SA_0000001728_ARCHIVED | Detection of marketing infringements | EN |
| SA_0000001729_ARCHIVED | Penalties for marketing infringements | EN |
| SA_0000001730_ARCHIVED | Price measures | EN |
| WHS3_55 | Congenital Rubella Syndrome - number of reported cases | EN |
| TOBACCO_0000000192 | Prevalence of smoking any tobacco product among persons aged >= 15 years | EN |
| TOBACCO_0000000344 | Prevalence of current tobacco use among adolescents aged 13-15 years | EN |
| TOBACCO_0000000346 | Exposure to smoke at home | EN |
| TOBACCO_0000000347 | Exposure to smoke outside home | EN |
| TOBACCO_0000000362 | Smoking cessation support is available in hospitals | EN |
| TOBACCO_0000000365 | Smoking cessation support is available in the community | EN |
| TOBACCO_0000000371 | Varenicline - legally sold | EN |
| TOBACCO_0000000389 | Number of health warnings approved by the law for other smoked tobacco packaging | EN |
| SA_0000001724_ARCHIVED | National guidelines for implementing effective community-based interventions | EN |
| SA_0000001725 | National alcohol policy specifically involves young people activities | EN |
| SA_0000001732_ARCHIVED | New types of alcoholic beverages emerging | EN |
| SA_0000001733 | Consumer information about calories, additives, etc on containers | EN |
| SA_0000001733_ARCHIVED | Consumer information about calories, additives, etc on containers | EN |
| SA_0000001734_ARCHIVED | Number of standard alcoholic drinks displayed on containers | EN |
| WHS2_161 | Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular | EN |
| WHS2_171 | Distribution of causes of death among children aged <5 years (%) - Other diseases | EN |
| WHS2_515 | Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis | EN |
| WHS2_516 | Distribution of causes of death among children aged <5 years (%) - Congenital anomalies | EN |
| WHS2_523 | Distribution of causes of death among children aged <5 years (%) - Birth asphyxia | EN |
| WHS3_42 | Japanese encephalitis - number of reported cases | EN |
| WHS3_45 | Number of new leprosy cases | EN |
| WHS3_49 | Poliomyelitis - number of reported cases | EN |
| WHS3_522 | Number of reported cases of tuberculosis | EN |
| WHS3_53 | Mumps - number of reported cases | EN |
| TOBACCO_0000000361 | Access to a toll-free quit line | EN |
| TOBACCO_0000000364 | Smoking cessation support is available in offices of health professionals | EN |
| TOBACCO_0000000366 | Smoking cessation support is available in other settings | EN |
| SA_0000001722_ARCHIVED | Government support for community action | EN |
| SA_0000001723_ARCHIVED | Community-based interventions involving stakeholders | EN |
| SA_0000001725_ARCHIVED | National alcohol policy specifically involves young people activities | EN |
| SA_0000001726_ARCHIVED | Penalties for drink driving | EN |
| SA_0000001729 | Penalties for marketing infringements | EN |
| SA_0000001736 | Action Plan for implementation of alcohol policy | EN |
| SA_0000001737_ARCHIVED | Alcohol, regional per capita (15+) consumption (in litres of pure alcohol) | EN |
| SA_0000001740_ARCHIVED | Alcohol-attributable Years of Life Lost (YLL) score | EN |
| TOBACCO_0000000390 | Health warnings on other smoked tobacco packaging must be rotated | EN |
| TB_rr_mdr | Confirmed cases of RR-/MDR-TB | EN |
| tfr | Total fertility rate (per woman) | EN |
| TOBACCO_0000000210 | Fines on the establishment | EN |
| TOBACCO_0000000342 | Daily users of any smokeless tobacco product (crude rate) | EN |
| TOBACCO_0000000345 | Current smokers of cigarettes (youth rate) | EN |
| TOBACCO_0000000363 | Smoking cessation support is available in health clinics or other primary care facilities | EN |
| TOBACCO_0000000369 | Bupropion - legally sold | EN |
| TOBACCO_0000000372 | Varenicline - place available | EN |
| TOBACCO_0000000391 | Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging | EN |
| WHS2_164 | Distribution of causes of death among children aged <5 years (%) - Malaria | EN |
| TOBACCO_0000000393 | Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health | EN |
| TOBACCO_0000000505 | Year of survey of youth | EN |
| TOBACCO_0000000367 | Nicotine replacement therapy - legally sold | EN |
| TOBACCO_0000000368 | Nicotine replacement therapy - place available | EN |
| WHS2_165 | Distribution of causes of death among children aged <5 years (%) - Pneumonia | EN |
| WHS2_170 | Distribution of causes of death among children aged <5 years (%) - HIV/AIDS | EN |
| WHS2_174 | Distribution of years of life lost by broader causes (%) - Injuries | EN |
| WHS3_41 | Diphtheria - number of reported cases | EN |
| TOBACCO_0000000392 | Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale | EN |
| TOBACCO_0000000395 | Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country | EN |
| WHS3_48 | Malaria - number of reported confirmed cases | EN |
| WHS3_50 | Yellow fever - number of reported cases | EN |
| WHS3_54 | Number of reported cases of tuberculosis (DOTS) | EN |
| WHS3_56 | Neonatal tetanus - number of reported cases | EN |
| WHS3_57 | Rubella - number of reported cases | EN |
| WHS3_62 | Measles - number of reported cases | EN |
| SA_0000001731 | Level of taxation adjusted for inflation | EN |
| SA_0000001731_ARCHIVED | Level of taxation adjusted for inflation | EN |
| SA_0000001732 | New types of alcoholic beverages emerging | EN |
| SA_0000001735 | Alcohol content displayed on containers | EN |
| SA_0000001735_ARCHIVED | Alcohol content displayed on containers | EN |
| SA_0000001736_ARCHIVED | Action Plan for implementation of alcohol policy | EN |
| SA_0000001737 | Alcohol, regional per capita (15+) consumption (in litres of pure alcohol) | EN |
| SA_0000001739 | Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI | EN |
| SA_0000001739_ARCHIVED | Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI | EN |
| TB_ret_rel_ep | Relapse cases: extrapulmonary | EN |
| SA_0000001526_ARCHIVED | Off-premise sales restrictions on hours | EN |
| SA_0000001527_ARCHIVED | Off-premise sales restrictions on places | EN |
| SA_0000001532_ARCHIVED | On-premise sales restrictions on hours | EN |
| SA_0000001533 | On-premise sales restrictions on places | EN |
| SA_0000001535_ARCHIVED | On-premise sales restrictions at specific events | EN |
| SA_0000001536_ARCHIVED | On-premise sales restrictions to intoxicated persons | EN |
| SA_0000001537_ARCHIVED | Restrictions on sponsorship of sporting events | EN |
| SA_0000001539_ARCHIVED | Restrictions on sales promotion from producers (parties, events) | EN |
| SA_0000001692_ARCHIVED | Framework of national alcohol policy | EN |
| SA_0000001695 | Cautions and arrests for public drunkenness, per 100,000 population | EN |
| SA_0000001699 | Age limits off-premise sales | EN |
| SA_0000001704 | Data collection on alcohol-related health indicators | EN |
| SA_0000001705 | System for monitoring alcohol-related harm | EN |
| SA_0000001710 | Public-funded alcohol research/monitoring programmes | EN |
| SA_0000001711 | Public funds designated for alcohol research/monitoring programmes, in Euros | EN |
| WHOSIS_000010 | Adults aged ≥ 20 years who are obese (%) | EN |
| WHOSIS_000012 | Prevalence of smoking any tobacco product among adults (≥15 years) (%) | EN |
| WHOSIS_000013 | Prevalence of current tobacco use among adolescents (13-15 years) (%) | EN |
| WHOSIS_000015 | Life expectancy at age 60 (years) | EN |
| WHS10_7 | Number of national population surveys - adult health | EN |
| WHS10_8 | Civil registration coverage of cause-of-death (%) | EN |
| WHS2_126 | Distribution of years of life lost by major cause group | EN |
| TOTENV_1 | Deaths attributable to the environment | EN |
| TOTENV_6 | Disability-adjusted life years (DALYs) attributable to the environment (%) | EN |
| SA_0000001743 | Alcohol-attributable fractions, all-cause deaths (%) | EN |
| SA_0000001744_ARCHIVED | Alcohol, regional prevalence of alcohol dependence (%) | EN |
| SA_0000001745 | Alcohol, regional prevalence of alcohol use disorders (%) | EN |
| SA_0000001741_ARCHIVED | Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) | EN |
| SA_0000001742 | Alcohol-attributable fractions (15+), road traffic crash deaths (%) | EN |
| SA_0000001744 | Alcohol, regional prevalence of alcohol dependence (%) | EN |
| SA_0000001745_ARCHIVED | Alcohol, regional prevalence of alcohol use disorders (%) | EN |
| SA_0000001746 | Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025 | EN |
| SA_0000001746_ARCHIVED | Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025 | EN |
| SA_0000001747_ARCHIVED | Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI | EN |
| SA_0000001748 | Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI | EN |
| SA_0000001748_ARCHIVED | Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI | EN |
| SA_0000001749_ARCHIVED | Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI | EN |
| SA_0000001751 | Alcohol, average daily intake in grams among drinkers with 95%CI | EN |
| SA_0000001751_ARCHIVED | Alcohol, average daily intake in grams among drinkers with 95%CI | EN |
| WHS4_107 | Children aged <5 years with diarrhoea receiving ORT (%) | EN |
| WHS4_129 | Hib (Hib3) immunization coverage among 1-year-olds (%) | EN |
| WHS4_154 | Antenatal care coverage - at least four visits (%) | EN |
| WHS5_512 | Population using solid fuels (%) | EN |
| WHS6_101 | Median availability of selected generic medicines (%) - Private | EN |
| WHS6_116 | Median consumer price ratio of selected generic medicines - Private | EN |
| WHS4_111_AGE1519 | Antenatal care coverage - at least one visit, among girls aged 15-19 (%) | EN |
| WHS4_117 | Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) | EN |
| WHS4_544 | Polio (Pol3) immunization coverage among 1-year-olds (%) | EN |
| WHS4_99 | Antiretroviral therapy coverage among HIV-infected pregnant women for PMTCT (%) | EN |
| WHS6_100 | Radiotherapy units (per 1 000 000 population) | EN |
| WHS6_102 | Hospital beds (per 10 000 population) | EN |
| WHS6_144 | Dentistry personnel density (per 10 000 population) | EN |
| TOTENV_11 | Deaths attributable to the environment in children under 5 years (%) | EN |
| WHS6_148 | Nursing and midwifery personnel density (per 10 000 population) | EN |
| TOTENV_70 | Total environment attributable deaths in children under 5 years | EN |
| TOTENV_8 | Total environment attributable deaths per 100’000 children under 5 years | EN |
| u5mr | Under-five mortality rate (deaths per 1000 live births) | EN |
| UHC_AVAILABILITY_SCORE | Primary data availability for UHC Service Coverage Index (SDG 3.8.1) (%) | EN |
| UHC_IHR | Compliance with international health regulations | EN |
| UHC_SCI_NCD | UHC Service Coverage sub-index on noncommunicable diseases | EN |
| UHC_TB_DT | Tuberculosis detection and treatment | EN |
| UV_1 | UV radiation | EN |
| TOTENV_5 | Deaths attributable to the environment (%) | EN |
| UHC_INDEX_ACTUAL | Index of Essential Service Coverage (Actual) | EN |
| SA_0000001752 | Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016 | EN |
| SA_0000001752_ARCHIVED | Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016 | EN |
| TOBACCO_0000000396 | Health warnings on other smoked tobacco packaging must include a photograph or graphic | EN |
| TOBACCO_0000000506 | Representativeness of youth survey | EN |
| TOTENV_4 | Age-standardized DALYs attributable to the environment (per 100 000 population) | EN |
| UHC_INDEX_REPORTED | UHC Service Coverage Index (SDG 3.8.1) | EN |
| UHC_NCD_NONELEVBP | Prevalence of non-elevated blood pressure (%) | EN |
| TOTENV_9 | Total environment attributable DALYs (’000) in children under 5 years | EN |
| SA_0000001754_ARCHIVED | Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI | EN |
| SA_0000001755 | 15-19 years old heavy episodic drinkers (population), % with 95%CI | EN |
| SA_0000001759 | 15-19 years old, current drinkers (%) | EN |
| SA_0000001760 | 15-19 years old total alcohol consumption in litres of pure alcohol | EN |
| SA_0000001761 | National guidelines for the prevention and reduction of alcohol-related harm in schools | EN |
| SA_0000001756_ARCHIVED | 15-19 years old heavy episodic drinkers (drinkers only), % | EN |
| SA_0000001757 | 15-19 years old abstainers, lifetime (%) | EN |
| SA_0000001757_ARCHIVED | 15-19 years old abstainers, lifetime (%) | EN |
| SA_0000001759_ARCHIVED | 15-19 years old, current drinkers (%) | EN |
| SA_0000001760_ARCHIVED | 15-19 years old total alcohol consumption in litres of pure alcohol | EN |
| WHS2_166 | Distribution of causes of death among children aged <5 years (%) - Injuries | EN |
| SA_0000001719 | Advertising restrictions on social media | EN |
| SA_0000001719_ARCHIVED | Advertising restrictions on social media | EN |
| SA_0000001722 | Government support for community action | EN |
| SA_0000001726 | Penalties for drink driving | EN |
| SA_0000001730 | Price measures | EN |
| SA_0000001734 | Number of standard alcoholic drinks displayed on containers | EN |
| SA_0000001761_ARCHIVED | National guidelines for the prevention and reduction of alcohol-related harm in schools | EN |
| SA_0000001763_ARCHIVED | Workplace representatives nationally involved to prevent and address alcohol-related harm | EN |
| WHS4_108 | Children aged <5 years with ARI symptoms who took antibiotic treatment (%) | EN |
| WHS4_115 | Births by caesarean section (%) | EN |
| WHS4_124 | Children aged 6-59 months who received vitamin A supplementation (%) | EN |
| WHS4_128 | Neonates protected at birth against neonatal tetanus (PAB) (%) | EN |
| TB_ret_taf | Retreatment cases: treatment after failure (pulmonary smear and/or culture positive) | EN |
| TB_tot_newrel | Tuberculosis - new and relapse cases | EN |
| TB_treatment_coverage | xxx | EN |
| TOBACCO_0000000211 | Fines on the patron | EN |
| WHS6_140 | Number of community health workers | EN |
| WHS6_520 | Density of environment and public health workers (per 10 000 population) | EN |
| WHS7_103 | Private prepaid plans as a percentage of private expenditure on health | EN |
| TOBACCO_0000000370 | Bupropion - place available | EN |
| TOBACCO_0000000386 | Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging | EN |
| WHS2_167 | Distribution of causes of death among children aged <5 years (%) - Diarrhoea | EN |
| uweight3 | Underweight prevalence in children aged < 3 years (%) | EN |
| uweight5 | Underweight prevalence in children aged < 5 years (%) | EN |
| VIOLENCE_BULLIED | Bullied, past 30 days (%) | EN |
| SA_0000001753_ARCHIVED | Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI | EN |
| SA_0000001756 | 15-19 years old heavy episodic drinkers (drinkers only), % | EN |
| SA_0000001758 | 15-19 years old former drinkers (%) | EN |
| SA_0000001758_ARCHIVED | 15-19 years old former drinkers (%) | EN |
| SA_0000001764 | Server training | EN |
| SA_0000001764_ARCHIVED | Server training | EN |
| SA_0000001765 | Legal obligation for schools to include alcohol use prevention | EN |
| WHS7_105 | Per capita total expenditure on health (PPP int. \() |EN | |WHS9_87 |Net primary school enrolment ratio (%) |EN | |WHS9_88 |Population median age (years) |EN | |WHS9_94 |Civil registration coverage of causes of deaths (%) |EN | |WHS9_95 |Total fertility rate (per woman) |EN | |WHS9_CS |Cellular subscribers (per 100 population) |EN | |WHS7_120 |External resources for health as a percentage of total expenditure on health |EN | |UHC_SCI_INFECT |UHC Service Coverage sub-index on infectious diseases |EN | |UNICEF_PNCMOTHER |Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%) |EN | |UV_2 |UV radiation attributable deaths |EN | |SA_0000001763 |Workplace representatives nationally involved to prevent and address alcohol-related harm |EN | |WHS7_104 |Per capita government expenditure on health at average exchange rate (US\)) | EN |
| WHS7_108 | Per capita government expenditure on health (PPP int. \() |EN | |WHS7_149 |General government expenditure on health as a percentage of total expenditure on health |EN | |WHS7_150 |Out-of-pocket expenditure as a percentage of total expenditure on health |EN | |WHS7_156 |Per capita total expenditure on health at average exchange rate (US\)) | EN |
| WHS9_86 | Population (in thousands) total | EN |
| WSH_1 | SDG 3.9.2 WASH deaths | EN |
| WSH_10_HYG | Number of diarrhoea deaths from inadequate hygiene | EN |
| WSH_10_SAN | Number of diarrhoea deaths from inadequate sanitation | EN |
| WSH_10_WAT | Number of diarrhoea deaths from inadequate water | EN |
| SA_0000001768_ARCHIVED | Standard drink defined | EN |
| SA_0000001773_ARCHIVED | National surveys on adult alcohol consumption | EN |
| SA_0000001767_ARCHIVED | Legislation on alcohol testing at workplaces | EN |
| SA_0000001769 | National systems for monitoring alcohol consumption and harms | EN |
| SA_0000001769_ARCHIVED | National systems for monitoring alcohol consumption and harms | EN |
| SA_0000001774 | National surveys on youth alcohol consumption | EN |
| SA_0000001781 | 15-years old any alcoholic beverage consumed in past 12 months, (%) | EN |
| SA_0000001771_ARCHIVED | Comprehensive and regular reporting of alcohol situation | EN |
| SA_0000001779 | Level of enforcement of BAC limits | EN |
| WSH_10 | Number of diarrhoea deaths from inadequate water, sanitation and hygiene | EN |
| UHC_TOBACCONO | Prevalence of non-use of tobacco | EN |
| UNICEF_ORS | Children aged <5 years with diarrhoea receiving ORS (%) | EN |
| UNICEF_PNCNEWBORN | Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%) | EN |
| UV_3 | UV radiation attributable DALYs (’000) | EN |
| UV_5 | UV radiation attributable DALYs per 100’000 capita | EN |
| VIOLENCE_CHILD_EMOTIONAL | Lifetime prevalence of child emotional abuse (%) | EN |
| VIOLENCE_CHILD_PHYSICAL | Lifetime prevalence of child physical abuse (%) | EN |
| VIOLENCE_CHILD_SEXUAL | Lifetime prevalence of child sexual abuse (%) | EN |
| VIOLENCE_EXTENTIMP_CHILDHOMEVISIT | Child maltreatment: Extent of implementation of home-visiting programmes | EN |
| SA_0000001767 | Legislation on alcohol testing at workplaces | EN |
| SA_0000001768 | Standard drink defined | EN |
| WHS2_168 | Distribution of causes of death among children aged <5 years (%) - Measles | EN |
| WHS2_514 | Distribution of causes of death among children aged <5 years (%) - Prematurity | EN |
| WHS3_40 | Cholera - number of reported cases | EN |
| WHS3_43 | Pertussis - number of reported cases | EN |
| WHS3_46 | Total tetanus - number of reported cases | EN |
| WHS3_52 | Plague - number of reported cases | EN |
| WHS4_100 | Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) | EN |
| WHS4_106 | Care-seeking for children with symptoms of acute respiratory infection (%) | EN |
| WHS4_111 | Antenatal care coverage - at least one visit (%) | EN |
| SA_0000001740 | Alcohol-attributable Years of Life Lost (YLL) score | EN |
| SA_0000001741 | Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) | EN |
| SA_0000001742_ARCHIVED | Alcohol-attributable fractions (15+), road traffic crash deaths (%) | EN |
| SA_0000001743_ARCHIVED | Alcohol-attributable fractions, all-cause deaths (%) | EN |
| TOBACCO_0000000387 | Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging | EN |
| TOBACCO_0000000388 | Specific health warnings are mandated for other smoked tobacco packaging | EN |
| TOBACCO_0000000394 | Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging | EN |
| WHS7_134 | Social security expenditure on health as a percentage of general government expenditure on health | EN |
| WHS7_139 | Out-of-pocket expenditure as a percentage of private expenditure on health | EN |
| WHS8_110 | Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) | EN |
| WHS9_91 | Civil registration coverage of births (%) | EN |
| TOBACCO_0000000507 | Repeating interval for survey of youth (years) | EN |
| TOTENV_10 | Total environment attributable DALYs per 100’000 children under 5 years | EN |
| TOTENV_12 | DALYs attributable to the environment in children under 5 years (%) | EN |
| TOTENV_2 | Age-standardized deaths attributable to the environment (per 100 000 population) | EN |
| TOTENV_3 | Disability-adjusted life years (DALYs) attributable to the environment | EN |
| TOTENV_7 | Total environment attributable deaths (’000) in children under 5 years | EN |
| W-MM_Group | Anti-tobacco mass media campaigns | EN |
| WSH_20 | Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene | EN |
| WSH_20_HYG | Attributable fraction of diarrhoea to inadequate hygiene | EN |
| WSH_20_WAT | Attributable fraction of diarrhoea to inadequate water | EN |
| SA_0000001770 | Regular reports from national monitoring systems | EN |
| SA_0000001771 | Comprehensive and regular reporting of alcohol situation | EN |
| SA_0000001772 | Clinical guidelines for brief interventions | EN |
| SA_0000001772_ARCHIVED | Clinical guidelines for brief interventions | EN |
| SA_0000001773 | National surveys on adult alcohol consumption | EN |
| SA_0000001775 | National surveys on heavy espisodic drinking | EN |
| SA_0000001777 | Data collected on harm from alcohol at workplace | EN |
| WSH_30 | Number of diarrhoea DALYs from inadequate water, sanitation and hygiene | EN |
| VIOLENCE_EXTENTIMP_VICTIMSMEDICOLEGAL | Extent of implementation of medico-legal services for victims of sexual violence | EN |
| VIOLENCE_EXTENTIMP_YOUTHLIFESKILLS | Youth violence: Extent of implementation of life-skills and social development programmes | EN |
| VIOLENCE_HOMICIDENUM | Estimates of number of homicides | EN |
| VIOLENCE_HOMICIDERATE | Estimates of rates of homicides per 100 000 population | EN |
| W1_HW_law_A | Law mandates that health warnings appear on tobacco packages | EN |
| W11_outside_pack_A | Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale? | EN |
| SA_0000001777_ARCHIVED | Data collected on harm from alcohol at workplace | EN |
| W10_graphic_A | Do the health warnings on cigarette packaging include a photograph or graphic? | EN |
| W11_outside_pack_B | Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale? | EN |
| W12_imports_dutyfree_A | Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale | EN |
| SA_0000001781_ARCHIVED | 15-years old any alcoholic beverage consumed in past 12 months, (%) | EN |
| SA_0000001782 | 15-years old first drink at 13 years or younger, (%) | EN |
| SA_0000001784 | 15-years old, any alcoholic beverage consumed at least once a week, (%) | EN |
| SA_0000001786 | 13-15-years old any alcoholic beverage consumed in past 30 days, (%) | EN |
| SA_0000001786_ARCHIVED | 13-15-years old any alcoholic beverage consumed in past 30 days, (%) | EN |
| W13_ind_liability_A | Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry | EN |
| W13_ind_liability_B | Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry | EN |
| W14_harm_effects_C | Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health? | EN |
| W15_specific_hw_C | Does the law mandate specific health warnings on smokeless tobacco packaging? | EN |
| SA_0000001784_ARCHIVED | 15-years old, any alcoholic beverage consumed at least once a week, (%) | EN |
| SA_0000001787_ARCHIVED | 13-15-years old first drink before age 14, (%) | EN |
| SA_0000001790 | National drinking guidelines | EN |
| SA_0000001791 | Graduated licensing | EN |
| SA_0000001793 | Penalties for drink driving, repeated offense | EN |
| SA_0000001795 | Licensing required for imports of alcoholic beverages | EN |
| W14_harm_effects_A | Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health? | EN |
| W15_specific_hw_A | Does the law mandate specific health warnings on cigarette packaging? | EN |
| W15_specific_hw_B | Does the law mandate specific health warnings on other smoked tobacco packaging? | EN |
| WHS4_543 | BCG immunization coverage among 1-year-olds (%) | EN |
| WHS6_123 | Number of dentistry personnel | EN |
| WHS6_127 | Number of nursing and midwifery personnel | EN |
| WHS6_150 | Community health workers density (per 10 000 population) | EN |
| WHS6_517 | Number of pharmaceutical personnel | EN |
| WHS6_518 | Number of environment and public health workers | EN |
| WHS6_519 | Density of pharmaceutical personnel (per 10 000 population) | EN |
| SA_0000001749 | Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI | EN |
| SA_0000001754 | Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI | EN |
| SA_0000001755_ARCHIVED | 15-19 years old heavy episodic drinkers (population), % with 95%CI | EN |
| SA_0000001762 | National guidelines for alcohol problem prevention and counselling at workplaces | EN |
| SA_0000001762_ARCHIVED | National guidelines for alcohol problem prevention and counselling at workplaces | EN |
| SA_0000001765_ARCHIVED | Legal obligation for schools to include alcohol use prevention | EN |
| TOTENV_90 | Total environment attributable DALYs in children under 5 years | EN |
| UHC_DATA_AVAIL_CODE | Data availability for UHC index of essential service coverage (ranking) | EN |
| UHC_HRHSURGEONDENSITY | Surgeons (per 100 000) | EN |
| UHC_NCD_FPG | Mean fasting plasma glucose | EN |
| UHC_SCI_CAPACITY | UHC Service Coverage sub-index on service capacity and access | EN |
| UHC_SCI_RMNCH | UHC Service Coverage sub-index on reproductive, maternal, newborn and child health | EN |
| UV_4 | UV radiation attributable deaths per 100’000 capita | EN |
| WHS7_113 | General government expenditure on health as a percentage of total government expenditure | EN |
| WHS7_143 | Total expenditure on health as a percentage of gross domestic product | EN |
| SA_0000001799 | Licenses issued for wholesale/distribution, change since 2010 | EN |
| SA_0000001804 | Health warning labels on under-age drinking | EN |
| SA_0000001807 | Cancer, age-standardized death rates (15+), per 100,000 population | EN |
| SA_0000001809 | National system of epidemiological data collection for alcohol use | EN |
| SA_0000001810 | National system of data collection based on health service delivery | EN |
| W17_fines_C | Health warnings on smokeless tobacco packaging law requires or establishes fines for violations | EN |
| W18_misleading_terms_A | Ban on deceitful terms on cigarette packaging | EN |
| W18_misleading_terms_B | Ban on deceitful terms on other smoked tobacco packaging | EN |
| W20_flavours_A | Cigarette packaging and labelling must not use descriptors depicting flavours | EN |
| W21_emissions_quant_B | Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | EN |
| W17_fines_A | Health warnings on cigarette packaging law requires or establishes fines for violations | EN |
| W17_fines_B | Health warnings on other smoked tobacco packaging law requires or establishes fines for violations | EN |
| W2_pc_front_back_B | Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging | EN |
| W20_flavours_C | Smokeless tobacco packaging and labelling must not use descriptors depicting flavours | EN |
| W24_exp_date_C | Smokeless tobacco packaging and labelling must not display expiry dates | EN |
| W25_quitline_number_A | The quit line number must appear on cigarette packaging or labelling | EN |
| W25_quitline_number_B | The quit line number must appear on other smoked tobacco packaging or labelling | EN |
| W21_emissions_B | Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | EN |
| SA_0000001797 | Licenses issued for production, change since 2010 | EN |
| SA_0000001802 | Monopoly on wholesale /distribution of alcoholic beverages | EN |
| W26_plain_packaging_B | Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | EN |
| W3_pc_front_A | Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging | EN |
| SA_0000001813 | National organization for monitoring alcohol | EN |
| SA_0000001806 | Legal requirement for size of health warning labels | EN |
| SA_0000001811 | Report with epidemiological data on lcohol use and AUDs | EN |
| SA_0000001815 | Ethanol tax deducted from excise tax | EN |
| SA_0000001818 | Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2020 and 2025 | EN |
| SA_0000001821_ARCHIVED | Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI | EN |
| W22_emissions_qual_B | Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions | EN |
| W22_emissions_qual_C | Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions | EN |
| W24_exp_date_A | Cigarette packaging and labelling must not display expiry dates | EN |
| W25_quitline_number_C | The quit line number must appear on smokeless tobacco packaging or labelling | EN |
| W26_plainSPACEpackaging_A | Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | EN |
| W3_pc_front_C | Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging | EN |
| SA_0000001822 | Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI | EN |
| SA_0000001826 | Regional prevalence, AAFs (15+), road traffic crash deaths (%) | EN |
| SA_0000001831 | Average price 500 mls Spirits in US$ | EN |
| WHS7_147 | Private expenditure on health as a percentage of total expenditure on health | EN |
| WHS9_85 | Literacy rate among adults aged >= 15 years (%) | EN |
| WHS9_89 | Population proportion under 15 (%) | EN |
| WHS9_90 | Population living on <$1 (PPP int. $) a day (%) | EN |
| WHS9_92 | Population proportion over 60 (%) | EN |
| WHS9_93 | Gross national income per capita (PPP int. \() |EN | |WHS9_96 |Population living in urban areas (%) |EN | |VIOLENCE_CHILD_NEGLECT |Lifetime prevalence of child physical neglect (%) |EN | |VIOLENCE_EXTENTIMP_ALLTYPES |Extent of implementation of mental health services for victims of all types of violence |EN | |VIOLENCE_PHYSICAL_FIGHTING |Physical fighting, past 12 months (%) |EN | |W_Group |Warning about the dangers of tobacco |EN | |W10_graphic_B |Do the health warnings on other smoked tobacco packaging include a photograph or graphic? |EN | |W10_graphic_C |Do the health warnings on smokeless tobacco packaging include a photograph or graphic? |EN | |W11_outside_pack_C |Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale? |EN | |SA_0000001766 |Legal obligation for schools to interact with parents regarding education and well-being |EN | |SA_0000001766_ARCHIVED |Legal obligation for schools to interact with parents regarding education and well-being |EN | |SA_0000001770_ARCHIVED |Regular reports from national monitoring systems |EN | |SA_0000001774_ARCHIVED |National surveys on youth alcohol consumption |EN | |SA_0000001775_ARCHIVED |National surveys on heavy espisodic drinking |EN | |SA_0000001776 |Data collection on Foetal Alcohol Syndome |EN | |SA_0000001776_ARCHIVED |Data collection on Foetal Alcohol Syndome |EN | |SA_0000001782_ARCHIVED |15-years old first drink at 13 years or younger, (%) |EN | |SA_0000001783 |15-years old any alcoholic beverage consumed in past 30 days, (%) |EN | |SA_0000001783_ARCHIVED |15-years old any alcoholic beverage consumed in past 30 days, (%) |EN | |W12_imports_dutyfree_B |Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale |EN | |W13_ind_liability_C |Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry |EN | |W14_harm_effects_B |Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health? |EN | |W4_pc_back_B |Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging |EN | |SA_0000001823_ARCHIVED |Alcohol, tourist consumption (in litres of pure alcohol) |EN | |SA_0000001824 |Alcohol, regional alcohol per capita (15+) consumption (in litres of pure alcohol) |EN | |SA_0000001827 |Regional prevalence, AAFs (15+), cancer |EN | |SA_0000001829 |Average price 500 mls Beer in US\) | EN |
| SA_0000001830 | Average price 750 mls Wine in US$ | EN |
| sba5 | Births attended by skilled health personnel (in the five years preceding the survey) (%) | EN |
| SDGAIRBODA | Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized) | EN |
| SDGCONFLICT | Estimated direct deaths from major conflicts (per 100 000 population) | EN |
| SDGHIV | New HIV infections (per 1000 uninfected population) | EN |
| W16_number_hw_B | How many health warnings are approved by the law for other smoked tobacco packaging? | EN |
| W16_number_hw_C | How many health warnings are approved by the law for smokeless tobacco packaging? | EN |
| W18_misleading_terms_C | Ban on deceitful terms on smokeless tobacco packaging | EN |
| W19_colours_numbers_B | Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors | EN |
| SA_0000001787 | 13-15-years old first drink before age 14, (%) | EN |
| SA_0000001788 | Alcohol-related road traffic crashes with fatalities, per 100,000 population | EN |
| SA_0000001788_ARCHIVED | Alcohol-related road traffic crashes with fatalities, per 100,000 population | EN |
| SA_0000001789_ARCHIVED | Alcohol-related crimes (% of all crimes) | EN |
| SA_0000001792 | National legislation to prevent illegal alcohol sales | EN |
| SA_0000001796 | Licensing required for wholesale/distribution of alcoholic beverages | EN |
| SA_0000001798 | Licenses issued for retail sale, change since 2010 | EN |
| SA_0000001801 | Monopoly on imports of alcoholic beverages | EN |
| SA_0000001803 | Health warning labels on pregnancy | EN |
| W19_colours_numbers_C | Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors | EN |
| W2_pc_front_back_C | Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging | EN |
| W21_emissions_A | Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | EN |
| W22_emissions_qual_A | Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions | EN |
| W23_emissions_front_back_A | Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas | EN |
| W23_emissions_front_back_B | Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas | EN |
| W24_exp_date_B | Other smoked tobacco packaging and labelling must not display expiry dates | EN |
| W26_plain_packaging_A | Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | EN |
| SDGMALARIA | Malaria incidence (per 1 000 population at risk) | EN |
| WSH_2 | Water, sanitation and hygiene attributable deaths (’000) in children under 5 years | EN |
| WSH_30_WAT | Number of diarrhoea DALYs from inadequate water | EN |
| SDGAIRBOD | Ambient and household air pollution attributable death rate (per 100 000 population) | EN |
| WSH_4 | Water, sanitation and hygiene attributable deaths per 100’000 children under 5 years | EN |
| WSH_SANITATION_SAFELY_MANAGED | Population using safely managed sanitation services (%) | EN |
| VIOLENCE_EXTENTIMP_CHILDPROTECTION | Extent of implementation of child protection services | EN |
| VIOLENCE_EXTENTIMP_ELDERCAREGIVER | Elder abuse: Extent of implementation of caregiver-support programmes | EN |
| VIOLENCE_EXTENTIMP_PARTNERVIOLPREVENTION | Intimate partner violence: Extent of implementation of dating violence prevention programmes | EN |
| vita | Children aged 6-59 months who received vitamin A supplementation (%) | EN |
| W1_HW_law_B | Law mandates that health warnings appear on other smoked tobacco packages | EN |
| W1_HW_law_C | Law mandates that health warnings appear on smokeless tobacco packages | EN |
| W12_imports_dutyfree_C | Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale | EN |
| W16_number_hw_A | How many health warnings are approved by the law for cigarette packaging? | EN |
| W19_colours_numbers_A | Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors | EN |
| W2_pc_front_back_A | Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging | EN |
| SA_0000001789 | Alcohol-related crimes (% of all crimes) | EN |
| SA_0000001794 | Licensing required for exports of alcoholic beverages | EN |
| SA_0000001800 | Monopoly on exports of alcoholic beverages | EN |
| SA_0000001805 | Health warning labels on drink-driving | EN |
| SA_0000001808 | Alcohol-attributable fractions (15+), cancer deaths | EN |
| SA_0000001812 | Report with data from health services on alcohol use and AUDs | EN |
| SA_0000001814 | Taxation of ethanol production | EN |
| W20_flavours_B | Other smoked tobacco packaging and labelling must not use descriptors depicting flavours | EN |
| W21_emissions_quant_C | Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | EN |
| W23_emissions_front_back_C | Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas | EN |
| W26_plain_packaging_C | Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | EN |
| W27_smokeless_prod_ban | The sale of all smokeless tobacco products is completely banned | EN |
| W3_pc_front_B | Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging | EN |
| W4_pc_back_A | Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging | EN |
| W5_top_side_A | Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package | EN |
| SA_0000001816 | Tax incentives for production low/no alcohol content beer | EN |
| SA_0000001817 | Tax incentives for production of other alcoholic beverages | EN |
| SA_0000001819 | Heavy episodic drinking (youth 15 -19 years) past 30 days (%) | EN |
| SA_0000001821 | Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI | EN |
| SA_0000001823 | Alcohol, tourist consumption (in litres of pure alcohol) | EN |
| SDGDISASTER | Average death rate due to natural disasters (per 100 000 population) | EN |
| SDGHEPHBSAGPRV | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | EN |
| SDGHPVRECEIVED | HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%) | EN |
| SDGIHR | Average of 13 International Health Regulations core capacity scores | EN |
| SDGNTDTREATMENT | Reported number of people requiring interventions against NTDs | EN |
| SDGODA | Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US\(), by recipient |EN | |SDGSUICIDE |Crude suicide rates (per 100 000 population) |EN | |W6_font_B |Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging? |EN | |W8_princ_langs_C |Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country? |EN | |W9_no_obscure_A |Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps |EN | |SDGCODCOMPLETENESS |Completeness of cause-of-death data (%) |EN | |SDGHIV1524 |New HIV infections among adults 15-24 years old (per 1000 uninfected population) |EN | |SDGODA01 |Total net official development assistance to medical research and basic health sectors per capita (US\)), by recipient country | EN |
| WSH_8 | Water, sanitation and hygiene attributable DALYs per 100’000 children under 5 years | EN |
| WSH_WATER_BASIC | Population using at least basic drinking-water services (%) | EN |
| SDGODA02 | Official development assistance for medical research and basic health sectors as a percentage of GNI (%), by donor country | EN |
| SDGPOISON | Mortality rate attributed to unintentional poisoning (per 100 000 population) | EN |
| SDGROADAGE | Age-standardized road traffic mortality (per 100 000 population) | EN |
| SDGSHP | Skilled health professionals density (per 10 000 population) | EN |
| WSH_20_SAN | Attributable fraction of diarrhoea to inadequate sanitation | EN |
| WSH_3 | Water, sanitation and hygiene attributable deaths per 100’000 capita | EN |
| WSH_30_HYG | Number of diarrhoea DALYs from inadequate hygiene | EN |
| wast5 | Wasting prevalence in children aged < 5 years (%) | EN |
| WHOSIS_000003 | Neonatal mortality rate (per 1000 live births) | EN |
| WHOSIS_000006 | Infants exclusively breastfed for the first six months of life (%) | EN |
| SE_LSC_RDNG | Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%) | EN |
| SDGOOP | Out-of-pocket expenditure as a percentage of total expenditure on health | EN |
| SDGPM25 | Concentrations of fine particulate matter (PM2.5) | EN |
| SE_DEV_ONTRK | Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%) | EN |
| WSH_5 | Water, sanitation and hygiene attributable DALYs (’000) | EN |
| WSH_6 | Water, sanitation and hygiene attributable DALYs (’000) in children under 5 years | EN |
| WSH_7 | Water, sanitation and hygiene attributable DALYs per 100’000 capita | EN |
| WSH_SANITATION_BASIC | Population using at least basic sanitation services (%) | EN |
| WSH_WATER_SAFELY_MANAGED | Population using safely managed drinking-water services (%) | EN |
| SHS_10 | Second-hand smoke attributable DALYs (’000) in children under 5 years | EN |
| SHS_11 | Second-hand smoke attributable DALYs per 100’000 children under 5 years | EN |
| SE_G23_MATH | Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%) | EN |
| SG_DMK_SRCR_FN_ZS | Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care (%) | EN |
| W6_font_C | Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging? | EN |
| W7_rotation_B | Are the health warnings on other smoked tobacco packaging rotating? | EN |
| W7_rotation_C | Are the health warnings on smokeless tobacco packaging rotating? | EN |
| W8_princ_langs_A | Are the health warnings on cigarette packaging written in the principal language(s) of the country? | EN |
| SHS_5 | Second-hand smoke attributable DALYs (’000) | EN |
| SHS_7 | Second-hand smoke attributable DALYs per 100’000 capita | EN |
| stunt3 | Stunting prevalence in children aged < 3 years (%) | EN |
| stunt5 | Stunting prevalence in children aged < 5 years (%) | EN |
| W8_princ_langs_B | Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country? | EN |
| W9_no_obscure_C | Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps | EN |
| wast3 | Wasting prevalence in children aged < 3 years (%) | EN |
| WHOSIS_000002 | Healthy life expectancy (HALE) at birth (years) | EN |
| WHOSIS_000005 | Low-birth-weight newborns (%) | EN |
| TB_1 | Tuberculosis treatment coverage | EN |
| TB_c_dst_rlt_ret_pct | Previously treated cases tested for RR-/MDR-TB (%) | EN |
| TB_c_lab_cul_5m | Laboratories providing tuberculosis diagnostic services using culture (per 5 million population) | EN |
| TB_c_lab_dst_5m | Laboratories providing drug susceptibility testing (DST) (per 5 million population) | EN |
| TB_c_mdr_tx | Cases started on MDR-TB treatment | EN |
| WHOSIS_000001 | Life expectancy at birth (years) | EN |
| WHOSIS_000004 | Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) | EN |
| SG_REG_BRTH | Proportion of children under 5 years of age whose births have been registered with a civil authority | EN |
| TB_c_new_snep_tsr | Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases | EN |
| TB_c_newinc | Tuberculosis - new and relapse cases | EN |
| TB_e_inc_num | Number of incident tuberculosis cases | EN |
| TB_e_mort_exc_tbhiv_num | Number of deaths due to tuberculosis, excluding HIV | EN |
| SE_LSC_MATH | Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%) | EN |
| SE_PRE_PARTN | Participation rate in organized learning (one year before the official primary entry age) (%) | EN |
| SG_REG_CENSUS | Proportion of countries that have conducted at least one population and housing census in the last 10 years (%) | EN |
| SG_REG_CENSUSN | Number of countries that have conducted at least one population and housing census in the last 10 years | EN |
| SI_POV_DAY1 | Proportion of population below the international poverty line of US$1.90 per day (%) | EN |
| SH_STA_FGMS | Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%) | EN |
| SHS_1 | Percentage of children under 15 years exposed to second-hand smoke | EN |
| SHS_8 | Second-hand smoke attributable deaths (’000) in children under 5 years | EN |
| SHS_9 | Second-hand smoke attributable deaths per 100’000 children under 5 years | EN |
| SUNBEDEXISTSUBNATIONAL | Existence of subnational regulation | EN |
| SUNBEDREG_CONTROL | Restriction and inspection of facilities | EN |
| SI_POV_EMP1 | Employed population below the international poverty line of US\(1.90 per day (the working poor) (%) |EN | |SP_DYN_MRBF15 |Proportion of women aged 20-24 years who were married or in a union by age 15 (%) |EN | |SUNBEDEXIST |Existence of national regulation |EN | |SUNBEDREG_SAFETY |Safety requirements |EN | |TB_c_lab_sm_100k |Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population) |EN | |TB_c_notified |Total number of notified TB cases |EN | |TB_c_ret_tsr |Treatment success rate: previously treated TB cases |EN | |TB_c_xdr_tsr |Treatment success rate: XDR-TB cases |EN | |TB_conf_mdr_tx_pct |Confirmed cases of MDR-TB started treatment for MDR-TB (%) |EN | |TB_e_inc_tbhiv_num |Number of incident tuberculosis cases, (HIV-positive cases) |EN | |TB_c_mdr_tsr |Treatment success rate for patients treated for MDR-TB (%) |EN | |W4_pc_back_C |Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging |EN | |W5_top_side_B |Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package |EN | |W5_top_side_C |Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package |EN | |W6_font_A |Does the law mandate font style, font size and colour of health warnings on cigarette packaging? |EN | |SA_0000001820 |Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%) |EN | |SA_0000001822_ARCHIVED |Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI |EN | |SA_0000001825 |Regional prevalence, AAFs (15+), liver cirrhosis deaths (%) |EN | |SA_0000001828 |Regional prevalence, AAFs ,all-cause deaths (%) |EN | |sba |Births attended by skilled health personnel (in the two or three years preceding the survey) (%) |EN | |SDG_SH_DTH_RNCOM |Number of deaths attributed to non-communicable diseases, by type of disease and sex |EN | |SDG_SH_STA_SCIDEN |Number of suicide deaths |EN | |WSH_30_SAN |Number of diarrhoea DALYs from inadequate sanitation |EN | |WSH_HYGIENE_BASIC |Population with basic handwashing facilities at home (%) |EN | |WSH_SANITATION_OD |Population practising open defecation (%) |EN | |SDGTOBACCO |Age-standardized prevalence of current tobacco smoking among persons aged 15 years and older |EN | |SDGWSHBOD |Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2) |EN | |SE_G23_RDG |Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%) |EN | |W7_rotation_A |Are the health warnings on cigarette packaging rotating? |EN | |W9_no_obscure_B |Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps |EN | |WHOSIS_000007 |Healthy life expectancy (HALE) at age 60 (years) |EN | |SE_PRM_MATH |Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%) |EN | |SE_PRM_RDNG |Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%) |EN | |SHS_2 |Percentage of women (15+ years) exposed to second-hand smoke |EN | |SHS_3 |Percentage of men (15+ years) exposed to second-hand smoke |EN | |SHS_4 |Second-hand smoke attributable deaths |EN | |SHS_6 |Second-hand smoke attributable deaths per 100'000 capita |EN | |SP_DYN_MRBF18 |Proportion of women aged 20-24 years who were married or in a union by age 18 (%) |EN | |SUNBEDEXISTYEAR |Year of national implementation of regulation |EN | |SUNBEDREG_ACCESS |Access restrictions |EN | |SUNBEDREG_INFO |Information requirements |EN | |SUNBEDREG_TRAINING |Training requirements |EN | |TB_c_dst_rlt_new_pct |New cases tested for RR-/MDR-TB (%) |EN | |TB_c_new_tsr |Treatment success rate: new TB cases |EN | |TB_c_tbhiv_tsr |Treatment success rate: HIV-positive TB cases |EN | |TB_e_inc_num_014 |Number of incident tuberculosis cases in children aged 0 - 14 |EN | |TB_e_inc_tbhiv_100k |Incidence of tuberculosis (per 100 000 population) (HIV-positive cases) |EN | |GDO_q8x3_1 |Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x3_6 |Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x4_1 |Majority provider of diagnostic services in community for dementia [public, private] |EN | |GDO_q8x3_3 |Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x3_4 |Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] |EN | |GDO_q8x4_3 |Majority provider of psychosocial and rehabilitation services in community for dementia [public, private] |EN | |GDO_q8x5_2 |Estimated number of people receiving behaviour and psychological management services in community for dementia |EN | |GDO_q8x5_5 |Estimated number of people receiving palliative and end-of-life care services in community for dementia |EN | |GDO_q9_6 |Outpatient social centres |EN | |GDO_q9x2_5 |Estimated percentage of residential long-term care facilities following national dementia standards |EN | |GDO_q8x5_4 |Estimated number of people receiving activities of daily living support services in community for dementia |EN | |GDO_q8x5_6 |Estimated number of people with dementia receiving social and financial protection for dementia |EN | |GDO_q9_2 |Care facilities [long-term care] |EN | |GDO_q9_4 |Adult day centres |EN | |GDO_q9x1_4 |Geriatric-specific hospital beds (per 10,000 population) |EN | |GDO_q9x2_3 |Dementia-specific residential long-term care beds (per 10,000 population) |EN | |GDO_q9x2_4 |Estimated number of people with dementia living in residential long-term care |EN | |GDO_q9x5_1 |Density of outpatient health centres (per 100,000 population) |EN | |GDO_q9x4_1 |Density of adult day centres (per 100,000 population) |EN | |GDO_q9x4_3 |Dementia-specific adult day centre places (per 10,000 population) |EN | |GDO_q9x6_2 |Estimated number of people with dementia receiving services at outpatient social centre |EN | |GHED_CHE_pc_US_SHA2011 |Current health expenditure (CHE) per capita in US\) | EN |
| GHED_CHEGDP_SHA2011 | Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%) | EN |
| TB_e_mdr_num | Estimated MDR-TB cases among notified pulmonary TB cases | EN |
| TB_e_prev_num | Number of prevalent tuberculosis cases | EN |
| GDO_q9_1 | Dementia care facilities [hospitals] | EN |
| GDO_q9_3 | Care facilities [hospice centres] | EN |
| GDO_q9_5 | Outpatient health centres | EN |
| GDO_q9x1_3 | Dementia-specific hospital beds (per 10,000 population) | EN |
| GDO_q9x1_5 | Total dementia hospital admissions (per 100,000) | EN |
| GDO_q9x1_7 | Estimated percentage of hospitals following national dementia standards | EN |
| GDO_q9x2_1 | Density of residential long-term care facilities (per 100,000 population) | EN |
| GDO_q9x4_2 | Adult day centre places (per 10,000 population) | EN |
| GDO_q9x6_1 | Density of outpatient social centres (per 100,000 population) | EN |
| GHE_YLLNUM | Years of life lost from mortality (YLLs) | EN |
| GHE_YLLRATE | Years of life lost from mortality (YLLs) (per 100 000 population) | EN |
| GHED_CHE_pc_PPP_SHA2011 | Current health expenditure (CHE) per capita in PPP int$ | EN |
| GHED_EXT_pc_PPP_SHA2011 | External health expenditure (EXT) per capita in PPP int$ | EN |
| GHED_PVT-D_pc_PPP_SHA2011 | Domestic private health expenditure (PVT-D) per capita in PPP int$ | EN |
| GOE_Q007 | Public funding for eHealth | EN |
| GOE_Q011 | Strategy implementation funding available for eHealth | EN |
| GOE_Q014 | Proportion of donor/non public development funding | EN |
| GHED_EXTCHE_SHA2011 | External health expenditure (EXT) as percentage of current health expenditure (CHE) (%) | EN |
| GHED_GGHE-DCHE_SHA2011 | Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%) | EN |
| GHED_OOPSCHE_SHA2011 | Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%) | EN |
| GDO_q9x5_2 | Estimated number of people with dementia receiving services at outpatient health centre | EN |
| GHE_YLDNUM | Years of healthy life lost due to disability (YLDs) | EN |
| GHED_EXT_pc_US_SHA2011 | External health expenditure (EXT) per capita in US$ | EN |
| GOE_Q030_3 | Providing guidance on privacy and security | EN |
| GOE_Q030_4 | Providing oversight and enforcement of data ownership | EN |
| GOE_Q058 | Infrastructure | EN |
| GOE_Q059 | Funding | EN |
| GOE_Q061 | Cost-effectiveness | EN |
| GOE_Q063 | Legal | EN |
| GOE_Q069 | Country has telehealth policy or strategy | EN |
| GOE_Q070 | Strategy includes objectives as to how telehealth contributes to UHC | EN |
| GOE_Q081 | Evaluation of any government-sponsored telehealth programmes | EN |
| GOE_Q104_2 | Improving access to content and experts | EN |
| GOE_Q104_3 | Enabling access to education where learning facilities are limited | EN |
| GOE_Q118 | eLearning used for in-service training of health professionals | EN |
| GOE_Q120 | eLearning courses accredited by continuing medical education or professional licensing bodies | EN |
| GOE_Q132 | Lack of infrastructure | EN |
| GOE_Q001 | National universal health coverage strategy | EN |
| GOE_Q003 | National eHealth strategy | EN |
| GOE_Q006 | National health information system (HIS) policy or strategy | EN |
| GOE_Q008 | Private funding for eHealth | EN |
| GOE_Q009 | Donor/ non-public development funding for eHealth | EN |
| GOE_Q017 | Government-supported health internet sites provide information in multiple languages | EN |
| GHED_GGHE-D_pc_US_SHA2011 | Domestic general government health expenditure (GGHE-D) per capita in US$ | EN |
| GHED_GGHE-DGGE_SHA2011 | Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%) | EN |
| GHED_PVT-DCHE_SHA2011 | Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%) | EN |
| GOE_Q153 | Lack of capacity | EN |
| GOE_Q155 | Lack of funding | EN |
| GOE_Q156 | lack of evidence showing effectiveness of EHR | EN |
| GOE_Q157 | Lack of evidence showing cost-effectiveness or EHR | EN |
| GOE_Q028 | mHealth programmes are sponsored by government | EN |
| GOE_Q031 | Regulatory oversight of mobile apps for quality, safety and reliability | EN |
| GOE_Q047 | Government-sponsored mHealth programmes are being evaluated | EN |
| GOE_Q065 | Priorities | EN |
| GOE_Q103 | eLearning is used in pre-service education to teach health sciences students | EN |
| GOE_Q002 | strategy refers to the use of ICT to support UHC | EN |
| GOE_Q004 | National eHealth strategy refers to objectives of UHC | EN |
| GOE_Q013 | Proportion of private funding | EN |
| GOE_Q018 | Tertiary institutions provide students of health sciences with training on eHealth | EN |
| GOE_Q022 | Institutions offer in-service training to health professionals on ICT for health | EN |
| GOE_Q030_2 | Promoting standards and interoperability | EN |
| GOE_Q030_5 | Promoting the development and adoption of mHealth | EN |
| GOE_Q032 | Providing incentives and guidance for innovation research and evaluation of health | EN |
| GOE_Q057 | Capacity | EN |
| GOE_Q171 | To protect the privacy of individuals’ health-related data held in electronic format as an EHR | EN |
| GOE_Q104_1 | Reducing cost of delivering content | EN |
| GOE_Q119_2 | Improving access to content and experts | EN |
| GOE_Q133 | Lack of funding | EN |
| GOE_Q135 | Lack of evidence that eLearning is effective | EN |
| GOE_Q137 | Lack of demand for eLearning programmes | EN |
| GOE_Q140 | Competing educational priorities | EN |
| GOE_Q159 | Lack of legislation or regulations covering use of EHR | EN |
| GOE_Q162 | Competing health system priorities | EN |
| GOE_Q170 | To protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format | EN |
| GOE_Q174 | Which allows for the sharing of personal and health data between research entities | EN |
| GOE_Q109 | Pre-service eLearning programmes have been evaluated | EN |
| GOE_Q119_1 | Reducing cost of delivering content | EN |
| GOE_Q122 | eLearning programmes for in-service training of health professionals have been evaluated | EN |
| GOE_Q131 | Lack of capacity | EN |
| GOE_Q138 | Lack of suitable courses available | EN |
| GOE_Q139 | Insitutional educational policy does not include eLearning as an approach to teaching health sciences | EN |
| GOE_Q144 | Country has national EHR | EN |
| GOE_Q146 | Country has specific legislation governing the use of national EHR system | EN |
| GOE_Q154 | Lack of infrastructure | EN |
| GOE_Q160 | National strategy does not promote the adoption of EHR | EN |
| GOE_Q178 | Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice | EN |
| GOE_Q181 | Country has national policy or strategy on the use of social media by government organizations | EN |
| GOE_Q201 | Privacy and security laws need to be in place | EN |
| GOE_Q202 | Research into new analytical methods needs occur to meet the challenges of working with big data | EN |
| GOE_Q203 | Lack of integration between various health services | EN |
| GOE_Q176 | Which allows individuals to demand that their own data be corrected when held in an EHR if it is known to be inaccurate | EN |
| GOE_Q173 | Which governs the sharing of digital data between health professionals in health services in other countries through the use of an EHR | EN |
| GOE_Q175 | Which allows individuals electronic access to their own health-related data when held in an EHR | EN |
| GOE_Q177 | Which allows individuals to demand the deletion of health-related data from their EHR | EN |
| GOE_Q198 | Effective standards and best practices for data capture not fully established | EN |
| HIV_0000000009 | Reported number of people receiving antiretroviral therapy | EN |
| HCF_REL_ELECTRICITY | Percentage of health-care facilities with reliable electricity supply (%) | EN |
| HIV_0000000007 | Testing and counselling facilities, reported number | EN |
| HIV_0000000008 | Testing and counselling facilities, estimated number per 100 000 adult population | EN |
| GOE_Q199 | Insufficient incentives for data sharing | EN |
| HCF_NO_ELECTRICITY | Percentage of health-care facilities with no access to any electricity supply (%) | EN |
| HIV_0000000006 | Number of people dying from HIV-related causes | EN |
| HIV_0000000011 | Reported number of children receiving antiretroviral therapy | EN |
| HRH_05 | Number of pharmaceutical technicians/assistants | EN |
| HIV_0000000012 | Reported number of children receiving antiretroviral therapy, month and year of report | EN |
| HIV_0000000020 | Estimated number of pregnant women living with HIV | EN |
| HIV_0000000021 | Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission | EN |
| HIV_0000000023 | Estimated number of children needing antiretroviral therapy based on WHO methods | EN |
| HIV_0000000024 | Estimated antiretroviral therapy coverage among children | EN |
| HIV_ARTCOVERAGE | Estimated antiretroviral therapy coverage among people living with HIV (%) | EN |
| HRH_01 | Number of nursing personnel | EN |
| HRH_02 | Number of physicians | EN |
| HRH_03 | Number of midwifery personnel | EN |
| HIV_0000000015 | Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission | EN |
| HIV_0000000016 | Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission, reporting period | EN |
| HIV_0000000022 | Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines | EN |
| HIV_0000000025 | Testing and counselling facilities, reporting period | EN |
| HRH_04 | Number of pharmacists | EN |
| HRH_08 | Number of radiographers | EN |
| HRH_09 | Number of other health workers | EN |
| HRH_13 | Number of laboratory scientists | EN |
| HRH_15 | Number of dentists | EN |
| HRH_18 | Number of personal care workers | EN |
| HRH_33 | Nursing and midwifery personnel density (per 1000 population) | EN |
| HSS_COMPREHENSIVEHEALTHPOLICY | Countries that have a comprehensive national health sector policy/ strategy/ plan with goals and targets updated within the last 5 years | EN |
| HWF_0004 | Specialist medical practitioners (number) | EN |
| HWF_0006 | Nursing and midwifery personnel (per 10,000) | EN |
| HWF_0008 | Nursing personnel (number) | EN |
| HWF_0016 | Pharmaceutical Technicians and Assistants (number) | EN |
| HWF_0021 | Physiotherapists (number) | EN |
| HWF_0022 | Physiotherapy Technicians and Assistants (number) | EN |
| HWWS_1 | Handwashing with soap after using the toilet (%) | EN |
| IHR01 | Legislation | EN |
| HRH_10 | Number of dental technicians/assistants | EN |
| HRH_11 | Number of health management & support workers | EN |
| HRH_12 | Number of environment and public health workers | EN |
| HRH_14 | Number of laboratory technicians/assistants | EN |
| HRH_19 | Number of pharmaceutical personnel | EN |
| HRH_16 | Number of traditional medicine practitioners | EN |
| HRH_17 | Number of medical assistants | EN |
| HRH_20 | Number of laboratory health workers | EN |
| HRH_21 | Number of dentistry personnel | EN |
| HRH_22 | Number of community and traditional health workers | EN |
| HRH_23 | Number of other health workers | EN |
| HRH_24 | Number of nursing and midwifery personnel | EN |
| HRH_28 | Dentistry personnel density (per 1000 population) | EN |
| HRH_29 | Community and traditional health workers density (per 1000 population) | EN |
| IHR04 | Response | EN |
| IHR10 | Zoonosis | EN |
| IR_CARBAMATE_PRESENCE | Carbamate resistance reported for at least one site | EN |
| IR_PYRETHROID_PRESENCE | Pyrethroid resistance reported for at least one site | EN |
| HRH_26 | Physicians density (per 1000 population) | EN |
| HRH_27 | Laboratory health workers density (per 1000 population) | EN |
| HRH_30 | Other health workers density (per 1000 population) | EN |
| HRH_31 | Environmental and public health workers density (per 1000 population) | EN |
| HRH_32 | Health management & support workers density (per 1000 population) | EN |
| HRH_40 | Biomedical engineers density (per 10 000 population) | EN |
| HRH_41 | Number of licensed qualified surgeons actively working | EN |
| HRH_42 | Number of licensed qualified obstetricians actively working | EN |
| HRH_44 | Number of biomedical engineers | EN |
| ITU_IDI_RANK | ICT Development Index (IDI) rank | EN |
| LEAD_3 | Percentage of the adults (15+ years) with blood lead levels above 5ug/dl | EN |
| LEAD_5 | Lead attributable deaths | EN |
| HWF_0013 | Dental Prosthetic Technicians (number) | EN |
| HWF_0015 | Pharmacists (number) | EN |
| HWF_0019 | Medical and Pathology Laboratory scientists (number) | EN |
| HWF_0020 | Medical and Pathology Laboratory Technicians (number) | EN |
| HWF_0024 | Community Health Workers (number) | EN |
| IHR05 | Preparedness | EN |
| IR_CARBAMATE_EXTENT | Percentage of sites for which carbamate resistance was reported | EN |
| IR_INSECTICIDERESISTANCE_PREV | Number of insecticide classes to which resistance was reported | EN |
| ITU_ICT_1 | Percentage of individuals using the Internet | EN |
| HRH_46 | Number of biomedical technicians | EN |
| HWF_0001 | Medical doctors (per 10,000) | EN |
| HWF_0002 | Medical doctors (number) | EN |
| HWF_0007 | Nursing and midwifery personnel (number) | EN |
| ITU_ICT_2 | Mobile-cellular telephone subscriptions per 100 inhabitants | EN |
| ITU_IDI | ICT Development Index (IDI) | EN |
| LEAD_4 | Percentage of the adults (15+ years) with blood lead levels above 10ug/dl | EN |
| LEAD_6 | Lead attributable DALYs (’000) | EN |
| LEAD_9 | Lead attributable DALYs (’000) in children under 5 years | EN |
| HWF_0010 | Dentists (per 10,000) | EN |
| HWF_0014 | Pharmacists (per 10,000) | EN |
| HWF_0018 | Environmental and Occupational Health Inspectors and Associates (number) | EN |
| HWF_0023 | Traditional and Complementary Medicine Professionals (number) | EN |
| HWWS_2 | Handwashing with soap after cleaning child’s stool (%) | EN |
| IHR02 | Coordination | EN |
| IHR06 | Risk communication | EN |
| IHR08 | Laboratory | EN |
| IHR11 | Food safety | EN |
| IHR13 | Radionuclear | EN |
| imr | Infant mortality rate (deaths per 1000 live births) | EN |
| IR_ORGANOCHLORINE_EXTENT | Percentage of sites for which organochlorine resistance was reported | EN |
| IR_ORGANOPHOSPHATE_EXTENT | Percentage of sites for which organophosphate resistance was reported | EN |
| IR_ORGANOPHOSPHATE_PRESENCE | Organophosphate resistance reported for at least one site | EN |
| IR_PYRETHROID_EXTENT | Percentage of sites for which pyrethroid resistance was reported | EN |
| LEAD_10 | Lead attributable DALYs per 100’000 children under 5 years | EN |
| LEAD_2 | Percentage of the children under 15 years with blood lead levels above 10ug/dl | EN |
| LEAD_7 | Lead attributable deaths per 100’000 capita | EN |
| LEAD_8 | Lead attributable DALYs per 100’000 capita | EN |
| GDO_q9x2_2 | Residential long-term care beds (per 10 000 population) | EN |
| GDO_q9x3_1 | Density of hospice centres (per 100,000 population) | EN |
| GDO_q9x3_2 | Hospice centre beds (per 10 000 population) | EN |
| GDO_q9x3_3 | Dementia-specific hospice care beds (per 10,000 population) | EN |
| GHE_DALYNUM | Disability-adjusted life years (DALYs) | EN |
| GHE_DALYRATE | Disability-adjusted life years (DALYs) (per 100 000 population) | EN |
| GHE_YLDRATE | Years of healthy life lost due to disability (YLDs) (per 100 000 population) | EN |
| GHED_GGHE-D_pc_PPP_SHA2011 | Domestic general government health expenditure (GGHE-D) per capita in PPP int$ | EN |
| GHED_GGHE-DGDP_SHA2011 | Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%) | EN |
| GHED_OOP_pc_PPP_SHA2011 | Out-of-pocket expenditure (OOP) per capita in PPP int$ | EN |
| GHED_OOP_pc_US_SHA2011 | Out-of-pocket expenditure (OOP) per capita in US$ | EN |
| GHED_PVT-D_pc_US_SHA2011 | Domestic private health expenditure (PVT-D) per capita in US$ | EN |
| GOE_Q010 | Public-private partnerships for eHealth | EN |
| GOE_Q012 | Proportion of public funding | EN |
| GOE_Q015 | Proportion ofpublic private partnerships funding | EN |
| GOE_Q030_1 | Regulating mobile devices and software | EN |
| GOE_Q060 | Effectiveness | EN |
| GOE_Q062 | Demand | EN |
| GOE_Q064 | Policy | EN |
| GOE_Q119_3 | Enabling access to education where learning facilities are limited | EN |
| GOE_Q134 | Not possible to gain a health sciences degree entirely through eLearning | EN |
| GOE_Q136 | Lack of evidence over cost-effectiveness | EN |
| LEPTO_DALY | Disability-adjusted life years (DALYs) due to leptospirosis | EN |
| LEPTO_DALY100K | Disability-adjusted life years (DALYs) (per 100 000 population) due to leptospirosis | EN |
| LEPTO_MORBIDITY | Estimated leptospirosis incidence (per 100 000 population) | EN |
| LIFE_0000000032 | ndx - number of people dying between ages x and x+n | EN |
| LEPTO_YLL100K | Years of life lost (YLLs) (per 100 000 population) due to leptospirosis | EN |
| LIFE_0000000029 | nMx - age-specific death rate between ages x and x+n | EN |
| LIFE_0000000034 | Tx - person-years lived above age x | EN |
| LIFE_0000000035 | ex - expectation of life at age x | EN |
| M_def_1_prev_youth | Youth indicator 1 rate | EN |
| M_def_1_text_adult | Adult indicator 1 definition | EN |
| LEPTO_YLD100K | Years of healthy life lost to disability (YLDs) (per 100 000 population) due to leptospirosis | EN |
| M_def_1_text_youth | Youth indicator 1 definition | EN |
| M_def_2_prev_adult | Adult indicator 2 rate | EN |
| M_Est_cig_curr_crude | Current cigarette smoking, crude adjusted | EN |
| M_Est_cig_daily | Estimate of daily cigarette smoking prevalence (%) | EN |
| M_smkless_age_range_youth | Youth survey age range - smokeless | EN |
| M_Est_tob_daily | Estimate of daily tobacco use prevalence (%) | EN |
| M_Est_tob_daily_crude | Daily tobacco smoking, crude adjusted | EN |
| M_Group | Monitoring tobacco use and prevention policies | EN |
| M_smkless_age_range_adult | Adult survey age range - smokeless | EN |
| M_smkless_def_text_adult | Adult smokeless tobacco use indicator definition | EN |
| M_smkless_def_text_youth | Youth smokeless tobacco use indicator definition | EN |
| M_smkless_survey_title_youth | Name of survey of youth - smokeless | EN |
| M_smkless_svy_yr_adult | Year of survey of adults - smokeless | EN |
| M_survey_title_youth | Name of survey of youth | EN |
| M_svy_national_adult | Representativeness of survey of adults | EN |
| CARE_SOURCE | Care-seeking by type of patient and source of care (%) | EN |
| FOODBORNE_DTH_GE5 | Foodborne deaths, aged 5 years and above | EN |
| M_smkless_svy_national_youth | Representativeness of survey of youth - smokeless | EN |
| M_survey_title_adult | Name of survey of adults | EN |
| M_svy_national_youth | Representativeness of youth survey | EN |
| M_svy_yr_adult | Year of latest adult prevalence survey | EN |
| RADON_Q501_1 | Reference level for dwellings (Bq/m3) | EN |
| FINPROTECTION_IMP_P_215_LEVEL_SH | Total population pushed further below the $2.15 a day poverty line by household health expenditures (%, regional, global) | EN |
| M_def_2_prev_youth | Youth indicator 2 rate | EN |
| M_def_2_text_adult | Adult indicator 2 definition | EN |
| M_def_2_text_youth | Youth indicator 2 definition | EN |
| M_Est_tob_curr | Estimate of current tobacco use prevalence (%) | EN |
| M_smkless_prev_adult | Adult smokeless tobacco use indicator rate | EN |
| M_smkless_prev_youth | Youth smokeless tobacco use indicator rate | EN |
| M_smkless_survey_title_adult | Name of survey of adults - smokeless | EN |
| PRISON_D4_CARDIOVASC_DIAG_TOT | In-prison cardiovascular disease diagnosis (number of diagnoses) | EN |
| R_admin_unique_identifier | Tax administration - Unique identifier | EN |
| Yth_nonsmoked_svy_yr | Year of latest youth prevalence survey (nonsmoked) | EN |
| STI_GONORRHOEA_PREVALENCE_PER100 | Prevalence of gonorrhoea in individuals (%) | EN |
| O_Cytisine_sold | Cytisine - legally sold | EN |
| HEPB_HBSAG_CARRIER | Hepatitis B surface antigen (HBsAG) carriers (per 100 000 population) | EN |
| NCD_CCS_PA_GUIDELINES_OLDADULTS | Existence of national guidelines for physical activity for older adults | EN |
| IHRSPAR_CAPACITY13 | Radiation Emergencies | EN |
| PHE_HHAIR_POP_CATEGORY_FUELS | Population with primary reliance on fuels and technologies for cooking, by fuel type (in millions) | EN |
| M_svy_age_youth | Youth survey age range | EN |
| M_svy_yr_youth | Year of survey of youth | EN |
| NCD_CCS_ARB | General availability of Angiotensin II receptor blockers (ARBs) in the public health sector | EN |
| NUT_BF_EIBF | Early Initiation of Breastfeeding, Children born in the last 24 months | EN |
| NCD_CCS_MORT_TARGET | Existence of a national target on NCD mortality | EN |
| PRISON_D4_HIV_DIAG_TOT | In-prison HIV diagnosis (number of diagnoses) | EN |
| NCD_CCS_PA_SVY | Has conducted a recent, national adult risk factor survey covering physical inactivity | EN |
| NCD_CCS_PA_POL_WALKBIKE | Existence of policy promoting physical activity: walking and cycling | EN |
| MALARIA_IMPORTED | Number of imported malaria cases | EN |
| R_earmarking | Reported use of earmarked tobacco taxes | EN |
| Rev_import | Tobacco tax revenues - import duties | EN |
| TB_ps_prev_bc_100k_sp | Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population | EN |
| IHRSPAR_CAPACITY03 | Zoonotic Events and the Human-animal Interface | EN |
| NCD_CCS_TOB_SVY | Has conducted a recent, national adult risk factor survey covering tobacco use | EN |
| NUT_CF_ZVF | Zero vegetable or fruit consumption, 6-23 months | EN |
| E_compl_e14 | Compliance with ban on appearance of tobacco products in TV and/or films (score) | EN |
| bfearly | Early initiation of breastfeeding (in the two years preceding the survey) (%) | EN |
| FINPROTECTION_IMP_P310_LEVEL_MILLION | Total population pushed further below the $3.20 a day poverty line by household health expenditures (millions, regional, global) | EN |
| TB_cc_prct_Q5 | Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q5 (highest) income or expenditure quantile. | EN |
| FINPROTECTION_IMP_BNLFHU_FURIMP_HH | Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national) | EN |
| Yth_curr_cig_smoking | Prevalence of current cigarette smoking among adolescents (%) | EN |
| MALARIA_EST_DEATHS | Estimated number of malaria deaths | EN |
| SA_0000001836 | Alcohol-related road traffic deaths (% of all road traffic deaths) | EN |
| PRISON_B16_SUICIDERISK | In-prison standardized protocol for suicide | EN |
| E_compl_e10 | Compliance with ban on promotional discounts (score) | EN |
| ASSISTIVETECH_SOURCESOFAT | Sources of assistive products (%) | EN |
| MALARIA_PF_INDIG | Number of indigenous P. falciparum malaria cases | EN |
| FOODBORNE_DALY_100k_LT5 | Foodborne disability-adjusted life years per 100,000, aged less than 5 years | EN |
| PRISON_D4_MH_DIAG_TOT | In-prison mental disorder diagnosis (number of diagnoses) | EN |
| ORALHEALTH_UNTREATEDCARIESPERMANENT | Prevalence of untreated caries of permanent teeth in people 5+ years (%) | EN |
| MALARIA_EST_INCIDENCE | Estimated malaria incidence (per 1000 population at risk) | EN |
| E23_vending_machines | Ban on tobacco vending machines | EN |
| FINPROTECTION_IMP_P365_POP | Population pushed further below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban) | EN |
| AIR_71 | Ambient air pollution attributable DALYs in children under 15 years | EN |
| TAXBEV_TOTALTAXES | Total taxes on beverages (%) | EN |
| WHOSIS_000016 | Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) | EN |
| FINPROTECTION_IMP_P_365_LEVEL_MILLION | Total population pushed further below the $3.65 a day poverty line by household health expenditures (millions, regional, global) | EN |
| TB_notif_num | Number of people notified with new episode of TB in a given year | EN |
| Yth_nonsmoked_svy_title | Name of latest youth prevalence survey (nonsmoked) | EN |
| SDGHEALTHFACILITIESESSENTIALMEDS | Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis | EN |
| TB_cc_prct_Q1 | Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q1 (lowest) income or expenditure quantile. | EN |
| PRISON_B9_1_NURSES_RATIO | Nurses in prisons (FTEs per 1000 prisoners) | EN |
| FINPROTECTION_IMP_P_215_LEVEL_MILLION | Total population pushed further below the $2.15 a day poverty line by household health expenditures (millions, regional, global) | EN |
| FOODBORNE_ILL_TOTAL | Foodborne illnesses, all ages | EN |
| ASSISTIVETECH_Q06 | Workforce availability for assistive technology | EN |
| PRISON_D4_HEPB_DIAG_TOT | In-prison Hepatitis B diagnosis (number of diagnoses) | EN |
| PRISON_C16_LABTESTS | In-prison laboratory tests | EN |
| M2_adult_representative | Most recent survey among adults was representative of the national population | EN |
| SA_0000001833 | Alcohol-attributable DALYs per 100,000 people (age standardized) | EN |
| PRISON_F1_DRUGUSERS_TOT | In-prison people who use/have used drugs (number of prisoners, in the last 12 months) | EN |
| NCD_CCS_bone_marrow | General availability of bone marrow transplantation in the public health system | EN |
| PRISON_D4_MDRTB_DIAG_TOT | In-prison MDR-TB diagnosis (number of diagnoses) | EN |
| TAXBEV_PRICE | Beverage price | EN |
| NCD_CCS_CHOL_SVY | Has conducted a recent, national adult risk factor survey covering raised total cholesterol | EN |
| FOODBORNE_DALY_CASE_GE5 | Foodborne disability-adjusted life years per case, aged 5 years and above | EN |
| HEMOGLOBINLEVEL_PREGNANT_MEAN | Mean hemoglobin level of pregnant women (aged 15-49 years) | EN |
| RADON_Q202 | Existence of any subnational radon activity | EN |
| FOODBORNE_DALY_TOTAL | Foodborne disability-adjusted life years, all ages | EN |
| PRISON_D4_TB_DIAG_TOT | In-prison TB diagnosis (number of diagnoses) | EN |
| STI_CHLAMYDIA_PREVALENTCASES | Prevalent cases of chlamydia in individuals (in millions) | EN |
| TAXBEV_VATSALES | Value-added/sales tax on beverages (%) | EN |
| SDGIHR2021 | Average of 15 International Health Regulations core capacity scores, SPAR version, 2nd edition | EN |
| cpmowho | Contraceptive prevalence - use of modern methods (%) | EN |
| FOODBORNE_DALY_LT5 | Foodborne disability-adjusted life years, aged less than 5 years | EN |
| HAZARD_YLD_GE5 | Years lived with disability caused by hazards, aged 5 years and above | EN |
| STI_GONORRHOEA_INCIDENCE_PER1000 | Incident cases of gonorrhoea in individuals (per 1000) | EN |
| P_compl_p5 | Compliance with smoke-free indoor offices law (score) | EN |
| IHRSPAR_CAPACITY02 | IHR Coordination and National IHR Focal Point Functions | EN |
| MALARIA_MICR_TEST | Number of malaria suspects examined by microscopy | EN |
| HEMOGLOBINLEVEL_CHILDREN_MEAN | Mean hemoglobin level of children aged 6-59 months | EN |
| MALARIA_EST_CASES | Estimated number of malaria cases | EN |
| FOODBORNE_YLL_CASE_LT5 | Foodborne years of life lost per case, aged less than 5 years | EN |
| IHRSPAR_CAPACITY12 | Chemical Events | EN |
| TB_e_inc_rr_num | Estimated number of MDR/RR-TB incident cases | EN |
| Adult_curr_e-cig | Prevalence of current e-cigarette use among adults (%) | EN |
| FINPROTECTION_IMP_PRELPL_POP | Population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban) | EN |
| CCH_SURVEY_AGREEMENT_MOH_OTHERSECTORS | Agreement in place between the Ministry of Health and other sector(s) in relation to health and climate change policy or programs | EN |
| NCD_CCS_ALC_TARGET | Existence of a national target on alcohol | EN |
| FINPROTECTION_IMP_P310_POP | Population pushed further below the \(3.20 a day poverty line by household health expenditures (%, national, rural, urban) |EN | |TB_cc_prct_DRTB |Percentage of TB-affected households facing costs >20% of household income or expenditure due to DR-TB. |EN | |ORALHEALTH_SUGAR_AVAILABILITY |Per capita availability of refined sugar (g/day) |EN | |NLIS_NU_CA_114 |NLIS: Continued breastfeeding at 1 year in infants 12-15 months (%) |EN | |R_Price_lowest_cost_estimate |Cheapest brand of cigarettes - price in currency reported |EN | |CCH_SURVEY_PLAN_STRATEGY_DEVELOPED |National health and climate change plan or strategy developed |EN | |TB_notif_num_newrel_ep |Number of people diagnosed with new episode of pulmonary TB who have extrapulmonary TB. |EN | |IHRSPAR_CAPACITY08 |National Health Emergency Framework |EN | |E_compl_e6 |Compliance with ban on advertising at point of sale (score) |EN | |NCD_HYP_PREVALENCE_C |Prevalence of hypertension among adults aged 30-79 years, crude |EN | |GLASSAMC_GPW13_T4B |Target ≥60% of total antibiotic consumption being Access group antibiotics (GPW13 target 4b) |EN | |MALARIA_RDT_TEST |Number of malaria suspects examined by rapid diagnostic test (RDT) |EN | |TB_cc_prct_Q4 |Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q4 income or expenditure quantile. |EN | |NCD_CCS_TEL_HYDRO_COMBO |General availability of Fixed dose combination avail (telmisartan + hydrochlorothiazide) in the public health sector |EN | |CCH_SURVEY_MOH_FOCALPOINT |Designation of a focal point responsible for health and climate change within the Ministry of Health |EN | |TAXBEV_EARMARKEDEXCISETAX |Use of earmarked excise tax on beverages |EN | |CCH_SURVEY_MULTISTAKEHOLDER_MECHANISM_EXISTS |Existence of a multi-stakeholder mechanism on health and climate change |EN | |IHRSPAR_CAPACITY07 |Human Resources (SPAR) |EN | |PHE_HHAIR_POP_POLLUTING_FUELS |Population with primary reliance on polluting fuels and technologies for cooking (in millions) |EN | |ORALHEALTH_HWF_DENTALPROSTHETICTECH_10K |Dental prosthetic technicians (per 10 000 population) |EN | |IHRSPAR_CAPACITY06 |Surveillance (SPAR) |EN | |SA_0000001832 |Alcohol-attributable all-cause deaths per 100,000, age standardized |EN | |MALARIA_ITN_COVERAGE |Population with access to an insecticide-treated bed net (ITN) for malaria protection (%), modelled |EN | |Adult_curr_smokeless |Prevalence of current smokeless tobacco use among adults (%) |EN | |E22_subnational_authority_exists |Subnational bans on tobacco advertising, promotion and sponsorship authority exists |EN | |IHRSPAR_CAPACITY05 |Laboratory (SPAR) |EN | |STI_CHLAMYDIA_INCIDENCE_PER1000 |Incident cases of chlamydia in individuals (per 1000) |EN | |ASSISTIVETECH_SATISFACTIONACTIVITIES |Satisfaction with assistive products for different environments and activities (%) |EN | |NCD_CCS_BPmsmt |General availability of blood pressure measurement at the primary health care level |EN | |vbcg |BCG immunization coverage among one-year-olds (%) |EN | |NCD_CCS_FOOD_TAX |Existence of tax on foods high in fat, sugars or salt |EN | |NCD_CCS_BP_SVY |Has conducted a recent, national adult risk factor survey covering raised blood pressure/hypertension |EN | |uwgt5 |Underweight prevalence in children aged < 5 years (%) (Health inequality monitor) |EN | |CARE_SEEK |Care-seeking by type of patient and source of care (%) (see CARE_SOURCE) |EN | |ORALHEALTH_UHC_ADVANCE_CURATIVE |Oral health interventions as part of health benefit packages: Advanced curative oral health care |EN | |PRISON_D3_DEATHS_TOT |In-prison total deaths |EN | |TOB_R_PRICE |Retail price for tobacco and other nicotine products |EN | |R_admin_overt_marking |Tax administration - Marking is overt |EN | |R_afford_price_gap_decreased |Price gap decreased over the last two years |EN | |NCD_HYP_DIAGNOSIS_A |Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, age-standardized |EN | |R_afford_trend_growth_rate |Affordability - trend growth rate |EN | |HAZARD_ILL_LT5 |Illnesses caused by hazards, aged less than 5 years |EN | |Yth_daily_smokeless |Prevalence of daily smokeless tobacco use among adolescents (%) |EN | |ASSISTIVETECH_Q07 |Availability of education/training for assistive technology |EN | |MH_27 |Publication year of the policy or plan (latest revision) |EN | |NLIS_NU_CA_095 |NLIS: Minimum acceptable diet (MAD) in children 6-23 months (%) |EN | |FOODBORNE_DTH_100K_LT5 |Foodborne deaths per 100,000, aged less than 5 years |EN | |TAXBEV_EXCISE |Excise taxes on beverages (%) |EN | |HIV_0000000028 |Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population |EN | |NCD_CCS_EyePlan |Existence of operational policy/strategy/action plan for eye health |EN | |NCD_CCS_CANCER_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of cancer |EN | |TAXBEV_ABV |Alcohol content in beverage in percent of volume, (alcohol by volume) (ABV %) |EN | |MALARIA_INDIG |Number of indigenous malaria cases |EN | |GHE_YLD_NUMERIC |Years of healthy life lost due to disability (YLDs) |EN | |Adult_daily_smokeless |Prevalence of daily smokeless tobacco use among adults (%) |EN | |NCD_CCS_PA_POL_CHILDCARE |Existence of policy promoting physical activity: childcare settings |EN | |TAXBEV_OTHERTAXES |Other taxes on beverages (%) |EN | |MALARIA_CONF_CASES |Number of confirmed malaria cases |EN | |NCD_CCS_ALC_MGMT_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of alcohol use disorders |EN | |FOODBORNE_YLL_100K_TOTAL |Foodborne years of life lost per 100,000, all ages |EN | |IMMUNIZATION_VACCINATIONCARDSSEEN |Proportion of vaccination cards seen (%) |EN | |NUT_BF_CBF |Continued breastfeeding 12-23 months |EN | |TB_Notification_agesex_num |The number of new and relapse cases of tuberculosis detected in a given year by age and sex |EN | |ORALHEALTH_DENTALHEALTHCARE_EXP_PERCAP |Per capita expenditure on dental healthcare (US\)) | EN |
| RADON_Q502_1 | Reference level for buildings with high public occupancy (Bq/m3) | EN |
| ASSISTIVETECH_Q08 | Existence of financial mechanisms for assistive technology | EN |
| PRISON_B17_INVOLVEMENT | In-prison patient involvement in healthcare planning and reform | EN |
| NCD_CCS_PBCR | Existence of population-based cancer registry | EN |
| FAMILYPLANNINGUNPDUHC | Women of reproductive age (15−49 years) who are married or in-union who have their need for family planning satisfied with modern methods (%), UNPD | EN |
| E_compl_e5 | Compliance with ban on billboard and outdoor advertising (score) | EN |
| AMR_INFECT_ECOLI | Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%) | EN |
| SDGFPALL | Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%) | EN |
| R_Ad_val | Taxes as a % of price - ad valorem excise | EN |
| FINPROTECTION_IMP_BNLFHU_P_HH | Households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national) | EN |
| ORAL_HEALTH_CANCER_LIPORALCAVITY_NEWCASE_NUMBER | Number of new cases of lip and oral cavity cancer | EN |
| FOODBORNE_YLD_LT5 | Foodborne years lived with disability, aged less than 5 years | EN |
| FOODBORNE_YLD_TOTAL | Foodborne years lived with disability, all ages | EN |
| NUTRITION_ANAEMIA_NONPREGNANT_PREV | Prevalence of anaemia in non-pregnant women (aged 15-49) (%) | EN |
| NCD_CHOL_MEANHDL_A | Mean HDL cholesterol, age-standardized | EN |
| STI_SYPHILIS_INCIDENTCASES | Incident cases of syphilis in individuals (in millions) | EN |
| PRISON_F1_INJECTDRUGUSERS_TOT | In-prison people who inject/have injected drugs (number of prisoners, over the last 12 months) | EN |
| Adult_nonsmoked_age_grp | Age range of latest adult prevalence survey (nonsmoked) | EN |
| ORALHEALTH_UHC_PREVENTIVE | Oral health interventions as part of health benefit packages: Routine and preventive oral health care | EN |
| ORALHEALTH_AVAILABILITY_URGENTCARE | Oral health: Urgent treatment for providing emergency oral care and pain relief | EN |
| TAXBEV_EXCISE_AUTOADJUST | Automatic adjustment of specific excise on beverage | EN |
| LBW_NUMBER | Low birth weight number (in thousands) | EN |
| NCD_CCS_PA_POL_PUBLIC | Existence of policy promoting physical activity: public open spaces | EN |
| ASSISTIVETECH_SATISFACTIONSERVICES | Satisfaction with assistive products and related services (%) | EN |
| ASSISTIVETECH_BARRIERAT | Barriers to accessing assistive products (%) | EN |
| NCD_HYP_CONTROL_C | Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, crude | EN |
| M1_adult_recent | Most recent survey among adults was recent (in the past 5 years) | EN |
| NUT_CF_MDD | Minimum dietary diversity 6-23 months | EN |
| PRISON_D3_DEATHS_SUICIDE_MRATE | In-prison suicide mortality rate (per 100 000 incarcerated persons per year) | EN |
| SDGIPVLT | Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime | EN |
| NUTRITION_ANAEMIA_REPRODUCTIVEAGE_PREV | Prevalence of anaemia in women of reproductive age (aged 15-49) (%) | EN |
| STI_TRICHOMONIASIS_PREVALENTCASES | Prevalent cases of trichomoniasis in individuals (in millions) | EN |
| NCD_CCS_OVWT_SVY | Has conducted a recent, national adult risk factor survey covering overweight and obesity | EN |
| FOODBORNE_YLL_LT5 | Foodborne years of life lost, aged less than 5 years | EN |
| FOODBORNE_YLD_CASE_LT5 | Foodborne years lived with disability per case, aged less than 5 years | EN |
| HAZARD_YLL_LT5 | Years of life lost caused by hazards, aged less than 5 years | EN |
| TAXBEV_MOSTSOLDSPIRIT | Most sold type of spirit | EN |
| E_compl_e3 | Compliance with ban on advertising in local magazines and newspapers (score) | EN |
| Youth_svy_age_range | Age range of most recent adolescent survey | EN |
| NCD_CHOL_MEANHDL_C | Mean HDL cholesterol, crude | EN |
| DEVICES25 | National Health Technology Assessment (HTA) unit including the assessment of medical devices, and diagnostics | EN |
| FINPROTECTION_IMP_NP_REL_LEVEL_MILLION | Total population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global) | EN |
| FINPROTECTION_IMP_PREL_LEVEL_MILLION | Total population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global) | EN |
| NCD_HYP_CONTROL_A | Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, age-standardized | EN |
| NTD_BU_END | Status of endemicity of buruli ulcer | EN |
| P_compl_p6 | Compliance with smoke-free restaurants law (score) | EN |
| TB_cc_prct_Q3 | Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q3 income or expenditure quantile. | EN |
| AMR_INFECT_MRSA | Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%) | EN |
| TB_notif_num_labconf | Number of people diagnosed with new episode of pulmonary TB who are bacteriologically confirmed. | EN |
| ASSISTIVETECH_TRAVELDISTANCEAT | Travel distance to obtain assistive products (%) | EN |
| FOODBORNE_YLD_CASE_TOTAL | Foodborne years lived with disability per case, all ages | EN |
| Yth_curr_smokeless | Prevalence of current smokeless tobacco use among adolescents (%) | EN |
| STI_GONORRHOEA_INCIDENTCASES | Incident cases of gonorrhoea in individuals (in millions) | EN |
| NCD_CCS_OBES_TARGET | Existence of a national target on obesity | EN |
| GHE_DALY_NUMERIC | Disability-adjusted life years (DALYs) | EN |
| RADON_Q707 | Inclusion of radon education for building professionals | EN |
| STI_GONORRHOEA_PREVALENTCASES | Prevalent cases of gonorrhoea in individuals (in millions) | EN |
| RADON_Q605 | Authorization/accreditation required for official radon measurement providers | EN |
| PRISON_F1_TOBACCO_TOT | In-prison people who currently use tobacco (number of prisoners) | EN |
| ASSISTIVETECH_Q10 | Existence of initiatives/collaborations on assistive technology | EN |
| TB_cc_prct_DSTB | Percentage of TB-affected households facing costs >20% of household income or expenditure due to DS-TB. | EN |
| Adult_curr_cig_smoking | Prevalence of current cigarette smoking among adults (%) | EN |
| TB_notif_num_agesex | Number of people diagnosed with new episode TB who by age group and sex. | EN |
| Camp_media_monitor | Process evaluation was employed to assess implementation of the campaign | EN |
| NCD_CCS_HearingPlan | Existence of operational policy/strategy/action plan for hearing health | EN |
| PRISON_B14_ERRORS | In-prison standardized process for medication errors | EN |
| HIV_0000000027 | Reported number of tests performed where results were received by a person (testing volume) | EN |
| GHE_DEATHS_NUMERIC | GHE Deaths | EN |
| NCD_CCS_CVD_GUIDE | Existence of evidence-based national guidelines/protocols/standards for the management of cardiovascular diseases | EN |
| R_Sp_excise | Taxes as a % of price - specific excise | EN |
| M_Est_cig_daily_std | Estimate of daily cigarette smoking prevalence (%) (age-standardized rate) | EN |
| NCD_HYP_TREATMENT_A | Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, age-standardized | EN |
| FOODBORNE_YLL_100K_GE5 | Foodborne years of life lost per 100,000, aged 5 years and above | EN |
| vzdpt | One-year-old children who have not received any doses of the DTP vaccine (%) | EN |
| E_compl_e12 | Compliance with ban on indentifying non-tobacco products with tobacco brand names (score) | EN |
| NCD_CCS_diab_retin | General availability of diabetic retinopathy screening in the public health system | EN |
| NUTRITION_ANAEMIA_REPRODUCTIVEAGE_NUM | Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) | EN |
| R_admin_covert_marking | Tax administration - Marking is covert | EN |
| M_Est_cig_curr_std | Estimate of current cigarette smoking prevalence (%) (age-standardized rate) | EN |
| FINPROTECTION_IMP_PG_215_STD | Increase in poverty gap due to household health expenditures, expressed as a proportion of the $2.15 a-day poverty line (%, national, rural, urban) | EN |
| TAXBEV_ALCOHOLSALESTATUS | Status of alcohol sale | EN |
| ORALHEALTH_UHC_GOVSCHEME | Oral health interventions as part of health benefit packages: Coverage of the largest government health financing scheme (%) | EN |
| NCD_CCS_PA_GUIDELINES_UNDER5 | Existence of national guidelines for physical activity for children under 5 | EN |
| TB_ps_prev_bc_100k | Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population | EN |
| MALARIA_ACT_TREATED | Number of malaria cases treated with artemisinin-based combination therapies (ACTs) | EN |
| NUT_BF_EBF2D | Exclusively breastfed for the first two days after birth | EN |
| Adult_curr_tob_use | Prevalence of current tobacco use among adults (%) | EN |
| FOODBORNE_YLD_GE5 | Foodborne years lived with disability, aged 5 years and above | EN |
| PRISON_F1_ALCOHOL_TOT | In-prison people who drink/drank alcohol (number of prisoners, in the last 12 months) | EN |
| PRISON_F1_BMI30_TOT | In-prison people who have BMI >= 30 (number of prisoners who are obese) | EN |
| PRISON_D4_CANCER_DIAG_TOT | In-prison cancer diagnosis (number of diagnoses) | EN |
| TB_ps_prev_bc_100k_bysex_sp | Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population by sex. | EN |
| TAXBEV_EXCISE_UNIFORMTIERED_NONALCOHOLIC | Uniform or tiered excise tax system applied on non-alcoholic beverage | EN |
| FOODBORNE_ILL_LT5 | Foodborne illnesses, aged less than 5 years | EN |
| R_type_variant | Most sold brand of other tobacco type | EN |
| ORALHEALTH_UHC_ESSENTIAL_CURATIVE | Oral health interventions as part of health benefit packages: Essential curative oral health care | EN |
| P_comprehensive_subnat | Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place | EN |
| FOODBORNE_DALY_CASE_TOTAL | Foodborne disability-adjusted life years per case, all ages | EN |
| NCD_CCS_TOB_MGMT_GUIDE | Existence of evidence-based national guidelines/protocols/standards for the management of tobacco dependence | EN |
| TAXBEV_ALCOHOLBASEDTIERED | If tiered on the beverage, the tiers are alcohol-based | EN |
| HAZARD_DALY_GE5 | Disability-adjusted life years caused by hazards, aged 5 years and above | EN |
| AMRGLASS_SURVL04 | Number of surveillance sites reporting to GLASS: In- and outpatient facilities | EN |
| P_compl_p7 | Compliance with smoke-free pubs and bars law (score) | EN |
| M5_youth_representative | Most recent school-based survey among adolescents was representative of the national population | EN |
| LBW_PREVALENCE | Low birth weight prevalence (%) | EN |
| ASSISTIVETECH_TOTALNEED | Prevalence of need of assistive products (%) | EN |
| HAZARD_YLL_GE5 | Years of life lost caused by hazards, aged 5 years and above | EN |
| NCD_CCS_PA_TARGET | Existence of a national target on physical inactivity | EN |
| FINPROTECTION_IMP_NP_215_LEVEL_SH | Total population pushed below the \(2.15 a day poverty line by household health expenditures (%, regional, global) |EN | |ORALHEALTH_UHC_REHABILITATION |Oral health interventions as part of health benefit packages: Rehabilitatative oral health care |EN | |FOODBORNE_DTH_100K_GE5 |Foodborne deaths per 100,000, aged 5 years and above |EN | |R_Price_lowest_cost_usd |Cheapest brand of cigarettes - price in US\) at official exchange rates | EN |
| PRISON_B9_1_PHYCHIATRISTS_RATIO | Psychiatrists in prisons (FTEs per 1000 prisoners) | EN |
| NCD_CHOL_MEANNONHDL_C | Mean Non-HDL cholesterol, crude | EN |
| Yth_daily_cig_smoking | Prevalence of daily cigarette smoking among adolescents (%) | EN |
| ASSISTIVETECH_Q04 | Existence of responsible ministry/authority on assistive technology | EN |
| GASPRSCRO | Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP | EN |
| Yth_nonsmoked_national | Representation of latest youth prevalence survey (nonsmoked) | EN |
| NUTRITION_ANAEMIA_PREGNANT_NUM | Number of pregnant women (aged 15-49 years) with anaemia (thousands) | EN |
| SDGODAWS | Amount of water- and sanitation-related official development assistance that is part of a government-coordinated spending plan (current US$ millions) | EN |
| P_compl_p2 | Compliance with smoke-free education facilities except universities law (score) | EN |
| ORALHEALTH_PRODLOSS_ORALDISEASES | Total productivity losses due to 5 oral diseases in million (US$) | EN |
| FINPROTECTION_IMP_P190_LEVEL_SH | Total population pushed further below the $1.90 a day poverty line by household health expenditures (%, regional, global) | EN |
| Adult_survey_title | Title of most recent survey of adults | EN |
| RADON_Q305 | Existence of national radon map | EN |
| PRISON_A2_PRISIONERS_N | Number of prisoners | EN |
| PRISON_B11_VACPREV_DTP | In-prison vaccination for DTP | EN |
| MALARIA_1STLINE_TREATED | Number of malaria cases treated with any first line tx courses (including artemisinin-based combination therapies (ACTs)) | EN |
| RADON_Q503_1 | Reference level for workplaces (Bq/m3) | EN |
| HEMOGLOBINLEVEL_REPRODUCTIVEAGE_MEAN | Mean hemoglobin level of women of reproductive age (aged 15-49 years) | EN |
| HAZARD_DTH_LT5 | Deaths caused by hazards, aged less than 5 years | EN |
| TAXBEV_ADVALOREMBASE | Base for ad valorem excise tax on beverage | EN |
| P_compl_p8 | Compliance with smoke-free public transport law (score) | EN |
| NCD_CHOL_MEANTOTALCHOL_A | Mean total cholesterol, age-standardized | EN |
| CM_04 | Number of deaths among children ages 5 to 9 years | EN |
| ORALHEALTH_AFFORDABILITY_FLUORIDETOOTHPASTE | Affordability of fluoride toothpaste | EN |
| AIR_73 | Ambient air pollution attributable YLL in children under 15 years | EN |
| FINPROTECTION_IMP_NPRELPL_POP | Population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban) | EN |
| PRISON_B11_VACPREV_MMR | In-prison vaccination for MMR | EN |
| HAZARD_ILL_TOTAL | Illnesses caused by hazards, all ages | EN |
| FOODBORNE_ILL_100K_LT5 | Foodborne illnesses per 100,000, aged less than 5 years | EN |
| FINPROTECTION_IMP_P310_LEVEL_SH | Total population pushed further below the $3.20 a day poverty line by household health expenditures (%, regional, global) | EN |
| TB_ps_prev_bc_100k_byagegroup | Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population by age group | EN |
| GASPRSCIP | Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP | EN |
| SRH_ABORTION_RATE | Abortion rate (model-estimated) | EN |
| Adult_nonsmoked_svy_title | Name of latest adult prevalence survey (nonsmoked) | EN |
| NCD_CCS_PA_TAX | Existence of tax incentives to promote physical activity | EN |
| vfull | Full immunization coverage among one-year-olds (%) | EN |
| FINPROTECTION_IMP_P215_POP | Population pushed further below the $2.15 a day poverty line by household health expenditures (%, national, rural, urban) | EN |
| PHE_HHAIR_PROP_POP_POLLUTING_FUELS | Proportion of population with primary reliance on polluting fuels and technologies for cooking (%) | EN |
| ORALHEALTH_NOMA | Oral health: Noma recognized as a national public health problem | EN |
| R_admin_tax_stamps_cig | Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes | EN |
| CHILDVIOL | Indicator 16.2.1: Proportion of children aged 1-17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month | EN |
| NUT_CF_MAD | Minimum Acceptable Diet 6-23 months | EN |
| FOODBORNE_YLL_TOTAL | Foodborne years of life lost, all ages | EN |
| NCD_CCS_path_lab | General availability of pathology services (laboratories) in the public sector | EN |
| PRISON_B11_VACPREV_HEPA | In-prison vaccination for Hepatitis A | EN |
| FINPROTECTION_IMP_PG_365_STD | Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.65 a-day poverty line (%, national, rural, urban) | EN |
| ASSISTIVETECH_Q01 | Existence of legislation on access to assistive technology | EN |
| HAZARD_DALY_LT5 | Disability-adjusted life years caused by hazards, aged less than 5 years | EN |
| TAXBEV_EXCISE_APPLIED_YN | Excise taxes are applied on beverages | EN |
| GASPRSAZM | Proportion of isolates with resistance to azithromycin reported to WHO-GASP | EN |
| Yth_daily_e-cig | Prevalence of daily e-cigarette use among adolescents (%) | EN |
| ORALHEALTH_NCD_STAFF | Presence of dedicated staff for oral health working on NCDs at the MoH | EN |
| AIR_72 | Ambient air pollution attributable deaths in children under 15 years | EN |
| FINPROTECTION_IMP_NP_365_LEVEL_MILLION | Total population pushed below the $3.65 a day poverty line by household health expenditures (millions, regional, global) | EN |
| FOODBORNE_ILL_GE5 | Foodborne illnesses, aged 5 years and above | EN |
| FINPROTECTION_IMP_P_365_LEVEL_SH | Total population pushed further below the $3.65 a day poverty line by household health expenditures (%, regional, global) | EN |
| FINPROTECTION_IMP_PG_RELPL_STD | Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line - 60% of median daily per capita consumption or income (%, national, rural, urban) | EN |
| PHE_HHAIR_POP_CLEAN_FUELS | Population with primary reliance on clean fuels and technologies for cooking (in millions) | EN |
| NCD_CCS_dilated_fundus | General availability of dilated fundus examination at the primary health care level | EN |
| STI_TRICHOMONIASIS_PREVALENCE_PER100 | Prevalence of trichomoniasis in individuals (%) | EN |
| Yth_curr_tob_smoking | Prevalence of current tobacco smoking among adolescents (%) | EN |
| PRISON_B11_VACPREV_HPV | In-prison vaccination for HPV | EN |
| Adult_curr_tob_smoking | Prevalence of current tobacco smoking among adults (%) | EN |
| MALARIA_MICR_POS | Number of malaria positive cases by microscopy | EN |
| ORALHEALTH_FLUORIDETOOTHPHASTE_LABOURDAYS | Number of labour days needed to buy annual supply of fluoride toothpaste per person | EN |
| NCD_CCS_TransFat | Existence of national policies on trans-fatty acid elimination | EN |
| PRISON_D3_DEATHS_COVID_MRATE | In-prison COVID-19 mortality rate (per 100 000 incarcerated persons per year) | EN |
| NCD_CCS_TOB_TARGET | Existence of a national target on tobacco | EN |
| FINPROTECTION_IMP_BNLFHU_TOT_HH | Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities - developed by WHO/Europe) by out-of-pocket payments (%, national) | EN |
| TAXBEV_SUGARCONTENT | Sugar-content of beverage per 100ml | EN |
| R_admin_tax_stamps_other | Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products | EN |
| MALARIA_EST_MORTALITY | Estimated malaria mortality rate (per 100 000 population) | EN |
| Yth_curr_tob_use | Prevalence of current tobacco use among adolescents (%) | EN |
| R_admin_identifier_track_and_trace | Tax administration - Marking/unique identifier contains data for track and tracing purposes | EN |
| NCD_CCS_SALT_TARGET | Existence of a national target on salt | EN |
| NUTRITION_WH_2_NUM | Wasting among children under 5 years of age (weight-for-height <-2 SD), number (in thousands), survey-based estimates | EN |
| AMRGLASS_SURVL05 | Total number of surveillance sites reporting to GLASS | EN |
| STI_CHLAMYDIA_PREVALENCE_PER100 | Prevalence of chlamydia in individuals (%) | EN |
| NCD_CCS_PA_MGMT_GUIDE | Existence of evidence-based national guidelines/protocols/standards for the management of physical inactivity | EN |
| NCD_HYP_TREATMENT_C | Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, crude | EN |
| ASSISTIVETECH_Q02 | Coverage of people in need of assistive technology by legislation | EN |
| CHILDMORT10TO19 | Adolescent mortality rate (per 1 000 age specific cohort) | EN |
| NCD_HYP_DIAGNOSIS_C | Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, crude | EN |
| E_compl_e13 | Compliance with ban on appearance of tobacco brands in TV and/or films (score) | EN |
| O_Cytisine_ins | Cytisine - cost covered | EN |
| FOODBORNE_DTH_LT5 | Foodborne deaths, aged less than 5 years | EN |
| PRISON_B9_1_DENTISTS_RATIO | Dentists in prisons (FTEs per 1000 prisoners) | EN |
| HWF_0026 | Nursing personnel (%) | EN |
| NCD_CCS_PA_POL_AGEING | Existence of policy promoting physical activity: active ageing | EN |
| E_comprehensive_subnat | Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place | EN |
| PRISON_C8_CONDOMS | In-prison condoms free of charge | EN |
| E17c_csr_promo_others | Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry | EN |
| NTD_YAWSNUM_SUSP | Number of suspected yaws cases reported | EN |
| NCD_CCS_DIAB_TARGET | Existence of a national target on diabetes | EN |
| FOODBORNE_YLL_CASE_GE5 | Foodborne years of life lost per case, aged 5 years and above | EN |
| M4_youth_recent | Most recent school-based survey among adolescents was recent (in the past 5 years) | EN |
| M3_adult_periodic | Survey previous to the most recent survey among adults was within the 5 years prior | EN |
| FOODBORNE_YLD_100K_TOTAL | Foodborne years lived with disability per 100,000, all ages | EN |
| NCD_CCS_DIET_AWARE | Implementation of a nutrition public awareness program | EN |
| TB_rdst_num_prct | The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. | EN |
| GASPTICIP | Number of isolates tested for ciprofloxacin | EN |
| ORALHEALTH_UNTREATEDCARIESDECIDUOUS | Prevalence of untreated caries of deciduous teeth in children 1-9 years (%) | EN |
| FOODBORNE_YLD_100K_LT5 | Foodborne years lived with disability per 100,000, aged less than 5 years | EN |
| E_compl_e15 | Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score) | EN |
| STI_TRICHOMONIASIS_INCIDENTCASES | Incident cases of trichomoniasis in individuals (in millions) | EN |
| E_compl_e1 | Compliance with ban on advertising on national television and radio (score) | EN |
| ICD11_IMPL_LVL | ICD-11 implementation progress level | EN |
| PRISON_B11_VACPREV_HEPB | In-prison vaccination for Hepatitis B | EN |
| FOODBORNE_DALY_CASE_LT5 | Foodborne disability-adjusted life years per case, aged less than 5 years | EN |
| GASPTIESC | Number of isolates tested for extended-spectrum cephalosporins | EN |
| TB_cc_prct_Q2 | Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q2 income or expenditure quantile. | EN |
| NCD_CCS_SALT_SVY | Has conducted a recent, national adult risk factor survey covering salt/sodium intake | EN |
| MALARIA_TOTAL_CASES | Total number of malaria cases (presumed + confirmed cases) | EN |
| NCD_CCS_PA_GUIDELINES | Existence of national guidelines for physical activity | EN |
| E6a_pt_of_sale | Ban on advertising at point of sale | EN |
| NCD_CCS_SatTransFat | Existence of national policies on saturated fatty acids / trans-fats | EN |
| NCD_CCS_alteplase | General availability of alteplase for acute stroke management in the public health system | EN |
| NCD_CCS_TEL_AML_COMBO | General availability of Fixed dose combination avail (telmisartan + amlodipine) in the public health sector | EN |
| TAXBEV_IMPORTDUTIES | Import duties on beverages (%) | EN |
| R_afford_cat | Affordability – category of change 2010-2020 (Yes (less affordable), No (more affordable), No change). | EN |
| Yth_nonsmoked_age_grp | Age range of latest youth prevalence survey (nonsmoked) | EN |
| bmi30wm | Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%) | EN |
| R_contains_nicotine | Cheapest brand of e-liquid of contains nicotine or not | EN |
| AIR_75 | Household air pollution attributable DALYs in children under 15 years | EN |
| MALARIA_PRES_CASES | Number of presumed malaria cases | EN |
| FINPROTECTION_IMP_NP_REL_LEVEL_SH | Total population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global) | EN |
| GLASSAMC_TC | Total consumption of antibacterials expressed as DDD per 1000 inhabitants per day | EN |
| Youth_survey_title | Title of most recent adolescent survey | EN |
| NCD_CCS_OBES_MGMT_GUIDE | Existence of evidence-based national guidelines/protocols/standards for the management of overweight/obesity | EN |
| PRISON_A1_CAPACITY | Official prison capacity (count) | EN |
| PRISON_D4_HEPC_DIAG_TOT | In-prison Hepatitis C diagnosis (number of diagnoses) | EN |
| R_afford_inflation_adjusted_price_lcu | Price in local currency adjusted by year on year changes in average consumer prices in each country | EN |
| CHILDMORT_MORTALITY_10TO14 | Mortality rate among children ages 10 to 14 years (per 1000 children aged 10) | EN |
| NCD_CCS_ComboInhaler | General availability of combination budesonide formoterol inhaler in the public health sector | EN |
| ASSISTIVETECH_PAYERSAT | Funding for assistive products (%) | EN |
| ORAL_HEALTH_CANCER_LIPORALCAVITY_100K | Incidence rate of lip and oral cavity cancer (per 100 000 population) | EN |
| Yth_curr_e-cig | Prevalence of current e-cigarette use among adolescents (%) | EN |
| Adult_nonsmoked_svy_yr | Year of latest adult prevalence survey (nonsmoked) | EN |
| FINPROTECTION_IMP_NP_215_LEVEL_MILLION | Total population pushed below the \(2.15 a day poverty line by household health expenditures (millions, regional, global) |EN | |R_admin_duty_free_banned |Ban on sale of duty-free or excise-free cigarettes |EN | |P_compl_all_sfe |Overall compliance with regulations on smoke-free environments (score) |EN | |ORALHEALTH_DENTALHEALTHCARE_EXP_TOTAL |Total expenditure on dental healthcare in million (US\)) | EN |
| R_min_price_policy | A minimum price policy is implemented | EN |
| HAZARD_YLL_TOTAL | Years of life lost caused by hazards, all ages | EN |
| PRISON_D4_SUD_DIAG_TOT | In-prison active drug use diagnosis (number of diagnoses) | EN |
| FOODBORNE_DALY_100k_TOTAL | Foodborne disability-adjusted life years per 100,000, all ages | EN |
| NUT_BF_EBF_NUMTH | Exclusive breastfeeding under six months (in thousands) | EN |
| NCD_CCS_radio | General availability of radiotherapy in the public sector | EN |
| M_Est_smk_daily_std | Estimate of daily tobacco smoking prevalence (%) (age-standardized rate) | EN |
| R_Total_tax | Taxes as a % of price - total tax | EN |
| HWF_0025 | Medical doctors (%) | EN |
| NLIS_NU_CA_003 | NLIS: Early initiation of breastfeeding within 1 hour of birth (%) | EN |
| GHE_YLL_NUMERIC | Years of life lost from mortality (YLLs) | EN |
| NLIS_NU_CA_115 | NLIS: Continued breastfeeding at 2 years in infants 20-23 months (%) | EN |
| PRISON_C8_NEEDLES | In-prison needles free of charge | EN |
| NUT_CF_EFF | Egg and/or Flesh Food Consumption 6-23 months | EN |
| NCD_CCS_DIET_SVY | Has conducted a recent, national adult risk factor survey covering unhealthy diet | EN |
| ORALHEALTH_AVAILABILITY_RESTORATIVE | Oral health: Basic restorative dental procedures to treat existing dental decay | EN |
| fpsmowho | Demand for family planning satisfied - use of modern methods (%) | EN |
| PRETERMBIRTH_NUMBER | Preterm birth (number) | EN |
| ORALHEALTH_DENOMINATOR_TTLPOP | Total population in thousands (oral health) | EN |
| STI_TRICHOMONIASIS_INCIDENCE_PER1000 | Incident cases of trichomoniasis in individuals (per 1000) | EN |
| FINPROTECTION_IMP_NP_365_LEVEL_SH | Total population pushed below the \(3.65 a day poverty line by household health expenditures (%, regional, global) |EN | |IHRSPAR_CAPACITY04 |Food Safety (SPAR) |EN | |vmsl |Measles immunization coverage among one-year-olds (%) |EN | |NCD_CCS_BP_TARGET |Existence of a national target on blood pressure / hypertension |EN | |O_mCessation |Provision of a mobile cessation service |EN | |HIV_0000000029 |Reported number of tests performed where results were received by a person (testing volume), reporting period |EN | |TB_notif_num_newrel_clindx |Number of people diagnosed with new episode of pulmonary TB who are clinically diagnosed. |EN | |FOODBORNE_DTH_TOTAL |Foodborne deaths, all ages |EN | |ASSISTIVETECH_USEPREVALENCE |Prevalence of use of assistive products (%) |EN | |FOODBORNE_DALY_100k_GE5 |Foodborne disability-adjusted life years per 100,000, aged 5 years and above |EN | |Adult_svy_age_range |Age range of most recent survey of adults |EN | |NUTRITION_ANAEMIA_NONPREGNANT_NUM |Number of non-pregnant women (aged 15-49 years) with anaemia (thousands) |EN | |FINPROTECTION_IMP_PREL_LEVEL_SH |Total population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global) |EN | |SE_PRM_PRSL_ZS |Persistence to last grade of primary (% of cohort) |EN | |ORALHEALTH_SEVEREPERIODONTALDISEASE |Prevalence of severe periodontal disease in people 15+ year (%) |EN | |ASSISTIVETECH_Q03 |Availability of public funding for assistive technology |EN | |NUT_BF_EBF |Exclusive breastfeeding under six months |EN | |TAXBEV_SUGARBASEDTIERED |If tiered on the beverage, the tiers are sugar-content-based |EN | |Adult_svy_yr |Year of most recent survey of adults |EN | |M6_youth_periodic |Survey previous to the most recent school-based survey among adolescents was within the 5 years prior |EN | |PRISON_B11_VACPREV_FLU |In-prison vaccination for seasonal flu |EN | |Youth_svy_national |Representativeness of most recent adolescent survey |EN | |TB_drs_rr_prct |Prevalence of rifampicin resistance among pulmonary TB cases. |EN | |PRISON_F1_EXERCISE_TOT |In-prison people who regularly exercise for a minimum of 150 minutes/week (number of prisoners) |EN | |PRISON_D4_STI_DIAG_TOT |In-prison STIs diagnosis (number of diagnoses) |EN | |PRISON_D3_DEATHS_DRUG_MRATE |In-prison drug overdose mortality rate (per 100 000 incarcerated persons per year) |EN | |AIR_74 |Household air pollution attributable deaths in children under 15 years |EN | |GASPTICFM |Number of isolates tested for cefixime |EN | |P_compl_p3 |Compliance with smoke-free universities law (score) |EN | |E21a_direct_ad_fines |Law requires fines for violations of advertising bans |EN | |NCD_CCS_urine_strips_gluc_ketone |General availability of urine strips for glucose and ketone measurement at the primary health care level |EN | |E21b_indirect_ad_fines |Law requires fines for violations of promotion and sponsorship bans |EN | |FOODBORNE_YLD_100K_GE5 |Foodborne years lived with disability per 100,000, aged 5 years and above |EN | |FOODBORNE_YLL_CASE_TOTAL |Foodborne years of life lost per case, all ages |EN | |TB_sb |Standards and benchmarks for TB and vital registration system surveillance |EN | |PRISON_B15_REPDRUGEVENTS |In-prison standardized process for adverse drug events |EN | |M_Est_tob_curr_std |Estimate of current tobacco use prevalence (%) (age-standardized rate) |EN | |ORALHEALTH_AVAILABILITY_SCREENING |Oral health screening for early detection of oral diseases |EN | |CCH_SURVEY_VULNERABILITY_ADAPTATION_ASSESSMENT |Climate change and health vulnerability and adaptation assessment conducted |EN | |RADON_Q401_1 |Existence of national radon action plan - Years covered |EN | |ORALHEALTH_DENOMINATOR_CHEPPP |Per capita current health expenditure in PPP (oral health) |EN | |FINPROTECTION_CATA_CTPFHU_40_HH |Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%, national) |EN | |NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD |Prevalence of cervical cancer screening among women aged 30-49 years (%) |EN | |NCD_CCS_PA_GUIDELINES_ADULTS |Existence of national guidelines for physical activity for adults |EN | |NCD_CCS_DIAB_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of diabetes |EN | |MALARIA_IRS_COVERAGE |Number of people protected from malaria by indoor residual spraying (IRS) |EN | |PRISON_D4_DIABETES_DIAG_TOT |In-prison diabetes mellitus diagnosis (number of diagnoses) |EN | |STI_SYPHILIS_PREVALENCE_PER100 |Prevalence of active syphilis in individuals (%) |EN | |FOODBORNE_DTH_100K_TOTAL |Foodborne deaths per 100,000, all ages |EN | |TB_rdst_num |The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. |EN | |SDGIHR2018 |Average of 13 International Health Regulations core capacity scores, SPAR version, 1st edition |EN | |vpolio |Polio immunization coverage among one-year-olds (%) |EN | |UHCTRANSFATS |Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N) |EN | |PHE_HHAIR_PROP_POP_CATEGORY_FUELS |Proportion of population with primary reliance on fuels and technologies for cooking, by fuel type (%) |EN | |E_compl_e11 |Compliance with ban on use of brand name of non-tobacco product for tobacco product (score) |EN | |GOE_Q158 |Lack of demand by health professionals and patients |EN | |GOE_Q161 |Lack of national or international standards for interoperability of EHR |EN | |GOE_Q168 |To define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth |EN | |GOE_Q169 |To address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria |EN | |GOE_Q172 |Which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR |EN | |GOE_Q182 |Policy or strategy makes specific reference tothe use of social media in the health domain |EN | |GOE_Q196 |Country has national policy or strategy regulating the use of big data in the health sector |EN | |GOE_Q197 |Country has national policy or strategy regulating the use of big data by private companies |EN | |GOE_Q200 |Capacity building required for new skills |EN | |HIV_0000000001 |Estimated number of people (all ages) living with HIV |EN | |HIV_0000000026 |Number of new HIV infections |EN | |HRH_06 |Number of community health workers |EN | |HRH_07 |Number of traditional birth attendants |EN | |HRH_25 |Pharmaceutical personnel density (per 1000 population) |EN | |HRH_43 |Number of licensed qualified anaesthesiologists actively working |EN | |HRH_45 |Biomedical technicians density (per 10 000 population) |EN | |HSS_MONITORPROGRESS |Countries that have monitored the progress of their national health policy/strategy/plan regularly |EN | |HSS_UHCLEGISLATION |Countries that have passed legislation on Universal Health Coverage (UHC) |EN | |HWF_0003 |Generalist medical practitioners (number) |EN | |HWF_0005 |Medical doctors not further defined (number) |EN | |HWF_0009 |Midwifery personnel (number) |EN | |HWF_0011 |Dentists (number) |EN | |HWF_0012 |Dental Assistants and Therapists (number) |EN | |HWF_0017 |Environmental and Occupational Health and Hygiene Professionals (number) |EN | |IHR03 |Surveillance |EN | |IHR07 |Human resources |EN | |IHR09 |Points of entry |EN | |IHR12 |Chemical |EN | |IR_ORGANOCHLORINE_PRESENCE |Organochlorine resistance reported for at least one site |EN | |itnch |Children aged < 5 years sleeping under insecticide-treated nets (%) |EN | |itnwm |Pregnant women sleeping under insecticide-treated nets (%) |EN | |LEAD_1 |Percentage of the children under 15 years with blood lead levels above 5ug/dl |EN | |LEADCONTROL |Legally-binding controls on lead paint |EN | |LEPTO_MORTALITY |Estimated leptospirosis deaths (per 100 000 population) |EN | |LEPTO_YLD |Years of healthy life lost to disability (YLDs) due to leptospirosis |EN | |LEPTO_YLL |Years of life lost (YLLs) due to leptospirosis |EN | |LIFE_0000000030 |nqx - probability of dying between ages x and x+n |EN | |LIFE_0000000031 |lx - number of people left alive at age x |EN | |LIFE_0000000033 |nLx - person-years lived between ages x and x+n |EN | |M_def_1_prev_adult |Adult indicator 1 rate |EN | |M_Est_cig_curr |Estimate of current cigarette smoking prevalence (%) |EN | |M_Est_cig_daily_crude |Daily cigarette smoking, crude adjusted |EN | |M_Est_tob_curr_crude |Current tobacco smoking, crude adjusted |EN | |M_smkless_svy_national_adult |Representativeness of survey of adults - smokeless |EN | |M_smkless_svy_yr_youth |Year of survey of youth - smokeless |EN | |M_svy_age_adult |Adult survey age range |EN | |NCD_CCS_CRD_GUIDE |Existence of evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseases |EN | |HCF_UNREL_ELECTRICITY |Percentage of health-care facilities with unreliable electricity supply (%) |EN | |IHRSPAR_CAPACITY01 |Legislation and Financing |EN | |Adult_nonsmoked_national |Representation of latest adult prevalence survey (nonsmoked) |EN | |R_Price_lowest_cost_ppp |Cheapest brand of cigarettes - price in PPP\) | EN |
| NCD_CCS_PA_POL_WORK | Existence of policy promoting physical activity: workplace initiatives | EN |
| PRETERMBIRTH_RATE | Preterm birth rate (per 100 live births) | EN |
| NUT_BF_EVBF | Ever breastfed | EN |
| P_compl_p1 | Compliance with smoke-free health-care facilities law (score) | EN |
| RADON_Q503 | Existence of national reference level for workplaces | EN |
| HAZARD_DTH_GE5 | Deaths caused by hazards, aged 5 years and above | EN |
| NCD_CCS_ESS_MEDS_TECH_TARGET | Existence of a national target on essential medicines and technologies | EN |
| R_Price_mp_estimate_ppp | Most sold brand of cigarettes - price in PPP$ | EN |
| P_compl_p4 | Compliance with smoke-free government facilities law (score) | EN |
| W21_emissions_quant_A | Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | EN |
| HAZARD_DTH_TOTAL | Deaths caused by hazards, all ages | EN |
| IHRSPAR_CAPACITY10 | Risk Communication (SPAR) | EN |
| SDGIPV | Proportion of ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months | EN |
| PRISON_F1_BMI25_TOT | In-prison people who have BMI >= 25 (number of prisoners who are overweight) | EN |
| E_compl_e_all_indir | Overall compliance with bans on promotion and sponsorship (score) | EN |
| NCD_CCS_DRUG_THERAPY_TARGET | Existence of a national target on drug therapy and counselling | EN |
| NUT_CF_MMF | Minimum Meal Frequency 6-23 months | EN |
| IHRSPAR_CAPACITY11 | Points of Entry (SPAR) | EN |
| FOODBORNE_DALY_GE5 | Foodborne disability-adjusted life years, aged 5 years and above | EN |
| TB_ps_prev_bc_100k_byagegroup_sp | Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population by age group | EN |
| E_compl_all_dir | Overall compliance with bans on direct advertising (score) | EN |
| Adult_svy_national | Representativeness of most recent survey of adults | EN |
| FINPROTECTION_IMP_NP215_POP | Population pushed below the \(2.15 a day poverty line by household health expenditures (%, national, rural, urban) |EN | |GASPRP |Reporting countries |EN | |HAZARD_YLD_TOTAL |Years lived with disability caused by hazards, all ages |EN | |NUT_CF_ISSSF |Introduction of solid, semi-solid or soft foods 6-8 months |EN | |STI_CHLAMYDIA_INCIDENTCASES |Incident cases of chlamydia in individuals (in millions) |EN | |MALARIA_SUSPECTS |Number of suspected malaria cases |EN | |NCD_HYP_PREVALENCE_A |Prevalence of hypertension among adults aged 30-79 years, age-standardized |EN | |O_Cytisine_where |Cytisine - place available |EN | |SDGIPV12M |Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months |EN | |MALARIA_INDIG_STATUS |Status of indigenous malaria cases |EN | |R_VAT |Taxes as a % of price - value added tax |EN | |MALARIA_PV_INDIG |Number of indigenous P. vivax malaria cases |EN | |NCD_CCS_PA_GUIDELINES_5to19 |Existence of national guidelines for physical activity for children and adolescents aged 5-19 |EN | |HAZARD_YLD_LT5 |Years lived with disability caused by hazards, aged less than 5 years |EN | |FOODBORNE_ILL_100K_GE5 |Foodborne illnesses per 100,000, aged 5 years and above |EN | |M_Est_smk_curr |Estimate of current tobacco smoking prevalence (%) |EN | |GASPRSCFM |Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP |EN | |NCD_CHOL_MEANTOTALCHOL_C |Mean total cholesterol, crude |EN | |STI_SYPHILIS_PREVALENTCASES |Prevalent cases of active syphilis (in millions) |EN | |E17a_csr_ban |Ban on Corporate Social Responsibility activities (CSR) |EN | |SA_0000001837 |Alcohol poisoning deaths, per 100,000 population |EN | |SRH_PREGNANCY_UNINTENDED_RATE |Unintended pregnancy rate (model-estimated) |EN | |SA_0000001838 |Alcohol-related cardiomyopathy deaths (% of all cardiomyopathy deaths) |EN | |HAZARD_DALY_TOTAL |Disability-adjusted life years caused by hazards, all ages |EN | |TB_ps_prev_bc_100k_bysex |Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population by sex. |EN | |E_compl_e9 |Compliance with ban on free distribution in mail or through other means (score) |EN | |Yth_daily_tob_smoking |Prevalence of daily tobacco smoking among adolescents (%) |EN | |R_afford_inflation_adjusted_price_ppp |Prices in purchasing power parity adjusted by year on year changes in average consumer prices in the United States of America |EN | |FOODBORNE_ILL_100K_TOTAL |Foodborne illnesses per 100,000, all ages |EN | |PRISON_B20_CLINICALREP |In-prison clinical health records |EN | |NLIS_NU_CA_049 |NLIS: Children with diarrhoea receiving zinc and ORS (%) |EN | |OHS_POLICYSTATUS |Existence of national policy instruments for occupational health and safety for health workers |EN | |NCD_CCS_PA_MASS_PART |Implementation of a recent mass participation event |EN | |TAXBEV_EXCISE_UNIFORMTIERED_ALCOHOLIC |Uniform or tiered excise tax system applied on alcoholic beverage |EN | |SRHINSTITUTIONALBIRTH |Institutional Births (birth taken place in a facility) (%) |EN | |PRISON_D4_COVID_TOT |In-prison COVID-19 diagnosis (number of diagnoses) |EN | |TB_cc_prct |Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB. |EN | |Rev_other |Tobacco tax revenues - other |EN | |NCD_CCS_cancer_surgery |General availability of cancer surgery in the public sector |EN | |STI_SYPHILIS_INCIDENCE_PER1000 |Incident rate of active syphilis (per 1000) |EN | |GASPRSESC |Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP |EN | |NLIS_NU_CA_041 |NLIS: Children with diarrhoea <5 y receiving oral rehydration therapy (ORT) and continued feeding (%) |EN | |NCD_CCS_CANCER_DEPT |General availability of cancer centres or cancer departments at tertiary level in the public sector |EN | |Youth_svy_yr |Year of most recent adolescent survey |EN | |M_Est_smk_daily |Estimate of daily tobacco smoking prevalence (%) |EN | |IHRSPAR_CAPACITY09 |Health Service Provision |EN | |PRISON_A2_PRISIONERS_PER100KPOP |Number of prisoners (per 100 000 inhabitants) |EN | |HAZARD_ILL_GE5 |Illnesses caused by hazards, aged 5 years and above |EN | |NUTRITION_ANAEMIA_CHILDREN_NUM |Number of children aged 6-59 months with anaemia (thousands) |EN | |NCD_CCS_PA_POL_COMM_BASED |Existence of policy promoting physical activity: community-based and sports initiatives |EN | |E17b_csr_promo_self |Ban on tobacco companies/the tobacco industry publicizing their CSR activities |EN | |VACCINEPREVENTABLE_WILDPOLIO |Number of reported cases of poliomyelitis by wild poliovirus (WPV) |EN | |NUTRITION_ANAEMIA_CHILDREN_PREV |Prevalence of anaemia in children aged 6-59 months (%) |EN | |CCH_SURVEY_SURVEILLANCE_WHICH_METEOROLOGICAL |Existence of a health surveillance system which includes meteorological information |EN | |Yth_daily_tob_use |Prevalence of daily tobacco use among adolescents (%) |EN | |FOODBORNE_YLD_CASE_GE5 |Foodborne years lived with disability per case, aged 5 years and above |EN | |DEVICES24 |National authority responsible for regulating medical devices |EN | |R_afford_cat_2 |Affordability - category of change over past 2 years |EN | |NCD_CCS_LIS_AML_COMBO |General availability of Fixed dose combination avail (lisinopril + amlodipine) in the public health sector |EN | |NCD_CCS_DIAB_SVY |Has conducted a recent, national adult risk factor survey covering raised blood glucose/diabetes |EN | |PRISON_B3_DELIVHEALTHCARE |Agencies responsible for delivering prison healthcare |EN | |CCH_SURVEY_SURVEILLANCE_SYSTEM_EXISTS |Existence of an health surveillance system |EN | |CHILDMORT_DEATHS_10TO14 |Number of deaths among children ages 10 to 14 years |EN | |NCD_CCS_ALC_SVY |Has conducted a recent, national adult risk factor survey covering harmful alcohol use |EN | |MH_26 |Year the law was enacted (latest revision) |EN | |MALARIA_RDT_POS |Number of malaria positive cases by rapid diagnostic test (RDT) |EN | |WSH_DOMESTIC_WASTE_SAFELY_TREATED |SDG 6.3.1 Proportion of safely treated domestic wastewater flows (%) |EN | |ASSISTIVETECH_Q05 |Availability of government/registered services for assistive technology |EN | |R_Price_mp_estimate_usd |Most sold brand of cigarettes - price in US\) at official exchange rates | EN |
| FINPROTECTION_IMP_P190_LEVEL_MILLION | Total population pushed further below the $1.90 a day poverty line by household health expenditures (millions, regional, global) | EN |
| NTD_YAWSNUM_CONF | Number of confirmed yaws cases reported | EN |
| FINPROTECTION_IMP_NP365_POP | Population pushed below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban) | EN |
| FINPROTECTION_IMP_P190_POP | Population pushed further below the $1.90 a day poverty line by household health expenditures (%, national, rural, urban) | EN |
| FOODBORNE_YLL_GE5 | Foodborne years of life lost, aged 5 years and above | EN |
| PRISON_B9_STAFF_RATIO | Healthcare staff in prisons (FTEs per 1000 prisoners) | EN |
| PRISON_B9_1_PHYSICIANS_RATIO | Physicians in prisons (FTEs per 1000 prisoners) | EN |
| PHE_HHAIR_PROP_POP_CLEAN_FUELS | Proportion of population with primary reliance on clean fuels and technologies for cooking (%) | EN |
| NCD_CCS_LIS_HYDRO_COMBO | General availability of Fixed dose combination avail (lisinopril + hydrochlorothiazide) in the public health sector | EN |
| FOODBORNE_YLL_100K_LT5 | Foodborne years of life lost per 100,000, aged less than 5 years | EN |
| sevwast5 | Severe wasting prevalence in children aged < 5 years (%) | EN |
| MALARIA_IPTP3_COVERAGE | Pregnant women attending antenatal care at least once and receiving at least 3 doses of Intermittent Preventive Treatment of Malaria for Pregnant Women (IPTp3) (%) | EN |
| ORALHEALTH_EDENTULISM_PREVALENCE | Prevalence of edentulism in people 20+ years (%) | EN |
| NCD_CCS_OvwtPlan | Existence of operational policy/strategy/action plan to reduce overweight/obesity | EN |
| R_Imp_duty | Taxes as a % of price - import duties | EN |
| R_tax_other | Taxes as a % of price - other taxes | EN |
| GLASSAMC_AWARE | Pattern of antibiotic consumption at national level (relative consumption by AWaRe classification) | EN |
| SA_0000001834 | Percent of all DALYs attributable to alcohol | EN |
| NCD_CHOL_MEANNONHDL_A | Mean Non-HDL cholesterol, age-standardized | EN |
| NCD_CCS_PRICE_SUBS | Existence of price subsidies for healthy foods | EN |
| NTD_LEPR13 | New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population | EN |
| PRISON_B13_ASSESSMENTS | In-prison regular assessments of essential medicines | EN |
| GASPTIAZM | Number of isolates tested for azithromycin | EN |
| TAXBEV_EXCISE_TYPE | Type of excise tax applied on beverage | EN |
| SA_0000001835 | Alcohol-related road traffic deaths, per 100,000 population | EN |
| Adult_daily_cig_smoking | Prevalence of daily cigarette smoking among adults (%) | EN |
| GASPTICRO | Number of isolates tested for ceftriaxone | EN |
| ASSISTIVETECH_Q09 | Existence of regulations/standards/guidelines/protocols on assistive technology | EN |
| Adult_daily_tob_use | Prevalence of daily tobacco use among adults (%) | EN |
| M_Est_smk_curr_std | Estimate of current tobacco smoking prevalence (%) (age-standardized rate) | EN |
| PRISON_A4_NEWPRISONERS_PER100KPOP | Number of people newly-admitted to prison (per 100 000 inhabitants) | EN |
| Adult_daily_tob_smoking | Prevalence of daily tobacco smoking among adults (%) | EN |
| M_Est_tob_daily_std | Estimate of daily tobacco use prevalence (%) (age-standardized rate) | EN |
| Adult_daily_e-cig | Prevalence of daily e-cigarette use among adults (%) | EN |
| NLIS_NU_CA_053 | NLIS: Introduction to solid, semisolid or soft foods in infants 6-8 months (%) | EN |
| NUTRITION_ANAEMIA_PREGNANT_PREV | Prevalence of anaemia in pregnant women (aged 15-49) (%) | EN |
| HEMOGLOBINLEVEL_NONPREGNANT_MEAN | Mean hemoglobin level of non-pregnant women (aged 15-49 years) | EN |
| NCD_CCS_foot_vibr | General availability of foot vibration perception by tuning fork at the primary health care level | EN |
| NLIS_NU_CA_116 | NLIS: Minimum dietary diversity (MDD) in children 6-23 months (%) | EN |
| vdpt | DTP3 immunization coverage among one-year-olds (%) | EN |